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This work provides an innovative point of view on obtaining 
nanoparticles  by supercritical fluids. Supercritical fluids have already been 
exploited in the  production and processing of micro or sub-micro particles, 
but the production of nanoparticles is still more ambitious, requiring a deep 
understanding of  the thermodynamic of multiphase systems involved and of 
the fluid  dynamics and mass transfer of the process.  
This thesis focused on the development of supercritical assisted process 
for the production of biopolymeric micro and nanocarrier for pharmaceutical 
and biomedical applications. After a wide study of the state of the, two 
different processes have been focused on the production of different kind of 
devices:  
1) Supercrititical Emulsion Extraction process (SEE) for the 
production of multifunctional nanodevices; 
 
2) Supercritical Assisted Injection in Liquid Antisolvent 
process (SAILA) for the production of stabilized 
nanoparticle water suspensions. 
 
Supercritical Emulsion Extraction (SEE) has been recently proposed in 
the literature for the production of drug/polymer microspheres with 
controlled size and distribution, starting from oil-in-water (o-w) and water-
in-oil-in-water (w-o-w) emulsions. This process uses supercritical carbon 
dioxide (SC-CO) to extract the “oil” phase of emulsions, leading to near 
solvent-free microparticles. SEE offers the advantage of being a one-step 
process and is superior to other conventional techniques for the better 
particle size control, higher product purity and shorter processing times; the 
SEE process has been proposed in the continuous layout, using a high 
pressure packed tower. However, monodisperse sub-micro, nanoparticles of 
biopolymer suitable for pharmaceutical formulations have not been produced 
until now by SEE.  
Therefore, this part of the work was performed on the production of 
monodisperse biopolymer nanoparticles. Particularly, emulsion formulation 
parameters have been tested, such as, different surfactant concentrations and 
biopolymer percentages in the oily phase, and several emulsification 
techniques (ultrasound or high speed emulsification) and their interactions 
with SEE processing have been tested to obtain small droplets dimensions 
from the micro size to the nano size range. Poly-lactic-co-glycolic acid 
(PLGA), poly-lactic acid (PLA) and poly-caprolactone (PCL) were the 
polymers selected to produce micro and nano devices, relative results are 
shown in Chapter 7.  
 
XII 
Then, after the optimization of the process conditions for the production 
of monodisperse sub-micro and nanoparticles encapsulation of drugs, 
proteins, peptides and metals has been carried out. For the encapsulation 
study the SEE technique starting from single or double emulsions was used 
for the production of nanospheres. 
The SEE technology has a great potential regarding the field of protein 
encapsulation thanks to the mild extraction condition and the short process 
time, and mainly thanks to the possibility to use multiple emulsions. For this 
reason, the SEE has been applied to the production of biopolymeric micro 
and nanoparticles of PLA and PLGA encapsulating peptides and proteins 
starting from double emulsion. Results are shown in Chapter 8. Bovine 
serum albumin (BSA) has been selected as protecting protein for growth 
factor, such as Vascular Endothelial Growth Factor (VEGF) and Bone 
Morphogenetic Proteins (BMP). Both micro and nanoparticles were 
produced; the effect of size of particles on protein loading and release has 
been evaluated. PLGA microspheres loaded with GFs were charged inside a 
bioactive alginate scaffold to monitor the effect of the local release of these 
biosignals on cells differentiation. Human Mesenchimal Steam Cells (h-
MSC), where used in view of the fact that they are a promising cell source 
for bone tissue engineering. Good cells differentiation indicates that the SEE 
process was successful in the encapsulation of proteins and peptides, 
preserving the functional structure of the proteins, thanks to the mild 
operating conditions used. 
Another important challenge that has been managed is also the 
production of nanocomposite biopolymeric particles encapsulating metal 
nanoparticles for the production of light sensitive drug delivery devices. The 
encapsulation of TiO2 and Au nanoparticles has been performed for different 
biomedical applications (Chapter 9 and 10). 
In this work PLA/nano-TiO2 microparticles have been produced using 
SEE for photodynamic therapy of cells and bacteria. Anatase type nano-TiO2 
ethanol stabilized suspension has been synthesized by precipitation from 
solutions of titanium alcoxides and directly used as the water internal phase 
a of double emulsion water in oil in water and also TiO2 fine powder was 
produced and used for encapsulation experiments using a solid in oil in 
water emulsion. Both micro and sub-microparticles have been produced. 
High TiO2 encapsulation efficiencies have been obtained. PLA/nano-TiO2 
particles have been characterized by TEM, TGA and XPS to investigate the 
dispersion of the metal oxide in the polymeric matrix. Photocatalytic activity 
of the produced nanostructured microparticles has been also investigated 
using bactetrial killing assay (StaphylococcusAureus) under UV light. Pure 
TiO2 nanoparticles and PLA/nano-TiO2 particles showed the same 
photocatalitic activity. 
Stimuli-responsive drug delivery systems were produced dispersing 
hollow gold nanoshells (HGNs) in PLA particles encapsulating Rhodamine 
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to obtain the photothermal controlled delivery of the model drug under near 
infrared irradiation (NIR). HGNs were synthesized via galvanic replacement 
of Cobalt with Gold using PVP as template stabilizer. HGNs with a mean 
diameter of 20 nm were produced; the maximum absorption coefficient was 
located in the optimal NIR region desired for biomedicine, 800 nm 
wavelength. PLA-HGNs nanocomposite particles encapsulating Rhodamine 
were produced using the SEE technique. Rhodamine was dissolved in the 
water internal phase of a double water-in-oil-in-water emulsion, whereas 
HGNs were dispersed in the polymeric solution of the oil phase. Thanks to 
the fast and efficient extraction of the solvent of the oily phase obtained by 
supercritical CO2, non coalescing and spherical PLA-HGNs nanostructured 
particles where obtained, with a mean dimension around 200 nm.  Particles 
where characterized by SEM, TEM and EDX analysis, HGNs loading was 
estimated by ICP. Rhodamine release form PLA-HGN nanostructured 
particles was evaluated under different NIR irradiation conditions 
demonstrating that release rate is controllable externally, depending of NIR 
expositions. A pulsatile Rhodamine release was obtained with NIR 
irradiation. 
The SEE plant was also used for the solvent removal from biopolymeric 
nanoparticles suspensions produced by nanoprecipitation (Chapter 11). 
Nanoprecipitation is a simple and effective process for the production of 
biopolymer nanoparticle suspensions. However, until now only a marginal 
attention has been given to the problem of the solvents elimination from the 
prepared suspensions. This part of the process is very important in 
pharmaceutical/medical applications, since even some parts per million 
(ppm) of these residues can hinder the application of the produced 
nanoparticles. A new approach to the problem of acetone and 
acetone/ethanol mixtures removal, from the suspension of nanoparticles has 
been proposed, using the SEE apparatus for the continuous counter-current 
extraction of the organic solvent from water based suspensions. The 
operating parameters (pressure, temperature and liquid to gas ratio) were 
optimized. Nanoprecipitation process assisted by supercritical solvent 
elimination has been tested on PLGA and PCL.  
Part of this PhD thesis was also focused on the development of a new 
supercritical assisted technique for the production of nanoparticles 
stabilized water suspensions, Chapter 12, 13,14. In this part of PhD 
thesis it has been proposed a novel supercritical assisted process for 
nanoparticle production, called Supercritical Assisted Injection in a 
Liquid Antisolvent (SAILA). In this process, an expanded liquid 
solution formed by supercritical carbon dioxide (SC-CO2) and an 
organic, water miscible solvent, is produced, in which a solid solute is 
solubilised. Then, the solution is depressurized into a water solution in 
which the solute is not soluble: the water based solution works as a 
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liquid antisolvent and nanoparticles are produced. In the SAILA 
process liquid-liquid antisolvent precipitation is obtained when the 
processed compound is soluble in the solvent and not soluble in the 
antisolvent; the particles size of the precipitates depends on the 
efficiency of the micromixing between the two liquids that, in turn, is 
related to their surface tension. The continuous injection of an 
expanded liquid solution improves the mixing with the antisolvent 
thanks to the reduced surface tension of the expanded liquid, thus 
producing smaller particles.  
 The process has been proved to be successful in the production of 
nanoparticles of PCL, selected as model compound. The effect of the process 
parameters on nanoparticle diameter has been studied; it decreases 
increasing the gas to liquid ratio, the water to solvent flow rate ratio, the 
saturator temperature and decreasing the polymer concentration. 
Nanoparticles with a mean diameter down to 64 nm have been obtained. 
Nanoparticle formation mechanism seems to be guided by the micromixing 
between the expanded liquid solution and the receiving water solution, 
followed by nucleation and growth of nanoparticles. The presence of 
surfactants in the water receiving solution avoids nanoparticles coalescence. 
Furthermore the SAILA process has been applied successfully to the 
production of stabilized nanoparticles suspensions of poorly water soluble 
drugs, several different compounds have been processed in order to extend 
the range of applicability of this process not only to the polymer but also 
active principles.  
In conclusion, in this PhD thesis, innovative supercritical assisted 
processes have been applied successfully to the production of nanoparticles. 
The SEE process conditions were optimized to produce biopolymeric 
monodisperse submicro or nanoparticles; the encapsulation of several 
challenging compounds were carried out using the double emulsion 
technique. The SEE process reveals to be a powerful and robust technique 
for the production of multifunctional nanodevices for nanomedicine 
applications. The nanoprecipitation process assisted by supercritical fluid for 
the extraction of the organic solvent has also been proved to be a valid 
alternative to the SEE technique for the production of biopolymeric 
monodisperse nanoparticles suspensions. A new supercritical assisted 
process has been developed and proposed in this thesis work named 
Supercritical Assisted Injection in a Liquid Antisolvent (SAILA). It has been 
demonstrated that the idea is original and innovative in the field of 
supercritical fluid processes and successful in the production of 














Scientists are popularly using the term nanotechnology to refer designing, 
characterization, production and application of structures, devices and 
systems with at least one dimension in the nanometer range (1 nm=one 
thousand millionth of a meter, 10−9 m). The size range of nanotechnology is 
often delimited to 100 nm down up to 0.2 nm; this is where materials have 
significantly different properties (Kaehler T., 1994).  
The nanomaterials are known for their unique mechanical, chemical, 
physical, thermal, electrical, optical, magnetic, biological and also specific 
surface area properties, which in turn define them as nanostructures, 
nanoelectronics, nanophotonics, nanobiomaterials, nanobioactivators, 
nanobiolabels, etc. In the last one decade a large variety of nanomaterials 
and devices with new capabilities have been generated employing 
nanoparticles based on metals, metal oxides, ceramics (both oxide and non-
oxide), silicates, organics, polymers, etc. One of the most important 
properties of materials in nano-size regime is the changing physical 
properties. Nanoparticles possess unique optical and electronic properties not 
observed for corresponding bulk samples. Owing to a substantial increase in 
the fraction of surface atoms and to increasing role of the surface effects not 
only the optical properties but also other characteristics of materials 
(structure of electronic energy levels and transitions, electron affinity, 
conductivity, phase transition temperature, magnetic properties, melting 
points, affinity to biological, polymer and organic molecules, etc.) also 
become dependent on the nanoparticle size and shape. Such a size dependent 
properties have been exploited for biological tagging, for example, as 
fluorescent biological labels.  
Hence, it is extremely important to control the size and also shape of the 
nanoparticles/nanocrystals in order to obtain a desired physical property. For 
this reason, a major challenge in the nanomaterials science is the accurate 
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control of the size and shape, which in turn is directly linked with the 
nanomaterials processing method. On the whole there are only two 
approaches known for the nanomaterial fabrication: bottom-up and top-down 
methods (Figure I. 1).  
 
 
Figure I. 1 Top-down and bottom-up approaches (Reverchon E. and Adami 
R., 2006) 
The bottom-up approach deals with the controlled assembly of atomic 
and molecular aggregates into larger systems (e.g. clusters, organic lattices, 
supermolecular structures and synthesized macromolecules). This covers the 
popular synthesis methods like: chemical synthesis, self-assembly, positional 
assembly, leading to the formation of particles, molecules, cosmetics, fuel 
additives, crystals, films, tubes, displays, atomic or molecular devices. 
Whereas the top-down approach deals with the reduction in structure sizes of 
microscopic elements to the nanometer scale by applying specific machining 
and etching techniques like: lithography, cutting, etching, grinding, etc., 
giving rise to electronic devices, chip masks, quantum well lasers, computer 
chips, precision engineered surfaces, high quality optical mirrors. The 
present thesis has been restricted to the nanomaterial fabrication for 
biomedical application, which insists upon the control of size and 
morphology of drug and drug/polymer powder and its multidimensional 
structure that is very essential to control the activity and drug delivery. 
Nanoparticles can be obtained from a great variety of processes involving 
the conversion of solid to solid or liquid to solid or gas to solid. The milling, 
Sol–gel, chemical vapor deposition and colloidal chemistry approaches are 
the most popularly used techniques for the production of nanomaterials. 
However, the stringent requirements for the biological applications like the 
therapeutic, bioimaging, hyperthermia, targeted drug delivery system, 
biosensors, MRI, etc., insist on the control of the size and shape of 
nanomaterials. There are several reviews already existing in the literature on 
the conventional methods of nanomaterial fabrication (Byrappa K. and 
Yoshimura M., 2001), (Rao B.C.N.R. et al., 2006), and also some occasional 
reviews on nanomaterial fabrication for pharmaceutical applications using 
supercritical fluids (SCF) (Vemavarapu C. et al., 2005), (Reverchon E. and 
Adami R., 2006). The SCF technique of materials processing is playing an 
important role in nanotechnology. Although a huge amount of literature data 
concerning SCF techniques, the knowledge on the nucleation, crystallization, 
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self-assembly, and the growth mechanism of the nanocrystals in the solution 
media are rather complicated and are still not well understood. Hence, such 
studies are very essential in order to understand the rational synthesis of 
high-quality nanoparticles and nanostructures. In following chapter 
principles for nanoparticle production using the conventional technology 
have been discussed, before introducing the SCF based techniques used for 















Biodegradable polymers have significantly influenced the development 
and rapid growth of various technologies in modern medicine, packaging, 
textile sector, etc.. Biodegradable polymers are mainly used where the 
transient existence of materials is required and they find applications as 
sutures, scaffolds for tissue regeneration, tissue adhesives, and transient 
barriers for tissue adhesion, as well as drug delivery systems. Each of these 
applications demands materials with unique physical, chemical, biological, 
and biomechanical properties to provide efficient therapies (Nair L.S. and 
Laurencin C.T., 2006). 
The incorporation of drugs in polymer particles has numerous 
advantages, such as controlling the drug release, increasing drug efficacy 
and reducing dosing frequency, targeting the drug delivery and preventing 
adverse effects on other organs. All these advantages enhance patient 
compliance and reduce costs. 
 These formulations typically employ artificial or natural polymers and/or 
other excipients that are biocompatible and/or biodegradable. The efficient 
size control of particles, and particle modifications are essential in enhancing 
controlled release and target delivery. Biopolymeric microparticles find also 
application in tissue engineering as building blocks for scaffolds. The 
microsphere-based tissue engineering scaffold designs offer several benefits, 
for example, ease of fabrication,  control over morphology and 
physicochemical characteristics, versatility of controlling the release kinetics 
of the encapsulated factors. The properties of a scaffold, in turn, can be 
tailored by altering the microsphere design and fabrication method, e.g., to 
create gradient-based scaffolds (Singh M. et al., 2010) 
In spite of the numerous advantages that biodegradable polymer 
particulates can provide, the development of such systems often poses a 
serious challenge due to lack of robust manufacturing techniques. Not only 
Chapter II 
6 
should these manufacturing techniques provide particles having predictable 
and controllable physical properties such as size distribution, composition, 
and structure; but, they must also conform to the rigorous requirements of 
product consistency, purity, and process scalability for pharmaceutical and 
biomedical applications (Chattopadhyay P. et al., 2006).  
 
II.1 Controlled drug delivery 
The basic goal of a controlled drug delivery system is to deliver a 
biologically active molecule at a desired rate for a desired duration, so as to 
maintain the drug level in the body within the therapeutic window. 
Conventionally, drugs are administered into the body via an oral or 
intravenous route. In these modes of administration, the therapeutic 
concentration of a drug is maintained in the body by repeated drug 
administration. The problem with this approach is that during each repeated 
administration, the concentration of drug in the body peaks and declines 
rapidly, particularly when the elimination rate of drug is very high. This can 
lead to an unfavourable situation where at certain times the drug 
concentration in the body will be too low to provide therapeutic benefit, and 
at other times the concentration will be too high resulting in adverse side 
effects. This is particularly of great concern when using very active drugs 
with narrow therapeutic windows. Moreover, this approach shows low 
compliance by the patient (Freiberg S. and Zhu X., 2004). 
Controlled drug delivery technology has developed into an attractive 
modality to solve many of the problems of traditional drug administration by 
regulating the rate as well as the spatial localization of therapeutic agents. In 
controlled drug delivery, usually the active agent will be entrapped in an 
insoluble matrix from which the agents will be released in a controlled 
mode. Furthermore, the release characteristics of the active agents can be 
effectively controlled by suitably engineering the matrix parameters. 
The microencapsulation technology has become one of the principal 
fields in the area of controlled drug delivery systems.  The term “control” 
includes phenomena such as protection and masking, reduction of 
dissolution rate, facilitation of handling and spatial targeting of the active 
ingredient. This approach facilitates the accurate delivery of small quantities 
of potent drugs; reduces drug concentrations at sites other than the target 
organ or tissue; protects labile compounds before and after administration 
and prior to appearance at the site of action (Gouin S., 2004). 
In controlled drug delivery, biopolymers are used as  approximately 
spherical particles ranging in size from less than 1 μm up  to 1000 μm where 
the entrapped substance is dispersed throughout the particle matrix (Figure 
II. 1). They are made of polymeric, waxy, or other materials, that is, 
biodegradable synthetic polymers and modified natural products such as 
starches, gums, proteins, fats and waxes. The natural polymers include 
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albumin, chitosan, dextran and gelatine, the synthetic polymers include 
polylactide acid and polyglycolic acid. 
Polymer Drug
 
Figure II. 1 Section of a microsphere 
Attempts are being made to develop novel delivery systems that can 
further fine-control the drug release pattern by synthesizing novel polymers 
as matrix systems, as well as by developing smart systems that can deliver 
multiple drugs in a controlled manner or under the effect of an external 
stimulus (Li M. et al., 2008). Furthermore in the controlled drug delivery, 
polydisperse micro/nanospheres are not desirable as a drug carrier, since 
they have wide range of surface areas and may have different drug release 
depending on their sizes (Ito F. and Makino K., 2004). The ability to make 
dispersions of a known, and controlled size distribution is important for 
controlled release of drug encapsulated in particles and knowing the exact 
size of the particles facilitates modelling the drug release and controls 
aspects such as the initial burst (Gasparini G. et al., 2008).  
Nanoparticles offer a number of advantages over microparticles as drug 
delivery systems. For example, nanoscale particles can travel through the 
blood stream without sedimentation or blockage of the microvasculature. 
Small nanoparticles can circulate through the body and penetrate tissues like 
tumours. In addition, nanoparticles can be taken up by cells through 
endocytosis. Microparticles do not enable intravenous administration and the 
size limits the cross of the intestinal lumen into the lymphatic system 
following oral delivery. The smallest capillaries in the body are 5-6 µm in 
diameter. The size of particles being distributed into the bloodstream must 
be significantly smaller than 5  µm, without forming aggregates, to ensure 
that the particles do not form an embolus. 
Nanoencapsulation enhances the transfer across the main hurdle: the 
brain blood barrier (BBB). An advantageous feature of particles smaller than 
220nm is that they could be easily sterilized by filtration, since the sizes of 
bacteria and viruses are larger. Furthermore, nanoparticles enhance 
dissolution rates in vitro and bioavailabilities in vivo of many drugs. For this 
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reason stabilized nanoparticle suspensions of drugs and Polymer/drug are of 
great importance in nanomedicine. 
Although the definition identifies nanoparticles has having dimensions 
below 100 nm, especially in the area of drug delivery relatively large 
(size>100nm) nanoparticles may be needed for loading a sufficient amount 
of drug onto the particles. In addition for drug delivery not only engineered 
particles may be used as carriers, but also the drug itself may be formulated 
at a nanoscale. 
 
II.2 Targeted Drug Delivery 
Targeted drug delivery systems are designed to deliver drugs at the 
proper dosage for the required amount of time to a specific site of the body 
where it is needed, thereby preventing any adverse effects drugs may have 
on other organs or tissues. Targeted delivery is relevant particularly in the 
case of highly toxic drugs such as chemotherapeutic drugs and highly active 
and fragile biotechnological molecules such as peptides and proteins. 
Furthermore, targeted drug delivery systems can be employed to deliver 
drugs to sites that are inaccessible under normal conditions such as the brain 
(Torchilin V.P., 2006). Depending on the mechanisms of action, targeted 
drug delivery systems can be classified into: 
 passive targeting  
 active targeting.  
Passive targeting makes use of delivery vehicles such as liposomes or 
micelles. These structures, due to their optimal size, can target cancer tissues 
or inflammatory sites with leaky vasculature as well as pass the blood–brain 
barrier.  
Active targeting makes use of the above-mentioned delivery vehicles or 
polymer–drug conjugates with a targeting agent like an antibody which can 
target a biomarker such as an antigen on a tissue or organ. Examples of 
biological coatings may include antibodies, biopolymers like collagen, or 
monolayers of small molecules that make the nanoparticles biocompatible.  
The next step in developing these carriers is an attempt to engineer 
nanocarriers, which, depending on particular requirements, can demonstrate 
a combination of various properties/functions, i.e. to construct and use 
multifunctional pharmaceutical nanocarriers (Figure II. 2). 
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Figure II. 2 Example of multifunctional pharmaceutical nanocarrier applied 
to medical or biological field (Salata O., 2004) 
 In a relatively simple case (it is known how to “produce” all individual 
properties in a reasonably simple way) one may want to have a drug-loaded 
nanocarrier demonstrating the following set of properties: (a) prolonged 
circulation in the blood; (b) ability to accumulate – specifically or non-
specifically – in the required pathological zone, (c) responsiveness to local 
stimuli, such as pH and/or temperature changes, resulting, for example, in 
accelerated drug release, (d) allow for an effective intracellular drug delivery 
and further to individual cell organelles, and (e) bear a contrast/reporter 
moiety allowing for the real-time observation of its accumulation inside the 
target.  
Some other properties can be added to the list, such as magnetic 
sensitivity. Examples of multifunctional matrices for oral and tumoral 
delivery have been already reviewed (Bernkop-Schnurch A. and Walker G., 
2001, Van Vlerken L.E. and Amiji M.M., 2006). Evidently, to prepare such 
smart multifunctional pharmaceutical nanocarrier, chemical moieties 
providing certain required individual properties have to be simultaneously 
assembled on the surface (within the structure) of the same nanoparticle. 
Moreover, these individual moieties have to function in a certain coordinated 
way to provide a desired combination of useful properties. However, 
systems like this still represent a challenge (Salata O., 2004).  
 
II.3 Microsphere-based Tissue Engineering Scaffold 
Tissue engineering (TE) is aimed at repairing and restoring damaged 
tissue employing three fundamental ‘‘tools’’, namely cells, scaffolds and 
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growth factors, which, however are not always simultaneously used (Luciani 
A. et al., 2008). On the other hand, recent experimental and clinical 
evidences indicates that the success of any TE approach mainly relies on the 
delicate and dynamic interplay among these three components and that 
functional tissue integration and regeneration depend upon their integration. 
Therefore, biomaterial scaffolds have to provide biological signals able to 
guide and direct cell function through a combination of growth factors 
sequestration and delivery. Several technologies have been used to make 
polymer porous scaffolds such as gas foaming (Murphy W.L. et al., 2000), 
salt leaching(Pamula E. et al., 2005), solvent casting  and their combination 
(Kim S.S. et al., 2006).  All these techniques for scaffolds production are 
classified as top-down methods. However, beside their well-known 
limitations regarding the control of porosity and interconnectivity along with 
poor mechanical properties of the resulting scaffold (Mikos A.G. et al., 
1993), these techniques are not suitable to include micro- depots in a 
regulated spatial pattern. 
In recent years a large number of investigations about the realization of 
porous scaffolds by sintering polymeric or ceramic microspheres have been 
reported. This new approach for scaffolds production is basically a bottom-
up approach. Since the first proposal of a microsphere based structures for 
tissue engineering, 3D scaffolds with a porous interconnected structure, it 
became evident that this approach could overcome some of the limitations 
presented by the classical approaches.  
The bottom-up approach can realize multifunctional polymer scaffolds 
with predefined pore dimension and degree of interconnectivity and 
containing interspersing microdepot for the release of bioactive molecules. 
Scaffolds were obtained through the thermal fusion of different kinds of 
biodegradable pharmacologically active microcarriers (PAMs) to obtain 
scaffolds with controlled porosity, mechanical properties and spatial-
temporal distribution of bioactive signals. The pores dimension and the 
mechanical properties are modulated by the size and formulation of the large 
microspheres while the rate and the time of release of protein are modulated 
by the formulation and size of the smaller microspheres. The results obtained 
are most promising and open the way for the development of microspheres 











The production of micro and nanocarrier for for controlled, targeted 
delivery and as building block for tissue engineering scaffolds is still a 
challenge, because good manufacturing techniques for these kinks of 
products should respect the many basic requirements: 
 Production of particles with controlled size distributions; 
 Mild operative conditions (which allow the processability of 
sensible drugs and proteins); 
 Continuous, robust and reproducible processing; 
 Possibility to process with FDA approved materials; 
 Possibility to encapsulate different drugs, proteins and also 
metal nanoparticles (allowing the production of 
multifunctional carriers); 
 Production of stabilized suspensions. 
Microspheres and nanospheres have been prepared by various techniques. 
Among these, the attention will be focused particularly on the techniques 
based on the emulsification of homogeneous solutions. The solvent 
extraction/evaporation of emulsion allows the production of particles with 
controlled particle sizes both in the nano and in the micrometric range 
changing accurately the emulsion production process. The nanoprecipitation 
technique can allow the production of nanoparticles of controlled size and 
distribution (Sosnik A. et al., 2008). These two techniques of particles 




III.1 Emulsions for the production of biopolymeric micro and 
nanoparticles 
Solvent evaporation/extraction of emulsions is applied in pharmaceutical 
industries to obtain microparticles for the controlled release of the drug. The 
polymer microspheres with drug trapped inside can degrade and release the 
encapsulated drug slowly with a specific release profile.  
There are different methods to produce microspheres by solvent 
evaporation/extraction technique. The choice of the method that will give 
rise to an efficient drug encapsulation depends on the hydrophilicity or the 
hydrophobicity of drug. For insoluble or poorly water-soluble drugs, the oil-
in-water (o/w) method is frequently used. This method is the simplest and 
the other methods derive from this one. It consists of four major steps 
(Figure III 1):  
(1) dissolution of the hydrophobic drug in an organic solvent containing 
the polymer;  
(2) emulsification of this organic phase, called dispersed phase, in an 
aqueous phase called continuous phase;  
(3) extraction of the solvent from the dispersed phase by the continuous 
phase, accompanied by solvent evaporation, transforming droplets of 
dispersed phase into solid particles; and  
(4) recovery and drying of microspheres to eliminate the residual solvent 
(Li M. et al., 2008). 
 
 
Figure III 1 Basic steps of microencapsulation by solvent evaporation (Li 
M. et al., 2008) 
This method is not suitable for the encapsulation of high hydrophilic 
drugs. There are two main reasons: (1) the hydrophilic drug may not be 
dissolved in the organic solvent; (2) the drug will diffuse into the continuous 
phase during emulsion, leading to loss of drug. The  alternative method of 
the w/o/w double emulsion has been proposed and therefore make it possible 
to encapsulate the hydrophilic drugs. According to this method, the aqueous 
solution of hydrophilic drug is emulsified with organic phase (w/o 
emulsion), this emulsion is then dispersed into a second aqueous solution 
forming a second emulsion (w/o/w double emulsion). Then, extraction of the 
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solvent from the dispersed phase by the continuous phase, accompanied by 
solvent evaporation, transforming droplets of dispersed phase into solid 
particles.  
 
III.1.1 Choice of materials: Disperse phase  
Polymer 
The biodegradability or biocompatibility is an essential property for the 
polymer used for pharmaceutical applications. ‘Biodegradability’ means that 
the components are degraded into harmless components which are 
metabolized. ‘Biocompatibility’ means that the component should be 
physiologically tolerable and should not cause an adverse local or systemic 
response after administration.  
Polymers and copolymers of lactic and glycolic acids are the most 
commonly used to develop drug delivery systems due to their safe and FDA 
(Food and Drug Administration) approved applications in humans. They can 
ultimately degrade by hydrolysis of their constituents, which are usual 
metabolic products. Other biodegradable polymers such as Polycaprolactone 
(PCL) and Polyvinilalcool (PVA) and Polylactic acid (PLA) have been 
studied for pharmaceutical and medical applications (Amass W. et al., 1998). 
Non-biodegradable polymers with good biocompatibility are also used as 
drug carriers, such as ethyl cellulose (degradable but no biodegradable) and 
polymethyl methacrylate (biocompatible but non-degradable). Ethyl 
cellulose can be administrated orally to protect the drug against gastro-
intestinal tract or administrated intraduodenally for a prolonged intestinal 
absorption (Takishima J. et al., 2002). Polymethyl methacrylate 
microspheres are extensively used as bone cement material in antibiotics 
releasing for bone infection (Stallmann H.P. et al., 2006) and bone tumours 
(Mestiri M. et al., 1993). Surgical removal is required afterwards because the 
polymethyl methacrylate is not degradable. 
The choice of polymer used as drug carrier depends also on the desired 
drug release rate, which is essentially determined by the polymer’s physical 
properties. If one polymer cannot offer a satisfying drug release, a single 
polymer, called so-polymer, can be synthesized from two different polymers. 
The properties of the co-polymer are improved since it has two segments on 
the chain.  
Solvent              
For microencapsulation techniques, a suitable solvent should meet the 
following criteria: 
 able to dissolve the chosen polymer; 
 poorly soluble in the continuous phase; 
 a high volatility and a low boiling point; 
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 low toxicity. 
Chloroform is frequently used, but due to its toxicity and low vapour 
pressure, it is gradually replaced by methylene chloride. Methylene chloride 
is the most common solvent for the emulsion formation because of its high 
volatility, low boiling point and high immiscibility with water. Its high 
saturated vapour pressure, compared to other solvents, promises a high 
solvent removal rate, which shortens the duration of fabrication of 
microspheres. However, this solvent is confirmed carcinogenic according to 
EPA (Environmental Protection Agency) data and the researchers are 
making great efforts to find less toxic replacements.  
Ethyl acetate shows promising potential as a less toxic substitute of 
methylene chloride. But due to the partial miscibility of ethyl acetate in 
water, microspheres cannot form if the dispersed phase is introduced directly 
into the continuous phase. The sudden extraction of a large quantity of ethyl 
acetate from the disperse phase makes the polymer precipitate into fibre-like 
agglomerates (Freytag T. et al., 2000). To resolve the problem created by the 
miscibility of solvent with water, the aqueous solution can be pre-saturated 
with solvent (Bahl Y. and Sah H., 2000). 
Ethyl formate shows also interesting results. Sah (Sah H., 2000) observed 
that the evaporation rate of ethyl formate in water is 2.1 times faster than that 
of methylene chloride although ethyl formate possesses a lower vapour 
pressure and a higher boiling point. This phenomenon is explained by the 
fact that more molecules of ethyl formate are exposed at the air-liquid 
interface because of its higher water solubility.  
Recently, some authors reported PLGA microspheres containing vitamin 
B12 prepared by emulsion extraction using a new emulsion composition 
formed by acetone, as the solvent for the oily phase and aqueous glycerol, 
taking advantage of the phase separation between the mixtures. Acetone was 
then “extracted” with water; indeed, moving the mixture composition in one 
phase region the PLGA/drug microsphere hardening has been obtained 
(Matsumoto A. et al., 2008). Although simple, the main disadvantage of this 
liquid-liquid emulsion extraction method is extremely low yields due to 
water dilution complications, such as microsphere recovery and drug 
leakage. 
In summary, less toxic solvents have been tested and show a promising 
future. But, there are not enough results to compare the quality of 
microspheres prepared by different solvents. Methylene chloride is still the 
most used solvent because it evaporates fast, shows high drug encapsulation 
efficiency and produces microspheres with a more uniform shape. 
Alternative components 
In certain cases, other constituents are added in the disperse phase such as 
co-solvents and porosity generators. A co-solvent is used to dissolve the 
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drug that is not totally soluble in the solvent in the disperse phase 
(Reithmeier H. et al., 2001). Organic solvents miscible with water such as 
methanol or ethanol are the common choices.  A porosity generator, called 
also porogen, is used to generate the pores inside the microspheres, which 
consequently increases the degradation rate of polymer and improves drug 
release rate. Organic solvents such as hexan, which do not dissolve 
poly(lactic acid) and poly(lactic-co-glycolic acid) can be incorporated into 
microspheres to form pores (Spenlehauer G. et al., 1988).   
  
III.1.2 Choice of materials: Continuous phase  
Surfactants 
The surfactant, also called tensioactive agent, is frequently employed for 
the dispersion of one phase in another immiscible phase and for the 
stabilization of obtained emulsion. It reduces the surface tension of 
continuous phase, avoids the coalescence and agglomeration of drops and 
stabilizes the emulsion. A suitable surfactant should be able to give 
microspheres a regular size and a small size distribution, guaranteeing a 
more predictable and stable drug release.  
Before choosing the type of surfactant and its concentration, it is 
important to know the polarity of the two immiscible phases, the desired size 
of microspheres and the demand on the sphericity of microspheres. 
Surfactants for emulsions are amphiphilic. That means one part of the 
molecule has more affinity to polar solutes such as water (hydrophilic) and 
the other part has more affinity to non-polar solutes such as hydrocarbons 
(hydrophobic). When it is present in an emulsion, the surfactant covers the 
surface of drops with its hydrophobic part in the drop and its hydrophilic part 
in the water.  
There are four different types of surfactant classified by the nature of the 
hydrophilic part of molecule: anionic, cationic, amphoteric and non-ionic.  
The anionic surfactants release a negative charge in the aqueous solution. 
They have a relatively high HLB (hydrophilic-lipophile balance) level 
because they have prone to be hydrophilic.  The cationic surfactants on the 
contrary release a positive charge in aqueous solution.  The amphoteric 
surfactants behave an anionic in alkali pH and as cationic in acid pH. Non-
ionic surfactants have no charge (Li M. et al., 2008). Among different 
surfactants, partially hydrolyzed PVA is mostly used because it gives the 
smallest microspheres (O'hagan D.T. et al., 1994). The increase of surfactant 
concentration reduces the size of microspheres. The addition of surfactants 
lowers the surface tension of the continuous phase and the diminution of the 
latter decreases the particle size. However, due to the critical micelle 
concentration (CMC), the surface tension cannot decrease infinitively. When 
surfactants concentration reaches a certain level, the solution surface is 
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completely loaded. Any further additions of surfactant will arrange as 




Besides the surfactant, the antifoam is sometimes added into aqueous 
phase in the case of strong agitation because the foaming problem will 
disturb the formation of microspheres. When the stirring speed increase, 
more air is entrained and foam forms. So anti-foams of silicon and non-
silicon constituents are used to increase the rate at which air bubbles are 
dissipated(Berchane N.S. et al., 2006). 
Recent studies show that it is possible to prepare microspheres without 
surfactant by replacing it with an amphiphilic biodegradable polymer. The 
advantage is to avoid the potential harm of surfactant residual on the surface 
or inside the final microspheres. 
 
III.1.3 Choice of the emulsification technique 
Emulsions are usually prepared by the application of mechanical energy 
produced by a wide range of agitation techniques. The droplet formation step 
determines the size and size distribution of the resulting microspheres. 
Microsphere size may affect the rate of drug release, drug encapsulation 
efficiency, product syringeability, in vivo fate in terms of uptake by 
phagocytic cells and biodistribution of the particles after subcutaneous 
injection of intranasal administration.  
Particle size are known to have significant influences on the release rate. 
The effects vary depending on the drug release mechanism. When the drug 
release is mainly controlled by diffusion, small microparticles tend to release 
the drug at a relatively high rate due to the large surface area and the short 
diffusion distance. On the other hand, when the release depends on the 
polymer degradation, the particle size controls the release rate by affecting 
additional features such as drug distribution and polymer degradation rate. In 
this regard, a variety of efforts have been made to obtain microparticles of 
monodisperse and controllable size. 
 
Stirring 
Stirring is the most straightforward method to generate droplets of few 
microns up to hundred microns of the drug/matrix dispersion in the 
continuous phase. In the simplest approach, external phase is filled into a 
vessel and agitated by an impeller. The drug/matrix dispersion is then added, 
dropwise or all at once, under agitation at a speed sufficient to reach the 
desired droplet size. Obviously, the impeller speed is the main parameter for 
controlling the drug/matrix dispersion’s droplet size in the continuous phase. 
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Increasing the mixing speed generally results in decreased microsphere mean 
size, as it produces smaller emulsion droplets through stronger shear forces 
and increased turbulence (Yang Y.Y. et al., 2001). The extent of size 
reduction that is attained depends on the viscosity of the disperse and 
continuous phases, the interfacial tension between the two phases, their 
volume ratio, the geometry and number of the impeller(s) and the size ratio 
of impeller and mixing vessel (Freitas S. et al., 2005). 
 
Ultrasounds emulsification 
Often subsequent the stirring, ultrasound emulsification consists in 
sonicating liquids at high intensities (Bilati U. et al., 2003). The sound waves 
that propagate into the liquid media result in alternating high-pressure 
(compression) and low-pressure (rarefaction) cycles, with rates depending on 
the frequency. During the low-pressure cycle, high-intensity ultrasonic 
waves create small vacuum bubbles or voids in the liquid. When the bubbles 
attain a volume at which they can no longer absorb energy, they collapse 
violently during a high-pressure cycle. This phenomenon is termed 
cavitation. During the implosion very high temperatures  and pressures are 
reached locally. The implosion of the cavitation bubble also results in liquid 
jets of up to 280m/s velocity. Ultrasound emulsification has been proven to 
generate very homogenous emulsions of water in oil (w/o) and oil in water 
(o/w) by the high cavitational shear. As the parameters of ultrasonication are 
well controllable, the particle size and distribution is well adjustable and 
repeatable. This methods is combined with the stirring emulsification is used 
in order to obtain very small droplets.  
 
Membrane emulsification 
Membrane emulsification (ME) is a new technique of emulsification used 
to obtain a better control of the PSDs. In conventional direct ME, fine 
droplets are formed in situ at the membrane/continuous phase interface by 
pressing a pure disperse phase through the membrane. In order to ensure a 
regular droplet detachment from the pore outlets, shear stress is generated at 
the membrane/ continuous phase interface by recirculating the continuous 
phase using a low shear pump. The rate of mixing should be high enough to 
provide the required tangential shear on the membrane surface, but not too 
excessive to induce further droplet break up. Another approach uses systems 
equipped with a moving membrane, in which the droplet detachment from 
the pore outlets is stimulated by rotation or vibration  of the membrane 
within a stationary continuous phase. Even in the absence of any tangential 
shear, droplets can be spontaneously detached from the pore outlets at small 
disperse phase fluxes, particularly in the presence of fast adsorbing 
emulsifiers in the continuous phase and for a pronounced noncircular cross 
section of the pores (Vladisavljevic G.T. and Williams R.A., 2005). 
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Depending on the membrane hydrophilicity/ hydrophobicity and the 
compositions of the two liquid phases, O/W, W/O emulsions may be 
produced. The single emulsion can be subjected to secondary emulsification 
to form a multiple emulsion or may undergo a process/reaction converting 
the droplets into solid particles or the continuous liquid phase into a solid 
phase(Nakashima T. et al., 2000).  
 
Prilling 
Another technique of droplet formation is the prilling. In this process, the 
forming droplets were detached from a needle by electrostatic forces. 
Particle collection and solvent removal occurred in a bath. The electric field 
was generated by connecting the needle to electric potentials of up to 4 kV 
and the collection bath to ground. Very large microspheres of 500 to 1500 
µm average diameter were obtained, whereby the largest particles formed 
with voltage-free dripping. It is important to set the appropriate prilling 
condition to avoid highly polydispersed size distributions(Freitas S. et al., 
2005). 
 
III.1.4 Solvent Evaporation/extraction of emulsions: advantages and 
disadvantages  
The solvent evaporation/extraction of emulsions allows the production of 
both microspheres and microcapsules of FDA approved biopolymers. This 
technique makes it possible to encapsulate hydrophilic and hydrophobic 
drugs using double (water-in-oil-in-water) and single (oil-in-water) 
emulsions respectively. Despite these potential advantages the solvent 
evaporation/extraction of emulsion technique suffers of some drawbacks. 
Indeed, This technology uses a simple vessel/stirrer setup, but may exhibit 
difficulties in producing large amounts of microspheres in a robust and well-
controlled manner. Solvent evaporation may also require elevate 
temperatures or reduced pressures to eliminate the liquid solvent. Solvent 
extraction uses relatively large amounts of a second solvent and, then, the 
mixture of these two solvents has to be recycled. They also require long 
processing times (several hours) to be completed and, as a consequence, 
aggregation phenomena occur between the droplets producing microspheres 
with a larger polydispersity respect to the starting emulsions(Yang Y.Y. et 
al., 2000). 
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III.2 Nanoprecipitation: an alternative method to  produce 
biopolymeric nanoparticles 
The nanoprecipitation method is also called solvent displacement or 
interfacial deposition. The nanocapsule synthesis needs both solvent and 
non-solvent phases(Quintanar-Guerrero D. et al., 1996).  
The solvent phase essentially consisting of a solution in a solvent or in a 
mixture of solvents (i.e. ethanol, acetone, hexane, methylene chloride or 
dioxane) of a polymer (synthetic, semi-synthetic or naturally occurring 
polymer), the active substance, and a lipophilic tensioactive.  
On the other hand, the non-solvent phase consists of a non-solvent or a 
mixture of non-solvents for the polymer, supplemented with one or more 
surfactants. In most cases, the solvent and non-solvent phases are called 
organic and aqueous phases, respectively. The solvents used for the solvent 
and non solvent phase are completely miscible. As a general tendency, the 
solvent is an organic medium, while the non-solvent is mainly water. 
However, it is possible to use either two organic phases or two aqueous 
phases as long as solubility, insolubility and miscibility conditions are 
satisfied. The nanocapsules are obtained as a colloidal suspension formed 
when the organic phase is added slowly and with moderate stirring to the 
aqueous phase. 
 
Figure III 2 Set-up used for preparation of nanoparticles by the 
nanoprecipitation method (Mora-Huertas C.E. et al., 2010) 
 
III.2.1 Choice of materials 
Polymers 
The polymers commonly used are biodegradable polyesters, especially 
poly-ɛ-caprolactone (PCL) (Zili Z. et al., 2005), poly(lactide) (PLA) and 
poly(lactide-co-glicolide) (PLGA) (Murakami H. et al., 1999). Eudragit can 
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also be used as many other polymers such as poly(alkylcyanoacrylate) 
(PACA). Synthetic polymers have higher purity and better reproducibility 
than natural polymers.  
 
Solvent and non solvent 
Regarding the polymer solvent, acetone is chosen in most of the cases. 
Other solvents such as ethanol are used in order for active substance or oil 
dissolution. Water or buffer solutions can be used as the non-solvent while 
the stabilizer agent is generally poloxamer 188 or polysorbate 80.  
This technique is mostly suitable for compounds having a hydrophobic 
nature. The presence of alcohol, as cosolvent, in the inner phase, seems to 
speed up the precipitation of the polymer and increases the phase separation 
of the polymer during the solvent diffusion (Peltonen L. et al., 2002). 
Also the type of non-solvent influence the PSD of the nanoparticles 
obtained via nanoprecipitation methods, since the higher the rate of 
diffusion, the smaller the nanoparticles (and the higher the yield of 
transformed polymer into nanoparticles) (Bilati U. et al., 2005b). 
 
III.2.2 Choice of the nanoprecipitation conditions 
In the nanoprecipitation method, the nanocapsules are obtained as a 
colloidal suspension formed when the organic phase is added to the aqueous 
phase. The key variables of the procedure seem to be: 
(1) stirring rate of non solvent,  
(2) feed rate of solvent,  
(3) non solvent ratio to the whole solvent, 
(4) temperature of non solvent,  
(5) surfactant concentration in non solvent,  
(6) biopolymer concentration in solvent (Tsukada Y. et al., 2009). 
 
A prototype composition for preparation of nanocapsules at laboratory-
scale using the nanoprecipitation method is show in Table III 1 
(nanocapsule size: approximately 150–200 nm).  
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Table III 1 Suggested composition for preparation of nanocapsules by 
nanoprecipitation 
Material Suggested composition 
Active substance 10–50mg 
Polymer 1.0–2.0% of inner phase solvent 
Inner phase solvent 10 ml 
Stabilizer agent 2.0–5.0% of external phase solvent 
External phase solvent 40 ml 
 
This technique presents clear advantages over other existing methods 
such as  
(a) the use of pharmaceutically acceptable organic solvents,  
(b) no need of high-pressure homogenizers or ultrasonication,  
(c) high yields,  
(d) high reproducibility;  
(e) easy to scale up (Quintanar-Guerrero D. et al., 1997) 
 
III.2.3 Mechanism of nanoparticles formation 
Disagreement exists regarding the mechanism of nanocapsule formation 
using this technique, research into polymer precipitation  and solvent 
diffusion have proved useful in this regard. On the basis of Sugimoto’s 
theory on polymer precipitation (Lince F. et al., 2008) indicated that the 
process of particle formation in the nanoprecipitation method comprises 
three stages: nucleation, growth and aggregation. The rate of each step 
determines the particle size and the driving force of these phenomena is 
supersaturation, which is defined as the ratio of polymer concentration over 
the solubility of the polymer in the solvent mixture. The separation between 
the nucleation and the growth stages is the key factor for uniform particle 
formation. Ideally, operating conditions should allow a high nucleation rate 
strongly dependent on supersaturation and low growth rate.  
On the other hand, in line with the research carried out by Quintanar on 
mass transfer between two liquids and the Gibbs–Marangoni effect, 
explained rapid nanoparticle formation as a process due to differences in 
surface tension (Quintanar-Guerrero D. et al., 1998). Since a liquid with a 
high surface tension (aqueous phase) pulls more strongly on the surrounding 
liquid than one with a low surface tension (organic phase solvent). This 
difference between surface tensions causes interfacial turbulence and 
thermal inequalities in the system, leading to the continuous formation of 
eddies of solvent at the interface of both liquids. Consequently, violent 
spreading is observed due to mutual miscibility between the solvents, the 
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solvent flows away from regions of low surface tension and the polymer 
tends to aggregate on the oil surface and forms nanocapsules. 
According to this explanation, nanocapsule formation is due to polymer 
aggregation in stabilized emulsion droplets, while apparently the nucleation 
and growth steps are not involved. Further experimentations are necessary to 
try to clarify the mechanism of formation of nanoparticles. 
 
III.2.4 Nanoprecipitation: advantages and disadvantages 
The nanoprecipitation technique allows a fast and easy production of 
biopolymeric nanoparticles, but despite this potential advantages this 
technique does not allow a reproducible processing because it is 
fundamentally a batch process. Furthermore, this technique has been 
extensively used in the literature for the production of nanoparticles, but still 
a deep understanding of the basic phenomena involved in particle formation 
is missing. This has led to results that are not easy to explain and difficult to 
control and predict. A systematic study about nanoparticle production using 
this technique is required. In addiction until now only a marginal attention 
has been given to the problem of solvent removal from prepared 
suspensions. This is a very important aspect of the process especially 











IV.1 Supercritical fluids properties 
Supercritical fluids (SCFs) are defined as any substance, the temperature 
and pressure of which are higher than its critical values, and which has a 
density close to or higher than its critical density. An increasing drive for 
greener processes in the chemical industry in the 1970s led to the wider 
exploitation of SCFs as alternative reaction media, and also for extraction 
and separation processes. The key benefits are perceived as the replacement 
of traditional solvents which are often hazardous, toxic and contribute 
strongly to ozone depletion and global warming.  
Like gases, SCFs possess high diffusivities, important for reaction 
kinetics, while also having liquid-like densities that allow them to act as 
effective solvents for many compounds. Small changes in pressure and 
temperature, especially near the critical point, can be used to tune the density 
of a supercritical fluid and therefore its solvating ability, hence giving 
increased control of reactions. As reagent-carrying media, the intermediate 
transport properties of SCFs should allow faster rates in diffusion limited 
reactions compared to liquid systems whilst at the same time providing 
higher solvation power and increased reactant loadings when compared to 
gas-phase systems (Fages J. et al., 2004).  
Carbon dioxide (CO2) is probably the most widely used supercritical 
fluid. CO2 has relatively easily accessible critical points of 31.06 °C and 7.38 
MPa, and tuneable density, as well as a high diffusivity, making it a 
promising reaction medium for organic compounds. CO2 is non-combustible 
and non-toxic as well as being relatively environmentally benign. It is also 
easily available as it occurs naturally as well as being the by product of 
many industrial processes. As a consequence of the recent focus on carbon 
storage approaches for power stations, it is clear that CO2 will become even 
more available and cheaper. One more virtue of CO2 is that it is a gas at 
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ambient temperatures and pressures so that it can easily be removed after 
reaction, leaving no solvent residues in the processed material. This contrasts 
strikingly with the high energy-costs of drying for the removal of 
conventional solvents and water. In small-scale reactions the CO2 
contribution to global warming is negligible, but for larger scale processes 
this could be overcome by the ease of recycling back into the reaction 
system (Mishima K., 2008). 
 
IV.2 Nanomaterials production 
A possible general classification of SCF based nanoparticles generation 
techniques can be proposed according to the role played by the SCF in the 
process. Indeed, SCFs have been proposed as solvents, solutes, anti-solvents. 
 
Rapid Expantion of Supercritical Solution (RESS) 
The rapid expansion of supercritical solutions (RESS) consists of the 
saturation of the supercritical fluid with a solid substrate; then, the 
depressurization of the solution through a heated nozzle into a low pressure 
chamber produces a rapid nucleation of the substrate in form of very small 
particles that are collected from the gaseous stream. The morphology of the 
resulting solid material, crystalline or amorphous, depends on the chemical 
structure of the material and on the RESS parameters (temperature, pressure 
drop, impact distance of the jet against a surface, nozzle geometry, etc.) 
(Jung J. and Perrut M., 2001). The very fast release of the solute in the 
gaseous medium should assure the production of very small particles. This 
process is particularly attractive due to the absence of organic solvents. The 
authors that first proposed RESS (Petersen R.C. et al., 1986, Matson D.W. et 
al., 1987) patented the process with respect to the possibility of producing 
nanoparticles; but, also microparticles and films formation were claimed. 
However, only several years later in the scientific literature appeared papers 
that confirmed this possibility. For example, (Turk M. et al., 2002) used the 
RESS process to produce β-sitosterol (an anticholesteremic) nanoparticles of 
about 200 nm mean diameter.  
An interesting variation of the RESS process is the rapid expansion of a 
supercritical solution into a liquid solvent (RESOLV) that consists of 
spraying the supercritical solution into a liquid. Operating in this manner, it 
should be possible to quench particles growth in the precipitator, thus 
improving the RESS process performance. Moreover, by interaction among 
the nucleating solid particles and the compounds contained in the liquid 
phase, a chemical reaction step can also be added. 
The potential features of RESS, are very interesting from the theoretical 
point of view; but, the results have not been particularly good in several 
cases. It is in many cases problematic to control the particle size of the 
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precipitates. During the expansion, the particles coalesce in the supersonic 
free jet generated in the precipitation vessel and, therefore, in many cases 
needlelike particles have been obtained. Sometimes, the formation of 
oriented needles can be explained by the presence of electrostatic charges on 
the surface of the particles, induced by the fast relative motion between the 
particles and the gas contained in the expansion chamber (Reverchon E. et 
al., 1995). RESOLV configuration has been demonstrated to be more 
effective in producing nanoparticles, since the liquid that receives the 
expanding jet, can suppress the particle growth. The addition of a stabilizing 
agent in the liquid also protects particles from agglomeration. 
The major limitation of RESS and RESOLV processes is that they are 
applicable only to products that show a reasonable solubility in the selected 
supercritical fluid. Unfortunately, many solid compounds with high 
molecular weight and polar bonds, that could be candidate to nanoparticles 
generation, show a very low or negligible solubility in SC-CO2, that is the 
most widely SCF used and show a reduced solubility in many other 
compounds that could be good candidates to act as SCF. RESOLV has also 
the problem of the recovery of particles from the liquid solution used to 
improve the process performance: in this configuration, the process is no 
more solventless. 
 
Supercritical Antisolvent precipitation (SAS) 
Supercritical anti-solvent precipitation (SAS) has been proposed using 
various acronyms; but, the process is substantially the same in all the cases. 
A liquid solution contains the solute to be micronized; at the process 
conditions, the supercritical fluid should be completely miscible with the 
liquid solvent; whereas, the solute should be insoluble in the SCF. Therefore, 
contacting the liquid solution with the SCF induces the formation of a 
solution, producing supersaturation and precipitation of the solute. The 
formation of the liquid mixture is very fast due to the enhanced mass transfer 
rates that characterize supercritical fluids and, as a result, nanoparticles 
could be produced. This process has been used by several authors using 
different process arrangements; however, the most significant differences are 
related to the way the process operates: in batch or semi-continuous 
mode(Reverchon E., 1999). In batch operation (GAS: Gas AntiSolvent) the 
precipitation vessel is loaded with a given quantity of the liquid solution and, 
then, the supercritical antisolvent is added until the final pressure is obtained. 
In the semi-continuous operation (SAS), the liquid solution and the 
supercritical anti-solvent are continuously delivered to the precipitation 
vessel in co-current or counter-current mode. An important role is also 
played by the liquid solution injection device (Dehghani F. and Foster N.R., 
2003). The injector is designed to produce liquid jet break-up and the 
formation of small droplets to produce a large mass transfer surface between 
the liquid and the gaseous phase. Several injector configurations have been 
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proposed in the literature and patented. High pressure vapor-liquid equilibria 
(VLEs) and mass transfer between the liquid and the SCF also play a 
relevant role in SAS. Particularly VLEs the ternary system solute-solvent-SC 
antisolvent and the position of the operating point in SAS processing with 
respect to these VLEs, can be decisive for the success of the process The 
formation of a single supercritical phase is the key step for the successful 
production of nanoparticles (Reverchon E. et al., 2002). The washing step 
with pure supercritical antisolvent at the end of the precipitation process is 
also fundamental to avoid the condensation of the liquid phase that otherwise 
rains on the precipitate modifying its characteristics. The mechanism of 
particles formation with the SAS process is substantially based on nucleation 
induced by antisolvent effect and consequent particle precipitation. The 
production of nanospheres is possible, but, instead, the production of 
nanocapsules is not possible, only coprecipitates can be produced (when the 
compounds show the same precipitation rate). Furthermore, FDA approved 
biocompatible polymers suitable for controlled release application did not 
give good micronization results with this technique.  
 
Supercritical Assisted Atomization  
The Supercritical Assisted Atomization (SAA) is a techniques that use 
CO2 as co-solute have something in common with the micronization by 
spray-drying: the SCF and the solution are intimately mixed and then 
sprayed in a drying atmosphere. This SCF-based micronization technique is 
very interesting because it can be applied to water-soluble compounds 
difficult to handle with the other SCF techniques without excluding the 
possibility of using other organic solvents. Atomization, also assisted by an 
inert gas, is generally used in the spray drying of solutions. The innovative 
aspect of the SAA process is the solubilization of SC-CO2 in the liquid 
solution formed by the solvent and the (solid) solute, and the subsequent 
atomization of the gas-solid-liquid mixture using a thin wall nozzle. Indeed, 
gases are released slowly from the liquid phase and their contribution to a 
two-step atomization is not relevant (Reverchon E. et al., 2006). Gases at 
supercritical conditions are released from the liquid phase by a faster process 
(Reverchon E. and Spada A., 2004); therefore, SC-CO2 can improve the 
atomization process, contributing to a two-step atomization. The operating 
conditions that are characteristic of the SAA process are the formation of a 
single, expanded liquid, phase in the mixing device. When SAA is properly 
conducted, two atomization processes take place: the first one is the 
production of primary droplets at the exit of the nozzle by pneumatic 
atomization and the second one is the destruction of these droplets by the 
fast release of CO2 from the internal of the droplet (decompressive 
atomization). Depending on the process temperatures and the chemical 
characteristics of the solid solute, amorphous or crystalline particles have 
been produced. The SAA process has been successfully performed using 
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water, organic solvents with relatively low boiling points (EtOH, MeOH, 
acetone) and mixtures of them. Solvents with high boiling points, typically 
used e.g. in SAS micronization (i.e. DMSO, NMP, toluene) cannot be used 
because of the difficulty of removing them during precipitation. The limit of 
this process is that the smallest particles produced depend on the dimensions 
of the smallest secondary droplets generated (one droplet-one particle 
process). The dimensions are connected to the classical parameters that 
control droplet dimensions during atomization: surface tension, viscosity and 
quantity of SCF dissolved in the liquid. The SAA process allows the 
successful production of particles in the range of dimension 1-3 µm. The 
production of nanoparticles has never been demonstrated until now. Another 
limitation of the SAA process that reduces the possibility to use this process 
for the production of devices for biomedical application is the need of 
elevated temperatures in the precipitation chamber, that can damage 
thermolable compounds.  
 
Supercritical Emulsion Extraction (SEE) 
The Supercritical Emulsion Extraction technique (SEE) is the innovative 
version of the conventional solvent evaporation technique for the production 
of micro and nanoparticles. 
This process has been recently proposed by some authors (Kluge J. et al., 
2009a, Della Porta G. and Reverchon E., 2008). This process provides a 
method of producing particles via solvent extraction of emulsion using 
supercritical fluid. A solute is dissolved in a suitable solvent to form a 
solution; the solution is then dispersed into an immiscible or partially 
miscible liquid to form an emulsion. Extracting the solvent from the oil 
phase of the emulsion, the SEE process produces an aqueous colloidal 
suspension of particles. Solvent used in the process can be recovered and 
recycled. In this process, SC-CO2 selectively extracts the organic solvent 
form the discontinuous phase resulting in supersaturation of the solute in the 
solvent. The supersaturation leads to the precipitation of the solute in the 
form of fine particles into the continuous phase. SC-CO2 extraction has a 
relatively faster extraction rate compared to extraction rates of other 
conventional techniques (processing in minutes instead of several hours), 
and this allows the formation of relatively smaller particles, with narrow size 
distributions, and very small solvent residues (Della Porta G. and Reverchon 
E., 2008).  
The solute is preferably a substance that is insoluble or slightly soluble in 
water. Thus, the method is particularly suitable for producing many 
pharmaceutical compositions, as many of which are either insoluble or 
slightly soluble in water, and are delivered to patients as aqueous colloidal 
suspensions.  
The supercritical fluid-soluble liquid or solvent forming the 
discontinuous phase is preferably an organic solvent or an oil, and thus either 
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immiscible or only partially miscible with water. Suitable preferred organic 
solvents that are immiscible in water include, for example, toluene, 
cyclohexane and higher alkanes. Organic solvents that are partially miscible 
in water include, for example, ethyl acetate, propyl acetate and 2-butanone. 
The supercritical fluid-insoluble liquid forming the continuous phase is 
preferably water.   
The PSD can be controlled by controlling the droplet size of the 
emulsions.  
An approach starting from an O/W emulsion and using SC-CO2 for the 
extraction of the emulsion organic phase was proposed by Chattopadhyay & 
co-workers (Chattopadhyay P. et al., 2006, Chattopadhyay P. et al., 2007, 
Shekunov B. et al., 2006) in the preparation of drug microparticles of 
megesterol acetate or cholesterol acetate and in the formation of lipid 
microspheres charged with ketoprofen and indometacin. Della Porta & 
Reverchon (Della Porta G. and Reverchon E., 2008, Della Porta G. et al., 
2010), recently, gave some indications on the mechanism of solvent 
extraction by SC-CO2 of an O/W emulsion and \a W/O/W for the production 
of PLGA microspheres loaded with different antiflammatory drugs, 
controlling their size, distribution, and drug loading by varying both 
emulsion and SC-CO2 process conditions. These studies confirmed that the 
SC emulsion processing combines the advantages of traditional emulsion 
based technology, namely control of particle size and surface properties, 
with the advantages of supercritical fluid extraction process, such as higher 
product purity and shorter processing times.  
The major limitation of supercritical extraction, shared with traditional 
evaporation processes, is the fact that these processes are intrinsically 
discontinuous. Indeed, a batch of emulsion can be treated for each process 
run. This fact produces some problems: repeatability of the batches and 
reduction of the process yield due to the material lost on the walls of the 
precipitation vessel. The problem of batches reproducibility is particularly 
important for pharmaceutical industry that to obtain the Food and Drug 
Administration (FDA) approval of a process has to accurately demonstrate 
that all processed batches produce exactly a product with the same 
characteristics. For this reason Della Porta and Reverchon (Della Porta G. et 
al., 2011b) suggested also the possibility of a continuous process layout 
where the SC-CO2 is continuously contacted with an O/W emulsion in a 
column to extract the organic solvent without interacting with dispersant 
phase. At the bottom of the column, a suspension of microstructured 
particles can be continuously collected.  
The SEE process is particularly suitable for the production of 
microspheres and microcapsuales of biopolymers loaded with drugs for 
controlled delivery application. The production of multifunctional devices 
for nanomedicine has never been demonstrated until now, but among the 








V.1 Objectives of the work 
The aim of this work is to study and optimize supercritical assisted 
processes for the production of micro and nanoparticles or biopolymeric 
nanocarriers.  
The supercritical emulsion extraction process, recently proposed in the 
literature, has been successfully applied to the production of biopolymeric 
microparticles and microspheres for the encapsulation of different drugs. 
However, submicro and nanoparticles have not yet been produced 
successfully with this technique. For this reason, a part of the work will be 
focused on the optimization of the process condition for the production of  
monodisperse submicro and nanospheres of different biopolymer. In 
particular, different emulsion formulation will be developed and 
standardized to enhance the control over particle size distributions.  
The SEE technique will also be applied for the production of complex 
nanodelivery devices. Proteins and growth factor will be encapsulated in 
PLGA and PLA particles producing the so called PAMs, which will be next 
charged in alginate scaffolds and tested for regenerative medicine. Light 
sensitive drug delivery devices will be also produced with this technique. 
Titanium oxide (activated by UV light) and Gold (activated by NIR 
irradiation) nanoparticles will be loaded in PLA nanocomposite deices for 
photodynamic therapy of cells and photothermally controlled drug delivery 
respectively.  
The SEE apparatus will be also applied for the extraction of the solvents 
from nanoparticles suspensions produced by nanoprecipitation technique. 
This technique allows a fast and reproducible production of biopolymer 
nanoparticles, but solvent removal from aqueous suspensions requires 
complicated post-precessing operations that may damage particles size 
distribution. We propose a supercritical solvent extraction from water based 
suspensions using the continuous counter-current apparatus used for the SEE 
technique. Different nanoprecipitation formulations will be tested leading to 
different final composition of the nanoparticle suspensions. Solvent used to 
obtain particles precipitation will be extracted using SC-CO2 solvent power. 
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Supercritical solvent extraction operating conditions will be optimized to 
reduce solvent residue well below the limits for pharmaceutical applications. 
In addition a new supercritical assisted process will be 
proposed for the production of nanoparticles.  
The basic idea of the new process, named Supercritical Assisted 
Injection in Liquid Antisolvent (SAILA) comes from the general 
principle according to which particles can be formed thanks to liquid-
liquid antisolvent, when the processed compound is soluble in the 
solvent and not soluble in the antisolvent. An expanded liquid solution 
formed by supercritical carbon dioxide (SC-CO2) and an organic, 
water miscible solvent, is produced, in which a solid solute is 
solubilised. Then, the solution is depressurized into a water solution in 
which the solute is not soluble: the water based solution works as a 
liquid antisolvent and nanoparticles are produced. 
The particles size of the precipitates depends on the efficiency of the 
micromixing between the two liquids that, in turn, is related to their 
surface tension. The continuous injection of an expanded liquid 
solution improves the mixing with the antisolvent thanks to the 
reduced surface tension of the expanded liquid, thus producing smaller 
particles. The SAILA process will be validated and feasibility tests 
will be conducted for the production of polymeric nanoparticles. A 
systematic study of the operating parameters will be done with the 
attempt of postulating a possible mechanism of particle formation. 
Furthermore, the applicability of this process to several different 













VI.1 SEE-C process 
The increasing interest in advanced controlled release formulations and 
the combination of their characteristics provide the increasing potential of 
supercritical fluids technology in the pharmaceutical industry. The 
preparation of controlled release formulations using supercritical fluid-
assisted techniques offers several unique features such as the ability to 
perform the process in a single stage without any exposure of the products to 
the external environment, the ease solvent removal, the use of high-grade 
stainless steel equipment and the inherent sterilizing effects, low handling 
and disposal expenses (York P., 1999). Furthermore, the supercritical fluid 
technology may facilitate the development of significant improvements in 
the efficiency of both currently marketed drugs and new therapeutic entities.  
Recently, Supercritical Emulsion Extraction (SEE) has been proposed in 
literature for the production of particles with controlled size and distribution, 
starting from oil-in-water (o-w) and water-in-oil-in-water (w-o-w) 
emulsions. In this process, SC-CO2 has been proposed for the selective 
extraction of the oily phase of emulsions, obtaining the polymer hardening 
and microspheres formation. The use of supercritical fluids as extraction 
media is a promising alternative for the formation of microparticles of active 
principles and pharmaceutical excipients. There are two main reasons for 
using this technique. Firstly, the selective solvating power of supercritical 
fluids makes it possible to extract the organic solvent from emulsions and 
produce microspheres. Secondly, the favorable mass transfer properties and 
high solubility of solvents in the supercritical fluid make the solvent removal 
rapid and efficient with low level of residual solvent as requested by the 
authorities. The process layout of SEE has been first proposed by 
Chattopadhyay et al.(Chattopadhyay P. and Gupta R.B., 2003, 
Chattopadhyay P. et al., 2006, Chattopadhyay P. et al., 2007) , obtaining 
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particles of nanometric and micrometric size with narrow particle size 
distribution. Particularly, they used SC-CO2 to eliminate the organic solvent 
from o-w emulsions for the preparation of drug microparticles of megestrol 
acetate, griseofulvin and cholesterol acetate, or for the formation of 
biopolymer particles charged with ketoprofen and indometacin. It has been 
reported that the mean diameter of the particles ranged between 0.1 and 2 
μm and the residual solvent was less than 50 ppm.  
In the apparatus used by Chattopadhyay et al. for the precipitation of 
particles the extraction of the solvent from emulsions was carried out in an 
electrically heated stainless-steel extraction column. The SCF fluid delivery 
system consisted of a liquid CO2 pump which provided SC-CO2 to the 
bottom of the extraction column through a frit. The emulsion was delivered 
from the top countercurrently, using an HPLC pump, and was injected 
through a capillary nozzle, which broke the emulsion into droplets, thereby 
increasing its surface area of contact with SC-CO2. After the contact with 
SC-CO2, an aqueous particles suspension was formed at the bottom of the 
column and removed through a needle valve. The effluent SC-CO2 was 
vented from the top of the column. The pressure inside the column was 
maintained constant using a backpressure regulator valve. 
A different process layout for the extraction of the emulsion organic 
phase using SC-CO2 was also proposed by Della Porta and Reverchon (Della 
Porta G. et al., 2010, Della Porta G. and Reverchon E., 2008). The apparatus 
proposed by Della Porta and Reverchon for the precipitation of particles in 
the supercritical fluid extraction operated in batch mode. The emulsion was 
placed into a cylindrical stainless steel vessel. SC-CO2, delivered using a 
high pressure diaphragm pump, was bubbled into the extraction vessel, 
through a cylindrical stainless steel porous dispenser located at the bottom of 
the extractor. The dispenser maximizes the contact between the two phases 
during the extraction. Temperature was controlled using an air-heated 
thermostated oven. The pressure inside the reactor was controlled by a 
micrometric valve located downstream the extractor. A separator located 
downstream the extractor was used to recover the liquid solvent extracted 
and the pressure in the separator was regulated by a backpressure valve. At 
the exit of the separator, a rotameter and a dry test meter were used to 
measure the CO2 flow rate and the total quantity of CO2 delivered, 
respectively. When the extraction process was complete, the microspheres 
suspension produced was removed from the bottom of the extractor vessel 
for analysis and further processing. 
Mazzotti and co-workers (Kluge J. et al., 2009a, Kluge J. et al., 2009b) 
also proposed the use of SC-CO2 for the production of particles of pure 
PLGA and PLGA loaded with lysozyme or ketoprofen through supercritical 
fluid extraction of emulsions. Particles with average sizes ranging between 
0.1 μm and a few μm with very narrow size distributions were produced. In 
the layout proposed by Mazzotti and co-workers for supercritical fluid 
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extraction of emulsions CO2 was drawn from a dip tube cylinder and pre-
cooled in a pressure module before being delivered to the reactor by a piston 
pump. The stream then passed a backpressure regulator above the desired 
reactor pressure, to reduce stream fluctuations generated by the piston pump. 
The emulsion was delivered to the reactor by an HPLC pump. Both streams 
were mixed at the inlet of the reactor in a two substance nozzle. The reactor 
was kept at the operating temperature by a thermostat. The particles were 
formed by solvent extraction from the organic emulsion droplets and 
remained suspended in the continuous water phase throughout the whole 
process. The product suspension accumulated at the bottom of the reactor 
was withdrawn through an outlet at the bottom of the reactor. The off-gas 
stream left the reactor through an outlet at the top. The pressure inside the 
reactor was controlled by a backpressure regulator located downstream, 
through which the off-gas stream was expanded to atmospheric pressure and 
was vented. 
It has been shown that the average size of particles is clearly related to 
the average size of droplets in the original emulsion. The size of the 
emulsion droplets mainly depends on the mixing rate or the degree of 
homogenization and the concentration of surfactant or polymer. Generally, a 
high degree of homogenization, higher concentrations of surfactant and 
lower concentrations of polymer tend to produce smaller droplets. Therefore, 
precipitation of particles with different sizes can be accomplished by varying 
the emulsion formulations and by optimization of the solvent-surfactant 
system.  
The SCF-based emulsion extraction is beneficial compared to the 
traditional emulsion evaporation/extraction. Indeed, SEE process combines 
the advantages of traditional emulsion based technology, namely control of 
particle size and surface properties, with the advantages of supercritical fluid 
extraction process, such as higher product purity and shorter processing 
times. Due to the enhanced mass transfer of SC-CO2, this process has a 
relatively faster extraction rate compared to other conventional techniques 
(processing in minutes instead of several hours) and, thus, adds to the 
formation of relatively smaller particles with narrow size distributions. In the 
SEE process, microparticles aggregation phenomena are not observed, due to 
the presence of the external water phase, immiscible with SC-CO2, which 
prevents their aggregation. High product purity and low content of residual 
solvents may be achieved at the same time, at moderate operating 
temperatures and with reasonable CO2 consumption. One of the major 
limitation of the SEE process, in these discussed configuration, is that the 
process remains intrinsically discontinuous, sharing this inconvenient with 
traditional solvent evaporation/extraction processes. Indeed, a batch of 
emulsion can be treated for each run with problems of repeatability of the 
batches and reduction of the process yield, due to the material lost. For this 
reason Della Porta and Reverchon (Della Porta G. et al., 2011b) suggested 
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also the possibility of a continuous process layout (SEE-C) where the SC-
CO2 is continuously contacted with an O/W emulsion in a column to extract 
the organic solvent without interacting with dispersant phase. At the bottom 
of the column, a suspension of microstructured particles can be continuously 
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In biomedical and pharmaceutical field, particles ranging between 100-
500 nm are generally indicated as nanoparticles (De Jong W.H. and Borm 
P.J.A., 2008) though more restrictive definitions assume smaller dimensions 
as the limit for nanoparticles production (Reverchon E. and Adami R., 
2006). The development of such microdevices poses a serious challenge, due 
to the lack of robust manufacturing techniques, that can provide particles 
with predictable and controllable size distribution, composition and 
structure. They have also to conform to rigorous requirements of product 
consistency, purity and process scalability (Chattopadhyay P. et al., 2006). It 
is particularly relevant to produce submicro or nanoparticles with very 
narrow particle size distributions (PSD) since, in that case, fluid dynamic 
and therapeutic behavior of all the particles would be similar to those having 
the mean diameter of the distribution and an ideal performance will be 
obtained. The polydispersity index (PDI) is a parameter that measures the 
dispersion of particles around the mean diameter, it is the ratio between the 
standard deviation (SD) and the mean diameter (MD) of the distribution of 
particles; the lower is the PDI, the sharper is the distribution. An optimum 
condition is reached when PDI is lower or equal to 0.1; in this case the 
system is defined as monodisperse; i.e., all the particulate system can be 
treated as formed by particles of the same dimensions. 
Different conventional methods have been reported for the preparation of 
micro and nanoparticles with different PDI, including dispersion 
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polymerization (Zhang X. et al., 2008), nanoprecipitation (Barichello J.M. et 
al., 1999), solvent evaporation of emulsions (Feng S.S. and Huang G.F., 
2001), spray drying (Vehring R., 2008). These techniques show some 
drawbacks, such as the difficulty in the removal of toxic solvents (Freitas S. 
et al., 2005, Odonnell P.B. and Mcginity J.W., 1997) and low encapsulation 
efficiency (Li M. et al., 2008), batch processing. 
The SEE process has been successfully used for the production of 
microspheres, overcoming most of the common drawbacks of  the 
conventional techniques. However, monodisperse sub-micro, nanoparticles 
of biopolymer suitable for pharmaceutical formulations have not been 
produced until now. 
Therefore, the aim of this part of the work is to demonstrate that SEE-C 
technology can produce very sharp or even monodisperse biopolymer 
submicro or nanoparticles. To obtain this result emulsion formulation 
parameters are tested, such as, surfactant concentration and biopolymer 
percentage in the oily phase, and different emulsification techniques 
(ultrasound or high speed emulsification) and their interactions with SEE-C 
processing are tested to obtain small droplets dimensions from the microsize 
to the nanosize range. Poly-lactic-co-glycolic acid (PLGA), poly-lactic acid 
(PLA) and poly-caprolactone (PCL) are the polymers tested to produce these 
micro and nano devices. SEE-C operative conditions are optimized to 
control the micro and nanodevice sizes and distributions, as well as, the 
solvent residue. The produced particles are characterized by morphology, 
size and poly-dispersity index. 
 
VII.2 Materials and methods 
VII.2.1 Materials 
CO2 (99.9%, SON, Naples, Italy), polyvinyl alcohol (PVA, MW: 30.000–
55.000), acetone (Ac, purity 99.9%), glycerol (GLY, purity 99%) and poly-
caprolactone (PCL, MW: 14.000), were purchased from Aldrich Chemical 
Co.. Poly-lactic acid (PLA, MW: 28.000, Resomer R 203H), PLGA (PLGA, 
75:25 MW: 20000, Resomer RG 752S) were provided by Boehringer and 
used as received.  
 
VII.2.2 Emulsion preparation 
To obtain a stable emulsion using acetone as the oily phase, glycerol was 
added in the external water phase. Indeed, it is known from the literature that 
when acetone, water, and glycerol are mixed, two phases can be formed due 
to phase separation in an appropriate (and relatively narrow) composition 
range; for an emulsion formulation, the ternary mixture composition should 
lie in this region. In a previous work (Della Porta G. et al., 2011a) we 
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verified that the optimal emulsion composition was O:W ratio 20:80 with the 
water phase formed by a solution of aqueous glycerol (20:80 of 
water:glycerol); this emulsion ratio was used also in this work. A known 
amount of polymer (from 1 to 10% w/w) was dissolved into 20 g of acetone 
to form an organic solution. Then, the solution was added into 80 g of 
aqueous glycerol (20/80 w/w) PVA solution to form an emulsion using a 
high-speed stirrer (mod. L4RT, Silverson Machines Ltd. Waterside, 
Chesham Bucks, UK) and in some experiments the emulsion obtained in this 
way was, then, sonicated to reduce the size of the droplets (Digital Sonifier 
Branson mod. 450, ½” diameter micro-tip, 20 kHz, nominal power 400 
Watt). 
80 gr of the prepared emulsion were processed using the SEE-C 
apparatus described in the previous chapter. Conventional Liquid Emulsion 
Extraction (LEE) of the oily solvent was performed for comparison 
purposes. Tipically, the remaining 20 g of emulsion was charged in a beaker 
and the solvent was extracted adding dropwise 60 g of aqueous-glycerol 
(ratio 50:50 water/glycerol), the resulting solution was stirred for 80 min at 
400 rpm; subsequently, 40 g of pure water were added dropwise and the 
extraction was performed at the same stirring conditions for other 100 min. 
Particles were recovered from the suspension by centrifugation at 6500 
rpm for 45 minutes and washed with distilled water. They were then 
recovered by membrane filtration (porosity: 0.1 or 0.4 µm). 
 
VII.2.3 Analytical methods 
The morphology of the produced particles were studied using a  Field 
Emission-Scanning Electron Microscope (FE-SEM mod. LEO 1525; Carl 
Zeiss SMT AG, Oberkochen, Germany). A sample of powder was dispersed 
on a carbon tab previously stuck to an aluminum stub. Samples were coated 
with gold (layer thickness 250Å) using a sputter coater (mod.108 A, Agar 
Scientific, Stansted, UK). Particles size distributions (PSD) were measured 
by dynamic light scattering by using a Malver Zeta Sizer instrument (mod. 
Zetasizer Nano S, Worcestershire, UK). 1 mL of the produced suspension 
was used for each test without any further dilution step.  
Acetone residues in the suspensions were measured to determine the 
efficiency of the SEE process in solvent removal. Solvent residues were 
measured using a head space sampler (mod. 50 Scan, Hewlett & Packard) 
coupled to a gas chromatograph interfaced with a flame ionization detector 
(GC-FID, mod. 6890 Agilent Series, Agilent Technologies Inc). The solvent 
was separated using a fused-silica capillary column 30 m length, 0.55 mm 
internal diameter, 0.1 μm film thickness (mod. DB-WAX). Oven 
temperature in the GC was set to 45°C for 10 min, then 15°C/min until 
150°C. The inlet temperature was set at 250°C, detector at 270°C. Helium 
was used as carrier gas (5mL/min), split mode ratio 1:10. Head space 
Chapter VII 
38 
conditions were: vial temperature 95°C, loop temperature 95°C, transfer line 
temperature 105°C. Head space samples were prepared in 10 mL vials filled 
with 1 mL of suspension. All measurements were performed in triplicates. 
 
VII.2.4 Experimental continuous apparatus description 
Process equipment consists of a high pressure packed column where gas 
and liquid phases (SC-CO2 and emulsion) are contacted counter currently 
and mass transfer between the two phases is improved by the internal 
packing elements.  
A schematic representation of SEE-C process is illustrated in Figure VII. 1. 
 
 
Figure VII. 1 Schematic representation of SEE-C process (Della Porta G. et 
al., 2011a). 
The SEE-C apparatus mainly consists of a 1680 mm long column with an 
internal diameter of 13.11 mm. The column is packed with stainless steel 
packings 4 mm nominal size with 1889 m-1 specific surface and 0.94 voidage 
(0.16-inch Pro-Pak, Scientific Development Company, State College, PA, 
USA), and is formed by five AISI 316 cylindrical sections connected by 4-
port elements. The extraction stages are three. The apparatus is thermally 
insulated by ceramic cloths and its temperature is controlled by six 
controllers (Series 93, Watlow, Milan, Italy) inserted at different heights of 
the column. SC-CO2 is fed at the bottom of the column by a high-pressure 
diaphragm pump (mod. Milroyal B, Milton Roy, Pont Saint-Pierre, France) 
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at a constant flow rate. The emulsion is taken from a reservoir and delivered 
from the top of the column, using a high pressure piston pump (mod. 305; 
Gilson, Villiers-le-Bel, France), at a constant flow rate. Particles formation 
in emulsion is achieved by removal of the internal organic oil phase from the 
emulsion droplets by extraction using SC-CO2. A separator located 
downstream the top of the column is used to recover the extracted “oily” 
solvent and the pressure in the separator is regulated by a backpressure valve 
(26-1700 Series, Tescom, Selmsdorf, Germany). At the exit of the separator, 
a rotameter (mod. N5-2500, ASA, Sesto San Giovanni, Italy) and a dry test 
meter (mod. LPN/S80AL class G2.5, Sacofgas, Milan, Italy) are used to 
measure the CO2 flow rate and the total amount of CO2 delivered, 
respectively. The microspheres suspension is continuously removed from the 
bottom of the extraction column by decompression, using a needle valve 
(mod. SS-31RS4, Swagelok, Brescia, Italy). A detailed representation of the 
SEE-C process layout is reported in Figure VII. 2: 
 
 
Figure VII. 2 Continuous tower diagram: C, CO2 supply; E, emulsion 
supply; PG_1 and PG_2, pressure gauges; SC_P, diaphragm pump used for 
high pressure SC-CO2; L_P, piston pump used for the emulsion; TC1…TC8, 
thermocouples; S, separator; R, rotameter; E_1 and E_2, heat exchangers; 
V_1…V_8, valves (Falco N. et al., 2012) 
The start-up of the extraction process begins delivering SC-CO2 from the 
bottom of the column until the operating pressure is reached. Then, the 
emulsion delivery is started at the top of the column. At the end of each run, 
the column is washed with distilled water to eliminate any processing 
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residue from the packing surface. After the SEE-C experiment, particles are 
recovered from the suspension and separated from the surfactant by 
centrifugation with a large volume of distilled water at a rotation speed of 
4500 rpm for 45 min. Then, the supernatant is discharged and particles are 
re-suspended in pure water, recovered by membrane filtration and dried at 
air for further processing.  
VII.3 Results & discussion 
VII.3.1 Definition of SEE-C operative conditions 
SEE-C operating conditions of pressure and temperature were chosen to 
allow the selective extraction of acetone from the oily phase of the emulsion. 
Considering the high pressure vapor-liquid equilibrium diagram (VLE) of 
the system acetone/CO2 (Sato Y. et al., 2010), that reports the equilibrium  
pressure/composition values at given temperature, the operating point was 
selected above the mixture critical point (MCP); i.e., at a pressure of 80 bar 
for a temperature of 38°C.  This temperature is also compatible with the  
glass transition temperatures of the selected polymers. At these operative 
conditions the solubility of the glycerol-water external phase in SC-CO2 is 
extremely small (Sabirzyanov A.N. et al., 2002, Sovova H. et al., 1997) and 
a selective extraction of the oily phase of the emulsions can be obtained. The 
counter-current operation in the packed column is also favored by large 
density differences between the two phases (liquid and SC-CO2) involved in 
the process, since it allows the counter-current flow inside the column. In the 
case of a supercritical fluid, the lower is the pressure the lower is the fluid 
phase density and the larger is the density difference at a fixed temperature. 
At 38°C and at 80 bar, a large difference in density between the emulsion 
and SC-CO2 is obtained, because densities are about 1 g/cm3 and 0.31 g/cm3, 
respectively. Another important operating parameter, to be taken into 
account when operating with a continuous extraction tower, is the liquid to 
gas ratio (L/G). Difficult separations are characterized by a very low L/G 
ratios; it means that high quantities of SC-CO2 are necessary per unit of 
liquid treated to obtain the desired extraction efficiency (Brunner G., 2009). 
However, it is not possible to decrease freely the L/G ratio since, when very 
large flow rates of the gas stream are used, the liquid is entrained by the gas 
and flooding occurs determining the failure of the process. In our  case, L/G 
ratio was fixed at 0.1, as a consequence of a previous optimization of the 
tower fluid dynamics (Falco N. et al., 2012). A CO2 flow rate of 1.2 kg/h and 
an emulsion flow rate of 2.3 mL/min were used according to the previous 
discussion.  
Another relevant process parameter in the continuous operation is the 
time required to obtain steady state conditions in the column. Indeed, during 
the continuous operation, mass transfer between the two phases is activated, 
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but, variations in the top and bottom product composition can be observed 
until steady state conditions have been obtained. Therefore, the SEE-C 
performance evaluations were always performed after reaching the steady 
state conditions. This initial phase of the process is also important to wet the 
column packing with the surfactant, that favors particles slipping on the 
packing surface. Indeed, the use of packed towers is commonly not 
suggested for processes involving the presence of a solid phase that could  
cover the packing surface, producing a reduction of the mass transfer and, 
then, the blockage of the column. However the dimensions of the 
microparticles produced in this work are always in the micronic or 
submicronic range; therefore, tend to remain suspended in the falling liquid 
film inside the column.  
Operating in this manner, also very low solvent residues (less than 500 
ppm) were measured in the recovered suspension, that are significantly 
lower than those that can be found after the conventional liquid emulsion 
extraction (LEE) (Della Porta G. et al., 2011a). Since the scope of this part 
of the thesis work is to produce submicro and nanoparticles of controlled 
size and distribution, some different emulsification procedures were also 
tested such as high speed emulsification coupled to ultrasonication steps, 
varying surfactant concentration and type and biopolymer content in the oily 
phase.  
 
VII.3.2 PCL: Effect of sonication 
The first emulsion parameter tested was the addition of a sonication step 
to the preliminary high speed emulsification. A synthesis of the results 
obtained is reported in the top part of Table VII 1. Since the preliminary 
stirring was very intense, when the emulsion with no sonication was 
processed by SEE-C, near monodisperse PCL particles were obtained (PDI ≈ 
0.1); but, the mean size of the particles dispersion was too large for the target 
of this study (MD = 619). Therefore, experiments with different sonication 
amplitudes and duration were performed. The mean diameter of the PCL 
particles was rapidly reduced to about one half with respect to the previous 
tests: 342 nm, operating at an amplitude of 30% for 1 min; but, the PDI 
increased to 0.16. A possible explanation is that the mechanical energy 
dissipated in the O/W system contributed to the breakage of the droplets, but 
gave also a contribution to the entropy of the system that was not counter 
balanced by a larger stability of the surfactant layer on the surface of the 
droplets. When, sonication amplitude and duration were furtherly increased, 
the mean size of the resulting particles was very similar to the one of the 
previous experiment (around 330 nm); but the PDI decreased to 0.11 for two 
minutes and to 0.10 for 60% amplitude sonication and 1 minute 
emulsification. It means that the length of the emulsification and the larger 
quantity of energy put in the starting emulsion, did not give a further 
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contribution to droplet diameters reduction, but contribute instead to 
surfactant layer stabilization. The best results in this series of experiments is 
obviously the one that give the smaller PDI producing monodisperse 
nanoparticles (60% amplitude sonication and 1 minute emulsification). 
In this part of the work some liquid extraction (classical) tests (LEE) 
were also performed on the  PCL emulsions previously discussed. The 
comparison between SEE-C and conventional results is reported in Figure 
VII. 3 and, as expected, the PSD obtained by LEE is moved to larger 
particles and the particle size distribution is enlarged, when compared to the 
corresponding results obtained by SEE-C. 
 
Table VII 1 Mean Diameter (MD) and poly-dispersity Index (PDI) of 
various biopolymers. O/W emulsion ratio 20:80; oily phase: Results 
obtained by LEE are also reported for comparison*.  
 










PCL 1 1 --- ---- 619 0.10 
1 1 30 1 342 0.16 
1 1 30 2 332 0.11 
1 1 60 1 328 0.10 
5 1 30 1 342 0.19 
10 1 30 1 761 0.25 
1 0.6 30 1 864 0.15 
1 1 30 1 360 0.16 
1 2 30 1 263 0.12 
1 3 30 1 292 0.10 
1 4 30 1 294 0.12 
PLGA 1 1 30 1 212 0.10 
5 1 30 1 761 0.25 
PLA 1 1 30 1 233 0.07 
5 1 30 1 241 0.07 
PCL* 1 1 30 1 710 0.30 
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Figure VII. 3 Particle size distribution of particles suspensions obtained by 
SEE-C and by liquid emulsion extraction technology (LEE).  
 
VII.3.3 PCL: effect of polymer percentage in oily phase 
Another parameter that can influence the size of the droplet/particle 
dimensions of an emulsion is the content of solute in the disperse (oily) 
phase. Therefore, some experiments of emulsification plus continuous 
supercritical drying were performed using the base emulsion conditions and 
increasing the percentage of PCL from 1 to 10% w/w in acetone. Examples 
of the results obtained are reported in Figure VII. 4, where PCL 
microparticles from 1 and 10% w/w emulsions are shown. In both cases, non 
coalescing spherical particles were obtained; but, while at 1 % w/w PCL 
nanoparticles with a sharp PSD were obtained, operating at 10% w/w PCL 
submicro particles with MD of 761 nm were produced. It is clear that the 
increase of PCL percentage adversely affect either the diameter, either the 
PDI of the produced particles; the variation of this second relevant property 




(a) MD: 342 nm; PDI: 0.16 nm (b) MD: 761 nm; PDI: 0.25 nm 
 
Figure VII. 4 SEM images of PCL nano and micro-particles obtained at 
different polymer concentration in the oily phase: (a) 1% w/w (b) 10% w/w 
and processed by SEE-C. 
VII.3.4 PCL: effect of surfactant quantity 
A series of experiments were performed, starting again from the base 
case, and modifying the surfactant (PVA) content from 0.6 to 4% w/w in the 
continuous water based phase. The results shown in Table VII 1 demonstrate 
that up to a 2% w/w content, PVA largely reduces the mean size of the PCL 
particles; then, (up to 4% w/w) an asymptotic value of both MD and PDI is 
obtained. These results are reported in Figure VII. 5 andFigure VII. 6. 
Figure VII. 5 shows the comparison, not only in terms of MD, but reporting 
the whole quasi-Gaussian distributions obtained in these experiments. 
Figure VII. 6 reports the MD against the PVA% in water and the asymptotic 
behaviour that originates at PVA% between 1 and 2% is evidenced. 
However, PDI in presence only of a large % of PVA, remains near the 
borderline of monodispersity (PDI≈0.1); i.e., the increase of PVA content 
does not induce a larger/uniform stabilization of the emulsion droplets 
around the mean value of the distribution. This effect is somewhat 
unexpected since it should be attended that a larger quantity of surfactant 
could allow the disperse phase to organize more uniformly: the larger 
availability of surfactant molecules should produce very similar droplets 
characterized by the same number of surfactant molecules around the oily 
droplet.  
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Figure VII. 5 Particle size distribution of the PCL suspensions obtained at 
different PVA concentrations in water phase (% w/w). 














Figure VII. 6 Mean Diameter of PCL nanoparticles obtained at different 
PVA concentrations (%, w/w), as surfactant of the water phase 
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VII.3.5 PLGA and PLA: effect of polymer percentage in the oily 
phase 
PLGA and PLA nanoparticles were also prepared. Different emulsion 
formulations were tested and processed by SEE-C fixing the biopolymer 
concentrations percentage at 1 and 5% w/w, in oily phase, respectively and 
the PVA concentration in the external water phase at 1% w/w; the sonication 
amplitude used was of 30% for 1 min. The results of this part of the study 
are also summarized in Table VII 1, in terms of MDs and PDIs of the 
produced nanoparticles. PLGA showed a very large increase of MD and 
PDI, with a MD variation from 212 nm (PDI 0.10 nm) to 761 nm (PDI of 
0.25 nm) varying the PLGA content from 1 to 5% w/w, respectively. On the 
contrary, PLA was practically insensitive to this parameter, in the same 
range explored. Indeed, PLA particles with mean diameters of 240 nm and 
PDI of 0.07 nm were produced in both cases. This effect is well evidenced in 
Figure VII. 7 a-b and Figure VII. 8 a-b where, SEM images of the PLGA 
and PLA, nanoparticles are reported, respectively, with the same 
enlargement. From Figure VII. 7 a-b, it is possible a qualitative evaluation 
of the increase of the MD and PDI, when the PLGA concentration was 
varied from 1 to 5% w/w; whereas, the two images reported in Figure VII. 8 
a-b confirmed the absence of an evident size difference between the PLA 
nanoparticles, produced at different polymer concentration. Moreover, in the 
case of PLA, a PDI values of 0.07 was always obtained. Why PLGA and 
PLA based emulsions shown this different behaviour with the polymer 
percentage variation and, particularly, why PLA was insensitive to this 
parameter? We excluded an effect of the molecular weight of the two 
polymers because the weights used are very close (see methods section). A 
possible explanation can be the different (equilibrium) solubility of the two 
polymers in acetone; therefore, if PLA is largely more soluble than PLGA 
(and PCL), its percentage variation used in the present work could not 
influence the droplet formation and could justify also the smallest PDI 
observed. As a consequence, we may also conclude that, fixed the others 
parameters of emulsion formulation, when the oily phase is prepared as a 
diluted system, the polymer concentration will not more influence the 
droplet dimension and monodispersed nanoparticles can easily be obtained. 
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(a) MS: 212 nm; PDI: 0.13 (b) MS: 761 nm; PDI: 0.25 
Figure VII. 7 SEM images of PLGA nanoparticles obtained at different 
polymer concentrations in the oily phase by SEE-C: (a) PLGA in oily phase 
of 1% w/w (b) PLGA in oily phase of 5% w/w. Other emulsion data: oil-in-
water emulsion, PVA 1% w/w; ultrasounds operating at amplitude of 30% 
for 1 min.  
 
  
(a) MS: 233 nm; PDI: 0.07 (b) MS: 241 nm; PDI: 0.07 
Figure VII. 8 SEM images of PLA nanoparticles obtained at different 
polymer concentrations in the oily phase by SEE-C: (a) PLA in oily phase of 
1% w/w (b) PLA in oily phase of 5% w/w. Other emulsion data: oil-in-water 
emulsion, PVA 1% w/w; ultrasounds operating at amplitude of 30% for 1 
min.  
VII.4 Conclusions 
SEE-C technology confirmed the possibility of the continuous fast 
processing of emulsions, eliminating the problems of droplets coalescence 
and solvent residues. As a consequence, the nanoparticles obtained showed 
diameters and distributions very near to that of the corresponding droplets in 
emulsion and it was possible to work directly to the optimization of the 
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droplets size and distribution to produce nanoparticles with a strictly control 
of their PDI. This target was not simple to be obtained and only the 
optimization of several emulsion processing parameters together with SEE-C 
operative conditions allowed the production of monodisperse or near 
monodisperse nanoparticles of the various polymers processed. Different 
polymers also shown different behaviors to the emulsion formulation 
parameters; indeed, different PLGA concentrations in the oil phase 
generated very different MDs and PDIs of the particle; whereas, in the case 
of PLA processing, the size of the nanoparticles obtained was not really 
sensitive to this parameter. The observed phenomenon could be only slightly 
related to the polymers molecular weight (that were almost similar), but 
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Proteins possess small half-lives and are not capable to diffuse through 
biological membranes. Their instability in the stomach and intestine makes 
oral delivery of these drugs difficult. Alternative administration by frequent 
injections is also tedious and expensive. Therefore, the development of 
biodegradable polymeric microspheres has been seen as a promising way to 
overcome the administering problems of these macromolecules (Yang Y.Y. 
et al., 2000). A vehicle is needed capable of encapsulating proteins, 
minimizing the mechanisms of degradation and maximizing the in vivo 
activity, and providing controlled release that can be delivered via parental 
administration is needed. 
Proteins and GFs controlled release from particulate devices has been 
widely reported in the literature (Determan A.S. et al., 2004). Frequently, 
these delivery systems were based on natural polymers, such as gelatin and 
alginate (Park H. et al., 2005, Gu F. et al., 2004). Particulate systems based 
on these polymers are able to encapsulate GFs with minimum loss of 
bioactivity of the encapsulated molecule. However, they lack the capacity to 
provide long-term release, particularly when formed as nanoparticles. These 
limitations can be overcome by particulate systems based on biodegradable 
polyesters (i.e., PLA, PLGA) (Slager J. and Domb A.J., 2002). 
Protein and GFs encapsulation in biodegradable polyesters microspheres 
is still a challenging task due to stability issues occurring during 
microsphere-processing, shelf-life and protein release. Techniques to entrap 
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protein in biopolymeric microspheres are all joined by the common aim of 
realizing experimental conditions as mild as possible (Freitas S. et al., 2005, 
Sinha V.R. and Trehan A., 2003).Indeed, few sustained release therapeutic 
protein products based on biodegradable polymers have received FDA 
approval due to the inherent instability of proteins when they are exposed to 
the conditions normally encountered during microparticle fabrication using 
conventional techniques. Other problems encountered are low encapsulation 
efficiencies and high burst release of the drug. For many therapeutic proteins 
achieving an acceptable dose volume (i.e., high drug content) while 
maintaining satisfactory release kinetics (i.e., minimal burst, acceptable 
duration) represents a very significant formulation challenge (Zheng C.-H. et 
al., 2004).  
The SEE-C technology has a great potential regarding the field of protein 
encapsulation thanks to the mild extraction condition and the short process 
time.  
For these reasons, the objectives is to demonstrate that it is possible to 
apply the SEE-C to the production of biopolymeric micro and nanoparticles 
encapsulating peptides and proteins starting from double emulsion. Bovine 
serum albumin (BSA) has been selected as model protein while Vascular 
Endothelial Growth Factor (VEGF) and Bone Morphogenetic Proteins BMP 
has been used as peptide. 
 
VIII.2 Materials and Methods 
CO2 (99.9%, SON, Naples, Italy), polysorbate (Tween 80, Aldrich 
Chemical Co.), Ethylacetate (EA, purity 99.9%, Aldrich Chemical Co.), 
distillate water, PLGA (50:50 MW: 38,000 Da, Resomer RG 504H; 
Boehringer, Firence, Italy), PLA, (MW: 28.000 Da, Resomer R 203H, 
Boehringer, Firence, Italy) were used as received. Bovine pancreas albumin 
(BSA, purity 99.9%) was obtained by Sigma-Aldrich Co. (Milan, Italy), h-
VEGF (recombinant) and h-BMP-2 were supplied from PeproTech. 
 
VIII.3 Emulsion preparation and SEE-C operative conditions 
w-o-w emulsions for the encapsulation of BSA (w-o-w ratio: 
1.5:28.5:170 w/o/w) were prepared using 1mL of water/PVA solution 
(0.04% w/w of PVA), as internal water phase, in which BSA was dispersed 
at 0.5% w/w, that was added into polymer/EA solutions (1-10% w/w of 
PLGA or PLA) and sonicated using the Digital Sonifier Branson (mod. 450, 
½” diameter micro-tip, 20 kHz). The primary w-o emulsion was, then, added 
into water Tween80 (0.6% w/w Tween80) solution to form the secondary 
emulsion using a high-speed stirrer (mod. L4RT, Silverson Machines Ltd., 
Waterside, Chesham Bucks, UK). w-o-w emulsions for the encapsulation of 
VEGF and BMP were produced following the same procedure described 
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above, adding in the water internal solution of BSA and PVA the VEGF and 
BMP at a concentration of 10µg/mL. 200 mL of emulsions were prepared 
each times and processed with the SEE-C technique. 
The extraction condition were 80 bar 38°C, liquid to gas ratio L/G 0.1. 
Before feeding the emulsion, the tower was conditioned with 30 mL of 
Tween80 aqueous solution, then was fed the emulsion. The bottom products 
recovered at different times were collected and mixed together. At the end of 
each run, particles  suspension was washed several times by centrifugation 
with distilled water, recovered by membrane filtration, and dried at air 
 
VIII.4 Droplets and Particles Morphology and Size Distributions 
Field Emission-Scanning Electron Microscope (FE-SEM, mod. LEO 
1525; Carl Zeiss SMT AG, Oberkochen, Germany) was used to study the 
morphology of the produced microspheres. A sample of powder was 
dispersed on a carbon tab previously stuck to an aluminum stub. Samples 
were coated with gold (layer thickness 250Å) using a sputter coater 
(mod.108 A, Agar Scientific, Stansted, UK). Droplet size distributions 
(DSD) and particle size distributions (PSD) of microparticles were measured 
by dynamic light scattering (DLS, mod. Mastersizer S, Malvern Instruments 
Ltd., Worcherstershire, UK). PSD and DSD of nanoparticles were measured 
by DLS  using a Malver Zeta Sizer instrument (mod. Zetasizer Nano S, 
Worcestershire, UK).  
 
VIII.5 Protein loading determination  
The amount of BSA loaded into the microspheres was monitored using 
the procedure described by Bilati et al.(Bilati U. et al., 2005a). Briefly, 10 
mg of dried microspheres were dissolved in 600 µL of acetonitrile in 
centrifuge tubes and sonicated until the complete transparency of the 
solution. Then, 1400 µL of water containing 0.1% TFA (0.1% aqueous TFA 
solution) were added dropwise to the corresponding centrifuge tube to 
dissolve BSA. The remaining undissolved polymer was separated by 
centrifugation at 2000 rpm for 2 minutes. The resulting clear supernatant 
solution was directly analyzed at room temperature by HPLC (model 1200 
series; Agilent Technologies Inc.) equipped with a LiCrosphere C18 column 
(250×4.6 mm), packed with 5 µm particles size of 100 Å pore size. The 
mobile phase was composed of acetonitrile/water mixture (32:68 v/v) 
containing 0.1% v/v TFA. The flow rate was 0.9 mL/min, the injection 
volume of the test sampled was 40 µL and the detecting wavelength was 214 
nm. The amount of BSA in solution was calculated by means of a calibration 
curve and then converted in the effective BSA loading as the amount (mg) of 
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BSA charged in microspheres (g). Encapsulation efficiency (EE) is the ratio 
of the final BSA loading to the nominal one. 
 
VIII.6 Results and discussion 
VIII.6.1 BSA encapsulation study 
Micro and nanoparticles of PLGA and PLA loaded with BSA were 
produced using a double emulsion w/o/w  with a water internal phase with 
different BSA (2.5-5 mg/mL) and PVA (0.04% w/w). All the data related to 
experiments shown in this chapter are reported in Table VIII. 1. In the case 
of microparticle production, the oily dispersed phase was formed by a 
polymer solution in ethyl acetate at 10% w/w. The water external phase was 
formed by water saturated with ethylacetate plus Tween80 as surfactant 
(0.6% w/w). The primary emulsion w/o was obtained by ultrasonication. 
Then the primary emulsion was added to the external water by a rotative 
system at 3300 rpm for 6 minutes. The emulsion prepared was processed 
with the SEE technique. Optical image of the emulsion prepared with 10% 
PLA and BSA loading 2.5 mgr/gr of polymer is reported in Figure VIII. 1, 
where also SEM image of particles obtained after the supercritical extraction 
is reported. The emulsion is stable with well defined droplets. Particles 
obtained after the solvent removal are spherical and non coalescing. DSD 
and PSD are compared in the same graph in Figure VIII. 1. After the SEE 
process it is typical a shrinkage of the DSD due to the removal of the 
solvent, thus final PSD is always smaller and narrower than DSD, as also 
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Table VIII. 1 Sample description of experiment discussed in this chapter. 
PSD data and efficiency of recovery (%) are also reported. SEE opetarive 
conditions: 80 bar, 38°C, L/G 0.1 
 
Sample Description D10; D50; D90 (µm) Recovery% 
F2 PLGA 10%  BSA 2.5 mg/g 





BSA 2.5 mg/g 
VEGF 10 µg/g 
D10 1.6; D50 2.7; 




BSA 2.5 mg/g 
BMP 10 µg/g 





BSA 2.5 mg/g 
VEGF 10 µg/g 
BMP 10 µg/g 
D10 1.3; D50 2.7; 
 D90 4.9 
90% 
F7 PLGA 5% BSA 5 mg/g 
D10 0.1; D50 0.4;  
D90 1.1 
95% 
F8 PLA 5% BSA 5 mg/g 
D10 0.2; D50 0.3; 
 D90 0.8 
90% 
F9 PLA 10% BSA 5 mg/g 
D10 0.8; D50 1.9;  
D90 4.1 
90% 
F10 PLGA 10% BSA 5 mg/g 

































Figure VIII. 1 Optical image of the emulsion and SEm image of particles 
obtained after the SEE process (PLGA 10%, BSA 2.5 mg/gr). DSD and PSD 
are also reported for comparison. 
 
PLGA microparticles were charged with different BSA loading to study 
the effect on the encapsulation effcincy. BSA 2.5 mg/g and 5 mg/g was 
charged with respect to the polymer. SEM images of particles obtained after 
the SEE process are reported in Figure VIII. 2 where also cumulative PSD 
are plotted together for comparison. Particles with a mean size around 2.5 
µm are obtained indipendtly from the BSA loading.  In both cases spherical 
and not aggregated particles are obtained after the SEE process. 
Furthermore, high recovery of particles has been obtained, as shown in 
Table VIII. 1. 
Microparticles of PLA were also produced for the encapsulation of BSA, 
to investigate the behaviour of another important biopolymer commonly 
used for controlled drug delivery. Results are shown in Figure VIII. 3, for 
the case of BSA loading of 5 mg/g of polymer. Emulsions produced were 
both stable with non coalescing droplets, no great changes in DSD were 
observed when the two different polymers were used, as also shown in the 
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optical microscope images of the emulsion of sample F9 (PLA 10% in the 
oil phase) and F10 (PLGA 10% in the oil phase). Smaller particles has been 
produced in the case of PLA (MD 1.88 µm) see Table VIII. 1 and Figure 
VIII. 3, thus a larger shrinkage effect has been reported in the case of sample 
F9. This result can be explained considering the different molecular weights 
of the polymer tested. PLA used has a lower molecular weight of PLGA, 
thus smaller particles can be expected due to the reduced viscosity of the oil 




BSA 2.5 mg/g  
 
Different BSA loading 
 
BSA 5 mg/g 
 
Figure VIII. 2 SEM images and PSD of particles of PLGA microparticles 




























Figure VIII. 3 Optica images and SEM images of emulsions and particles 
produced with 10 % of PLA (F9) and PLGA (F10) and BSA loaded at 
concentration of 5 mg/g. 
 
Also submicro particles of PLA and PLGA were produced; the oily phase 
was formed by a polymer solution in ethyl acetate at 5% w/w. The primary 
w/o emulsion was obtained again by ultrasonication. Then, it was added to 
the external water phase by a rotative system operating at 6000 rpm for 6 
minutes. At the end the final emulsion was sonicated again at 30% amplitude 
for 2 minutes. Examples of FE-SEM images of nanoparticles of PLGA and 
PLA with BSA loading of 5 mg/gr of polymer obtained after SEE-C 
processing are reported in Figure VIII. 4, respectively.  
 
 






Figure VIII. 4 SEM images of submicroparticles obtained with PLGA (F7) 
and PLA (F8) at a concetration of 5% w/w in the oil phase and BSA loading 
of 5 mg/g. 
Submicroparticles with a MD around 350 nm were obtained using  a 
lower amount of polymer and different emulsification conditions (i.e. speed 
and ultrasonication). All the samples prepared with this technique  
 
VIII.6.2 GF encapsulation study 
Microparticles of PLGA loaded with GFs were produced using the same 
emulsion described in the case of BSA encapsulation in PLGA 
microparticles; a double emulsion w/o/w was used in which in the internal 
water phase at the aqueous solution of BSA (2.5 mg/mL) was added 20 
ug/mL of VEGF (F3), or BMP (F4) and BMP/VEGF in the ratio 1/1. BSA 
also acts as stabilizing and protecting agent for the growth factor. The oil 
phase was composed of a polymeric solution in ethyl acetate at 10% w/w of 
PLGA. The water external phase was formed by water saturated with 
ethylacetate plus Tween80 as surfactant (0.6% w/w). The primary emulsion 
w/o was obtained again by ultrasonication. Then the primary emulsion was 
added to the external water phase and the emulsion was obtained agitating 
the system at 3300 rpm for 6 minutes. 
Figure VIII. 5 shows optical images of the emuslions obtained and 
corresponding SEM images of particles obtained after SEE process. Samples 
with only BSA loaded (F2) is also reported for comparison. The process is 
very reproducible, very similar emulsions were obtained in all the cases and 
consequenlty particles with an omogeneuos and reproducible PSD were 
produced as shown also in Figure VIII. 6. Particles with mean diameters in 
the range 2.4-2.7 µm were obtained as also shown on Table VIII. 1. in 










Figure VIII. 5 Optical images and SEM images of PLGA particles 
encapsulating GFs 
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Figure VIII. 6 Cumulative undersize PSD of PLGA microparticles 
suspensions encapsulating GFs 
 
VIII.6.3 PLGA microspheres charged with GF for steam cells 
differentiation 
PLGA microspheres loaded with GFs were charged inside a bioactive 
alginate scaffold to monitor the effect of the local release of these biosignals 
on cells differentiation. This part of the thesis was developed in 
collaboration with the University of Meriland where samples were sent for 
cell differentiation study. Human Mesenchimal Steam Cells (h-MSC), where 
used in view of the fact that they are a promising cell source for bone tissue 
engineering. Alginate beads were recovered from dynamic and static culture 
at different time points (1st, 7th, 21st and 28th days). The immunoassay 
analyses confirmed always a better cells differentiation in the bioreactor with 
respect to the static culture and revealed a greater influence of the BMP-2 
released in the scaffold on cell differentiation. 
 
VIII.7 Conclusions & Perspectives  
SEE was successfully applied for the production of micro and 
nanospheres of PLGA and PLA PAMs encapsulating protein and peptides. 
Thanks to the mild SEE operating conditions the functionality of the 
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encapsulated bioactive molecules was preserved. Indeed, PLGA-PAMs 
loaded with GFs were charged in bioactive alginate scaffolds. The ability of 
a bioactive living scaffold with a locally controlled release of GFs to 
enhance the growth and differentiation of h-MSCs cultivated in a dynamic 
system by a tubular perfusion bioreactor system bioreactor was 
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Titanium Dioxide nanoparticles 
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Supercritical Emulsion 
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Titanium oxide (TiO2), in form of nanoparticles, is one of the most 
important pigments and fillers used in painting, coating, packaging, 
biological and medical applications. Nano-TiO2 particles are chemically 
stable, relatively nontoxic and  environment friendly. It is well known that 
using UV illumination on TiO2 nanoparticles in aqueous solution it is 
possible to generate reactive oxygen species (ROS), such as hydroxyl 
radical, hydrogen peroxide, that allow the decomposition of some organic 
compounds (Chowdhury D. et al., 2005) Therefore, nano-TiO2 based 
suspensions, attracted a large interest for biomedical applications (Song M. 
et al., 2006), in the so called photodynamic therapy (PDT) of cells and 
bacteria, that is one of the most promising anticancer therapies under 
investigation (Harada Y. et al., 2011, Szacilowski K. et al., 2005, Cai R.X. et 
al., 1992).  
In terms of photocatalytic applications, the anatase crystalline form of 
titania has been reported to present the best combination of photoactivity and 
photostability and, consequently, it has been preferred for this kind of 
processes.  
Titania powders generally are obtained directly from titanium-bearing 
minerals or by precipitation from solutions of titanium salts or alcoxides 
(Mahshid S. et al., 2006). However due to high density and surface 
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properties of TiO2 nanoparticles, there are some drawbacks in their colloidal 
stability, such as particles agglomeration and sedimentation2. Thereby, to 
enhance the dispersion stability of TiO2 nanoparticles, several methods of 
polymer encapsulation have been proposed to resolve this problem. 
However, encapsulation should maintain the photoactivity of the produced 
microspheres; therefore, the selection of the preparation process and of the 
polymer are relevant parameters for a successful application.  
Traditional techniques have been until now not particularly successful in 
the efficient production of TiO2 loaded polymeric microspheres (De Oliveira 
A.M. et al., 2005, Park J.H. et al., 2007, Rong Y. et al., 2005a, Rong Y. et 
al., 2005b). SCFs based processes applied in this field, have been not 
particularly satisfactory in the case of RESS (Kongsombut B. et al., 2009); 
whereas, SEE has never been applied to TiO2 encapsulation (Furlan M. et al., 
2010).  
Therefore, the aim of this part of the work is to try the production of 
photoactivable, biodegradable and nanostructured PLA/TiO2 sub-
microparticles using SEE-C process. Anatase type nano-TiO2 has been 
synthesized by precipitation from solutions of titanium alcoxides. Two 
different kind of emulsions were tested: water in oil in water emulsion 
W/O/W and solid in oil in water emulsion S/O/W. In the first case, a nano-
TiO2 ethanolic stable suspension was used as the water internal phase of the 
emulsion; whereas, in the second case TiO2 fine powder was directly 
dispersed in the oil phase. Particles produced where characterized in terms of 
morphologies, TiO2 loading and dispersion in polymer matrix. Furthermore, 
the photocatalytic activity of pure TiO2 and nanostructured PLA/TiO2 
particles were tested using bacterial killing assay under UV irradiation. 
 
IX.2 Materials, apparatus and methods 
IX.2.1 Materials 
CO2 (99.9%, SON, Naples, Italy), polysorbate (Tween 80, Aldrich 
Chemical Co.), ethyl acetate (EA, purity 99.9%, Aldrich Chemical Co.) 
poly- (lactic) acid (PLA, MW: 28.000, Resomer R 203H) were used as 
received. 
 
IX.2.2 Production of TiO2 nanoparticles 
TiO2 nanoparticles were prepared using a microwave process. Briefly, 2 
mL titanium (IV) propoxide (Sigma-Aldrich, 97%) and 30 ml of absolute 
ethanol (Panreac, analytical grade) were mixed under magnetic stirring; then, 
3 mL of acetic acid (Panreac) were added. After 5 min under magnetic 
stirring, 5 mL of deionised water were added and at the end the mixture was 
poured into an autoclave that was sealed and heated up in a microwave oven 
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(Ethos Plus) up to 120ºC for 15 min. The final solid was isolated by 
centrifugation and thoroughly washed with ethanol several times. The 
washed particles were diluted with ethanol to a final concentration of 12 
mg/mL, whereas for the production of  dry powder, washed particles were 
dried at 80ºC.  
 
IX.2.3 Emulsion preparation 
Two different kind of emulsions were prepared: double emulsion water in 
oil in water (W/O/W) and solid in oil in water (S/O/W). For the preparation 
of the double emulsion, an ethanolic stabilized suspension of TiO2 
nanoparticles (12 mg/mL) was used as the water internal phase W1. The 
suspension was sonicated at 40% (Digital Sonifier Branson mod. 450, ½” 
diameter micro-tip, 20 kHz, nominal power 400 Watt) of the power for 1 
min, immediately before its utilization, to allow the complete dispersion of 
TiO2. The oil phase was prepared dissolving 1 gr of PLA in 20 gr of ethyl 
acetate. The primary emulsion W1/O was obtained adding 1 mL of W1 in the 
oil phase and sonicating at 40% of the power for 30 seconds. The sonication 
was repeated twice. Then the primary emulsion was added to 80 gr of the 
water external phase W2 ( 1% Tween 80 solution in water saturated with 
ethylacetate). The secondary emulsion was obtained by high speed stirring at 
7000 rpm for 6 min (mod. L4RT, Silverson Machines Ltd. Waterside, 
Chesham Bucks, UK). The W1/O/W2 emulsion obtained was furtherly 
sonicated to reduce droplets mean size (60% for 30 seconds, repeated twice). 
When the S/O/W emulsion was prepared a known amount of TiO2 powder 
was directly dispersed in to the oil phase, prepared as previously described. 
The dispersion (S/O) of the powder in the oil phase was obtained with 
sonication at 60% for 60 sec. The S/O/W emulsion was prepared adding the 
S/O suspension in to 80 gr of water external phase, prepared as previously 
described and emulsifing at the same condition described above.  
 
IX.2.4 Supercritical emulsion extraction process 
The emulsions prepared where processed using the SEE process. The 
detailed description of the experimental apparatus is reported elsewhere. The 
operative condition in terms of pressure and temperature are selected 
considering the vapor-liquid equilibrium diagram of solvent-CO2 system. In 
the case of ethyl acetate-CO2 the condition were fixed at 80 bar 38°C to 
operate above the mixture critical point (MCP). Another operative condition 
is the ration between the liquid and the gas (L/G ratio). This value is 
generally selected taking in to consideration the flooding phenomana. In this 
work the L/G ratio was fixed at 0.1, as optimized in previous works (Della 
Porta G. et al., 2011b).  
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IX.2.5 Particle characterizations 
Emulsions and corresponding suspensions obtained after the SEE process 
were characterized by particle size distribution (PSD) dynamic laser 
scattering (DLS) using a Nanosizer (NanoZS Malvern Instrument, UK) 
equipped with a He–Ne laser operating at 4.0 mW and 633 nm, to measure 
the hydrodynamic diameter of the particles. Particles were recovered from 
suspensions by membrane filtration (membrane porosity 0.1 µm) and dried 
at air. Particles morphology and approximate composition was observed 
using field emission-scanning electron microscope (FESEM, mod. LEO 
1525, Carl Zeiss SMT AG,Germany), coupled with an energy dispersive X-
ray spectroscopy (EDX, INCA Energy 350, UK). Transmission electron 
microscopy (TEM) was also used to characterize PLA/ TiO2 nanoparticle 
composites. X-ray photoelectron spectroscopy (XPS…) was used to obtain a 
surface chemical analysis of the nanoparticles obtained. Encapsulation 
efficiency was obtained with  thermogravimetric analysis (TGA), as the 
residue remaining after the total combustion of the polymeric component of 
the particles. The sample was placed in alumina crucibles and heated up to 
600 °C at a rate of 10 °C/min, under a constant air flow of 5 N cm3/min).  
 
IX.2.6 Photocatalitic reaction and bacterial viability assay 
A colony of Staphylococcus Aureus was suspended in 50 mL of tris-
buffered saline (TBS) solution and incubated for 24 h at 37°C. A 109 
CFU/mL bacterial suspension was obtained and further diluted to obtain 107 
CFU/mL bacterial concentration. 
In the photocatalitic experiments, the protocol reported by Tsuang et al. 
2008 (Tsuang Y.H. et al., 2008) was used. Briefly, stock aqueous PLA/TiO2 
suspensions (10 mg/mL) in deionized water were prepared immediately prior 
to the photocatalitic reaction and kept in the dark. Washed bacteria 
(approximately 107 CFU/mL) were resuspended in deionized water. Aliquots 
of 1 mL stock aqueous PLA/ TiO2 suspension were added in a 50 mL glass 
beaker containing 8 mL of sterilized deionized water and 1 mL of washed 
cells. The PLA/TiO2 slurry was placed on a magnetic stir plate with 
continuous stirring and was illuminated with 40 W black light bulb. The 
peak wavelenghth of the bulb was 365 nm. Samples were exposed to UV 
light for 5 hours. 
Loss of viability was determined by viable count procedure. The 
PLA/TiO2 bacterial slurry was exposed to UV light with continuous stirring. 
A Staphylococcus Aureus suspension without TiO2/PLA particles was 
illuminated as a control, and the reaction of PLA/TiO2 -bacteria slurry in the 
dark was also carried out. Samples were taken and the viable count was 
performed on agar plates after serial dilutions of the samples in sterilized 
PBS. All plates were incubated at 37°C for 24 h. 
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IX.3 Results and discussion 
IX.3.1 TiO2 nanoparticles production 
The XRD spectrum of the synthesized nanoparticles (Figure IX. 1) 
shows that microwave synthesis produce material with good crystallinity and 
all the characteristic lines attributed to the anatase phase (JCPDS Bº 2000) 
even at 110 ºC. The strongest peak was observed for the (1 0 1) reflection at 
25.2 º. Prominents peaks were also observed for  (0 04), (2 0 0 ) and (2 11 ) 
reflections. No extra peaks were detected indicating the absence of rutile or 
brookite phases. The crystallite size of the obtained material calculated by 
Scherrer equation wasestimated of 7 nm 
The morphology and particle size distribution of the synthesized 
nanoparticles was studied by electronic microscopy. TEM images revealed 
the formation of prismatic particles with mean size of 15±5 nm and narrow 
particle size distribution. The difference between TEM and XRD obtained 
sizes would indicate that each nanoparticle is formed by several crystallites.  
 




















Figure IX. 1 TEM image and XRD diffraction patterns of the microwave 
synthesized nanoparticles 
IX.3.2 PLA/TiO2 nanoparticles production: effect of emulsion 
formulation and titanium loading 
Composites nanoparticles PLA/TiO2 were prepared using the SEE-C 
technique. W1/O/W2 and S/O/W emulsions where used for the preparation of 




In the SEE processing the dimension of particles is directly connected 
with the dimension of the droplets in the emulsion. For this reason a direct 
control over droplet size distribution (DSD) in the emulsion is preliminary 
required.  
In the case of the double emulsion, emulsification parameters were 
changed to find the best condition for the production of droplets, and 
consequently of the particles, in the range 100-300 nm. In details, the 
ethanolic TiO2 suspension was sonicated at 40% of the power for 1 min, 
immediately before the preparation of the emulsion to allow the complete 
dispersion of TiO2. The primary emulsion W1/O was obtained adding 1 mL 
of W1 in the oil phase and sonicating at 40% of the power for 30 seconds. 
The sonication was repeated twice. Then, the primary emulsion was added to 
80 g of the water external phase W2 (1% Tween 80 solution in water 
saturated with ethylacetate). The secondary emulsion was obtained by high 
speed stirring at 7000 rpm for 6 min. In the attempt to produce smaller 
particles, the W1/O/W2 emulsion was furtherly sonicated to reduce droplets 
mean size (60% for 30 seconds, repeated twice). In Figure IX. 2 SEM 
images of particles produced with and without the final sonication step are 
reported. It is possible to note that particles are spherical and not aggregated 
in both cases; this result can be attributed to the fast and efficient extraction 
obtained operating with the continuous counter-current high pressure 
column.  Microparticles with a mean diameter (MD) of 0.9 µm  (Figure IX. 
2 (a)) were obtained  when weaker emulsification process was used; i.e., 
when the final sonication step was not applied; whereas sub-microparticles 
with MD of 265 nm (Figure IX. 2 (b)) with a narrower PSD were produced 
applying  the final emulsification using the sonication probe. For this reason 
the final sonication was always applied for all the other experiments reported 
in this work.  
 
  
(a) 0.9 µm ± 0.5 (b) 265 nm ± 69 
Figure IX. 2 Micro and nanoparticles of PLA+TiO2 produced changing 
emulsion preparation parameters (TiO2 1.2% w/w). 
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Once fixed the emulsification conditions, W1 volume was changed (1, 2 
and 3 mL) to produce different TiO2 theoretical loadings, respectively 1.2, 
2.4 and 3.6% w/w of TiO2 with respect to the polymer content. Table IX. 1 
reports all the particle size data of emulsions and particles discussed in the 
following. 
 
Table IX. 1 Mean diameter (MD) and Standard Deviation (SD) of droplets 
in emulsions and of composite particles produced after SEE processing, 
shrinkage factor % between droplets and particles mean diameter and TiO2 
theroretical and effective loading.  SEE operative conditions were: 80 bar, 



















T1* 1.2 85.42 1241±558 909±499 26 
T2 1.2 85.00 450±139 203±40 55 
T3 2.4 90.42 498±129 265±69 47 
T4 3.6 97.22 1214±582 559±263 54 
S/O/W  
T5 1.2 91.67 320±58 205±33 36 
T6 2.4 90.21 315±108 179±34 43 
T7 3.6 86.67 296±100 193±60 35 
 
* Produced without final sonication step. 
 
Increasing the volume of the W1 phase and, consequently, TiO2 %  a 
significant increase of particle mean diameters and of PSD has been 
observed, as shown in Table IX. 1 and Figure IX. 3 where PSD expressed in 
terms of volume% are reported. In conclusion, increasing the volume of the 
water internal phase, larger water droplets are obtained in the primary W-O 
emulsion, that results in the production of larger particles and in the 
enlargement of the PSD. The smallest particles were obtained in the case of 
1.2% TiO2 theoretical loading, in this case nanoparticles with a MS of 




























Figure IX. 3 PSD of PLA/TiO2 particles obtained starting from W1/O/W2 
emulsion with different W1 volume phase. 
The same TiO2 theoretical loading with respect to the polymer (1.2, 2.4 
and 3.6%w/w) was obtained directly suspending titanium powder in the oil 
phase. Results are shown in Table IX. 1 (lower part) and in Figure IX. 4 
where SEM image of particles produced with the S-O-W(b) is compared 
with that of particles produced with the W-O-W emulsion (a). The figure 
proposes SEM images of PLA particles with 1.2% w/w of TiO2 at the same 
enlargement; it is evident that both the emulsions led to the production of 
spherical non coalescing particles; no relevant changes in the morphologies 
of the PLA particles produced can be noted. Furthermore very small 
particles were obtained in both cases, with MD around 200 nm, as also 




Figure IX. 4 SEM images of particles produced starting from W1/O/W2 (a) 
and S/O/W (b) emulsion with 1.2 % titanium theoretical loading. 
Figure IX. 5 reports the PSDs of the experiment obtained starting from 
S-O-W emulsions, with different TiO2 theoretical loading; data are also 
reported Table IX. 1. From Figure IX. 5 it is possible to note that there is a 
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weak effect of TiO2 loading on the mean diameter of the particles obtained,  
that is always around 200 nm. But, increasing TiO2 content there is a more 
evident enlargement of the PSD. Also in this case, the increase of the TiO2 
theoretical loading produce higher polidispersity. 


















Solid in Oil Emulsion
TiO2 1.2%
 
Figure IX. 5 PSD of PLA/TiO2 particles obtained starting from S/O/W 
emulsion with different S loading 
Comparing the particles obtained using the two different emulsions, S-O-
W emulsions produce particles with smaller diameters and narrower PSD.  
In the case of W-O-W emulsion the increase of nano-TiO2 theoretical 
loading implies the consequent increase of the water internal phase, that has 
a larger effect on MD, then the increase of powder content used in the S-O-
W to increase the nano-TiO2 loading.  
 
IX.3.3 Nanocomposite characterization: TGA, EDX, XPS, TEM 
PLA particles were further characterized to evaluate the efficiency of 
TiO2 encapsulation inside polymeric particles and to verify if an 
homogeneous dispersion of the nanoparticles in to the polymeric matrix was 
obtained. For this reason a first EDX analysis was performed, to evaluate if 
TiO2 was encapsulated in nanospheres. Results are reported in Figure IX. 6, 
for the experiments with 3.6% theoretical TiO2 loading obtained starting 
from a W1/O/W2 emulsion (Figure IX. 6 (a)) and from a S/O/W emulsion 
(Figure IX. 6 (b)). TEM and CrioTEM images of the related samples are 
also reported in the same image. EDX spectra show that TiO2 is present in 
the samples, in both cases proposed. TEM micrographs also show that TiO2 
nanoparticles are inside the particles. Furthermore the TEM images show 
another important results: in the case of particles produced starting from the 
double emulsion, TiO2 nanoparticles are encapsulated in the polymeric 
matrix and also well dispersed inside it; whereas, particles obtained starting 
from the S/O/W emulsion show a non homogeneous distribution of TiO2 in 
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the polymer matrix and it is sometimes possible to see particles formed only 
by the polymer. Therefore, W1/O/W2 emulsion gives the better results in 
terms of distribution of metal oxide nanoparticles in the polymeric 
nanospheres. Therefore, the use of nano-TiO2 directly as ethanolic stabilized 
suspension as water internal phase gives the best results; in the S-O-W 
emulsion TiO2 tends to aggregate probably due to the low viscosity of the 
polymeric oil phase (PLA used has low molecular weight and apparent 
viscosity). Another important information that has been obtained from XPS 
analysis, is reported in Table IX. 2. X-ray photoelectron spectroscopy (XPS) 
is a quantitative spectroscopic technique that measures the elemental 
composition by irradiating a material with a X-rays beam while 
simultaneously measuring the kinetic energy and number of electrons that 
escape from the top 1 to 10 nm of the material analyzed; the result is a sort 
of map of the elements that form the surface of the material. Analyzing 
results of Table IX. 2, it is possible to note that nanoparticles produced 
starting from double emulsion behave completely different from those 
obtained starting from S/O/W emulsion. Indeed, particles produced starting 
from W1/O/W2 emulsion show TiO2 dispersed also on the surface, and the 
content of TiO2 on the surface increases with the increase of the theoretical 
loading; whereas, particles produced starting from S/O/W emulsion have 
low TiO2 content on the surface, as also confirmed by TEM images.  
(a) 
   
(b) 
   
 
Figure IX. 6 TEM and CrioTEM images of PLA/TiO2 particles and EDX 
spectra of related samples; (a) T4 sample, (b) T7 sample.  
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Table IX. 2 X-ray photoelectron spectroscopy (XPS) results related to 
PLA/TiO2 nanoparticles, surface compositions are reported in % 
 Sample C (%) O (%) TiO2 (%) 
W1/O/W2     
 T1 65.86 33.87 0.27 
 T2 68.74 30.95 0.31 
 T3 68.61 30.92 0.47 
 T4 68.57 30.70 0.73 
S/O/W     
 T5 69.23 30.59 0.18 
 T6 68.09 31.71 0.20 
 T7 68.82 30.01 0.17 
 
A possible explanation is that the tendency of water internal phase to 
migrate towards the water external phase allows a better radial distribution 
of nano-TiO2 in the polymeric spheres in the case of W/O/W emulsion.  
The effective loading was also calculated for all the samples by TGA.  
Figure IX. 7 reports the corresponding  thermogravimetric curves and the 
effective loading, correspensing encapsulation efficiency are reported in 
Table IX. 1. Looking at the results reported in  
Figure IX. 7 it is possible to conclude that the encapsulation efficiency 
(defined as effective loading/theoretical loading ratio) is always high ≈90%; 
better results are obtained using the double emulsion. The explanation can be 
that the viscosity of the oil phase used in this work is not high enough to 
avoid TiO2 settling and aggregation. For this reason S-O-W emulsions give 








Double Emulsion Solid in Oil Emulsion 
 
Figure IX. 7 Thermogravimetric analysis (TGA) results for nanoparticles 
produced starting from double emulsion and solid in oil emulsion. The 
effective loading is also reported. 
 
From Table IX. 1 and  
Figure IX. 7 it is evident that an increase of encapsulation efficiency is 
obtained increasing the TiO2 theoretical loading in the case of double 
emulsion, whereas a practically constant encapsulation efficiency is obtained 
increasing the TiO2 theoretical loading in the case of S/O/W emulsions; in 
this case the increase of the TiO2 content does not produce an improvement 
of the encapsulation efficiency due to problems of suspension instability in 
the oil phase. 
IX.3.4 Staphylococcus Aureus loss of viability under TiO2 
photocatalitic reaction 
Until now we have seen that TiO2 has been efficiently dispersed in PLA 
particles usingthe SEE technique, but the key characterization is related to 
the photoactivity of the produced materials.  
Photocatalitic activation of PLA/TiO2 nanoparticles was tested under UV 
light and quantified with the determination of Staphylococcus Aureus loss of 
viability. First TiO2 nanoparticles alone were tested following the protocol 
previously described in Materials and Methods section. When S. Aureus was 
treated with TiO2 powder under UV light, a considerable loss of viability was 
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observed, as reported in Figure IX. 8; about 98% of the cells were killed, 
with respect to the initial concentration, after 5 hours of UV irradiation. A 
control was always performed (the sample without TiO2 particles was 
exposed to the same UV irradiation) and no relevant change in survivor cell 
number was observed. 
When PLA/TiO2 particles were tested (results for sample T2 and T5 are 
reported in the same Figure), the same loss of viability was obtained as in the 
case of pure TiO2, indicating that the encapsulation of the metal oxide 
nanoparticles in the biopolymeric matrix does not affect photocatalitic 
activation of TiO2 particles; but, however increase their biocompatibility; 
therefore,  devices that are in situ activated and biocompatible are obtained. 
At the concentration of the powder tested, no relevant changes in results 























Figure IX. 8 The viability of bacteria under various TiO2 photocatalitic 
reaction 
 IX.4 Conclusions 
It has been demonstrated that SEE-C can be successfully used to produce 
PLA/TiO2 nanostructured particles. Higher encapsulation efficiencies were 
obtained with the respect to the  related literature, thanks to the fast and 
efficient extraction of the oily phase of the emulsions. The double emulsion 
W/O/W gave the most promising results, allowing the production PLA 
particles with a homogeneous TiO2 dispersion in the polymeric matrix.  
The photocatalitic activity of the nanostructured carriers was not reduced 
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Light-sensitive drug delivery systems (DDS) are receiving increasing 
attention owing to the possibility of developing materials sensitive to 
innocuous radiation (mainly UV, visible, or near infrared region) which can 
be applied on demand at well delimited sites  of the body (Barrett C. and 
Mermut O., 2005, Jiang H.Y. et al., 2006). Near infer red (NIR) resonant 
material are receiving increasing interest in this field because NIR light, with 
the range of wavelengths from 650 to 900 nm, has a deep light penetration 
into living tissues and, in this region, hemoglobin, lipids and water have the 
lowest absorption coefficient. Furthermore, NIR is innocuous and does not 
cause a significant heating in the area of its application (Donnelly R.F. et al., 
2005, Mccoy C.P. et al., 2007, Klohs J. et al., 2008).  Hollow Gold 
nanoshells  (HGNs) have attracted increasing interest as NIR resonant metal 
nanostructure for biomediacl applications; they are Gold shells filled with 
the imbedding medium(Xia Y. et al., 2000). In HGNs the ratio of shell 
diameter and thickness (defined as aspect ratio of the nanostructure) 
determines the peak position of the surface plasmon resonance and their 
uniformity determines its bandwidth (Zhang J. and Noguez C., 2008, 
Schwartzberg A.M. et al., 2006).  
The application of HGNs in photothermal therapy has been reported by 
Hirsh at al.(Hirsch L.R. et al., 2003); the authors  demonstrated that 
Silica/Au nanoshell particles could be used to deliver  a therapeutic dose of 
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heat to kill targeted cell without damaging normal cells because of local 
heating. Poly(N-isopropylacryloamine-co-acrylamide)-Au nanoshell 
composites containing methylene blue, ovoalbumine or bovine serum 
albumine (BSA) were synthetized and the drug release form this composites 
was reported to be enhanced by NIR irradiation(Sershen S.R. et al., 2000). 
However, these DDS are not appropriate for drug delivery because of their 
toxicity. Biodegradable multilayer polymer/metal nanoparticles have been 
also proposed in the literature. Rhodamine is encapsulated within PLGA and 
metal multilayers are deposited on these nanoparticles. The authors reported 
that the drug release from PLGA matrix is accelerated by increasing the 
temperature during NIR irradiation. However the physical deposition 
methods yields half-shell of metal layer and the drug is released from the 
remaining non coated surface. This leads to the generation of temperature 
and concentration gradients inside PLGA nanoparticles and considerable 
reduction of the total surface area available for drug release (Park H. et al., 
2008). HGNs were also used to initiate release form liposomes. Indeed, 
liposomes have been evaluated as drug nanocarriers for decades, but their 
clinical applications are often limited by slow release or poor availability of 
the encapsulated drugs y irradiating with NIR pulsed laser HGNs near 
complete release have been obtained within seconds. These DDS do not 
allow the control of the release rate, because when NIR is absorbed and 
converted into  heat the drug is instantaneously released  from the disrupted 
lipid membrane. In conclusion light based approach applied on DDS have 
been demonstrated to be promising but, unfortunately, these studies are still 
in a primordial research stage (Wu G.H. et al., 2008). 
For these reasons the aim of this study is the production of biocompatible 
and biodegradable PLA-HGNs composite devices for photothermal induced 
delivery of Rhodamine, used as model compound. HGNs were synthesized 
by galvanic replacement of Cobalt with Gold using PVP as template 
stabilizing agent. PLA-HGNs-Rhodamine composite delivery devices were 
produced using the Supercritical Emulsion Extraction technique (SEE). 
Rhodamine was dissolved in the aqueous phase of a W/O/W emulsion, 
whereas HGNs were dispersed uniformly in the polymeric organic phase. 
PLA was used as polymer matrix. DDS were characterized in terms of 
morphologies, Rhodamine loading,  HGNs loading and dispersion in PLA 
matrix. Rhodamine release form DDS produced was tested under different 
NIR irradiation conditions.   
 
X.2 Materials, apparatus and methods 
X.2.1 Materials 
CO2 (99.9%, SON, Naples, Italy), polysorbate (Tween 80, Aldrich 
Chemical Co.), ethyl acetate (EA, purity 99.9%, Aldrich Chemical Co.) 
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poly- (lactic) acid (PLA, MW: 28.000, Resomer R 203H), Rhodamine B 
(purity 99.9%) were used as received. 
 
X.2.2 Hollow Gold nanoparticles production 
Hollow Gold nanospheres (HGNs) were synthesized following protocol 
reported by Preciado-Flores et al.(Preciado-Flores S. et al., 2011) with some 
modifications. The synthesis was carried out using air free methods to 
reduce premature oxidation of the cobalt particles. Additionally, all 
glassware that was used was cleaned thoroughly with Alconox®, aqua regia, 
and ultrapure water. In a 500 mL two-necked round-bottom flask, 100 mL of 
ultrapure (18 MU) water was combined with 100 mL of 0.4 M cobalt 
chloride hexahydrate (CoCl2·6H2O) and 400 mL of 0.1 M sodium citrate 
trihydrate (Na3C6H5O7·3H2O). The solution was deaerated by bubbling with 
argon gas for 40 minutes with no magnetic stirring. To that solution, 100 mL 
of 1.0 M sodium borohydride (NaBH4) was injected, and the solution turned 
from a pale pink color to brown over the course of a few seconds indicating 
the formation of cobalt nanoparticles. Simultaneously, 100–900 mL of a 1 
wt% solution of poly (vinylpyrrolidone) (C6H9NO)n, with an average Mw of 
55 000, was injected. The as-formed cobalt nanoparticle solution was further 
deaerated by passing argon through the reaction flask for a further 40 
minutes until the evolution of H2 bubbles ceased, indicating the complete 
hydrolysis of borohydride. Subsequently, 30 mL of the cobalt nanoparticles 
were transferred to a 100 mL beaker and immediately added to a stirring 
solution of 10 mL of ultrapure water and 15 mL of 0.1 M chloroauric acid 
trihydrate (HAuCl4·3H2O), allowing the formation of CoCl2 and the 
reduction of Au3+. The solution was allowed to stir for another five minutes 
under ambient conditions to allow the complete oxidation of any unreacted 
cobalt and a slow change in color from brown to green indicates that the 
formation of hollow Gold spheres was completed. HGNs obtained were 
centrifugated several times and concentrated with liofilization. 
 
X.2.3 Emulsion preparation 
Double emulsion w-o-w were prepared for the production of PLA 
nanoparticles encapsulating Rhodamine (used as a model drug) and HGNs. 
w-o-w emulsion ratio was selected at 1-19-80. The water internal phase (1 
ml) was prepared dissolving Rhodamine in water to a final concentration of 
5 mg/mL. The oil phase was prepared dissolving 1 gr of PLA in to 19 gr of 
ethylacetate. HGNs were dispersed in the oil phase (from 5 to 15 mg) using 
an ultrasound probe at 40% of the power for 1 minute, (Digital Sonifier 
Branson mod. 450, ½” diameter micro-tip, 20 kHz, nominal power 400 
Watt). The ultrasound dispersion was repeated until the suspension became 
stable and homogeneus. The primary emulsion w-o was obtained dispersing 
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1 mL of the water internal phase in the oil phase, the HGNs dispersion in 
PLA solution, using ultrasound emulsification at 40% for 1 minute. Then the 
primary emulsion was added to 80 gr of the water external phase ( 1% 
Tween 80 solution in water saturated with ethylacetate). The secondary 
emulsion was obtained with high speed stirring at 7000 rpm for 6 min (mod. 
L4RT, Silverson Machines Ltd. Waterside, Chesham Bucks, UK). The w-o-
w emulsion obtained was furtherly sonicated to reduce droplets mean size 
(60% for 30 seconds, repeated twice).   
 
X.2.4 Supercritical Emulsion Extraction: apparatus and process 
conditions 
The SEE process allows the production of microparticles and 
nanoparticles extracting the oily solvent of an emulsion. The first step for 
microparticles formations is the production of an emulsion; it can be single 
oil-in-water emulsion o/w and double water-in-oil- water emulsion w/o/w. 
The polymer is generally dissolved in the oil phase, whereas the drug could 
be dissolvent in the oil phase (lipophilic compounds) or in the water internal 
phase (hydrophilic compounds). The emulsion is stabilized by a surfactant. 
In the supercritical conditions CO2 shows good solvent power for the 
majority of organic solvent, and low affinity with water. Thus, selecting 
opportunely the operative conditions it is possible to extract selectively the 
organic solvent of the oil phase, allowing the production of micro and 
nanoparticles. 
The supercritical extraction of the solvent is obtained using a continuous 
counter-current tower, described in details elsewhere (Della Porta G. et al., 
2011a). Looking at the binary vapor-liquid equilibrium diagram (VLE), 
Figure X. 1 (Kato M. et al., 2006), the mixture critical point for the system 
CO2-ethylacetate is at 80 bar and 40°C. In this condition ethyl acetate is 
completely miscible in SC-CO2 and it can be extracted. 
Photothermal controlled release of Rhodamine 
79 

















Figure X. 1 VLE diagram of the system CO2-ethylacetate adapted from 
Kato et al. 2006. 
When operating with continuous counter-current tower with dense gases, 
pressure and temperature conditions are selected from thermodynamic 
considerations (VLE diagram) as previously discussed; instead flow rate 
ratio (the liquid to gas ratio (L/G)) is selected from fluid dynamic 
considerations. In general increasing the gas flow rate there is an increase of 
the extraction efficiency, but it is not possible to decrease freely the L/G 
ratio since, when very large flow rates of the gas stream are used, the liquid 
is entrained by the gas and flooding occurs determining the failure of the 
process. In our  case, L/G ratio was fixed at 0.1, as a consequence of a 
previous optimization of the tower fluid dynamics. A CO2 flow rate of 1.2 
kg/h and an emulsion flow rate of 2.3 mL/min were used according to the 
previous discussion. 
 
X.2.5 Particle characterizations 
Emulsions and corresponding suspensions obtained after the SEE process 
were characterized by particle size distribution (PSD) using dynamic laser 
scattering (DLS) method using a Nanosizer (NanoZS Malvern Instrument, 
UK) equipped with a He–Ne laser operating at 4.0 mW and 633 nm, to 
measure the hydrodynamic diameter of the particles. Data are reported also 
in terms of mean diameters (MD) and polydispersity index (PDI). Particles 
were recovered from suspensions by membrane filtration (membrane 
porosity 0.1 µm) and dried at air. Particles morphology and approximate 
composition was observed using field emission-scanning electron 
microscope (FESEM, mod. LEO 1525, Carl Zeiss SMT AG,Germany), 
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coupled with an energy dispersive X-ray spectroscopy (EDX, INCA Energy 
350, UK). Transmission electron microscopy (TEM….) was also used to 
characterize  nanoparticles. Effective HGNs loading inside PLA 
nanoparticles was evaluated by inductively coupled plasma mass 
spectrometry. 20 mg of nanoparticles were digested in 5 mL of aqua regia 
for 5 days before the analysis.  
 
X.2.6 Rhodamine loading and NIR controlled release  
Rhodamine loading was determined by dissolving a known mass (∼2–5 
mg) of microspheres in 50 µL dimethylsulfoxide. PBS (500 µL) was added, 
and precipitated polymer was removed by centrifugation at 12.000 rpm for 
10 min. The concentration of Rhodamine in the supernatant was determined 
by measuring the absorbance at 550 nm in a multiwall plate 
spectrophotometer (model Cary 50; Varian, Palo Alto, California). 
In vitro release of Rhodamine was determined by resuspending∼20 mg of 
microspheres encapsulating Rhodamine in 2 mL of phosphate-buffered 
saline (PBS, pH 7.4) containing 0.5% Tween. Microsphere suspensions were 
continuously inverted at ∼100 revolutions per minute at 37°C. Samples were 
centrifuged, the supernatant was removed, and the spheres were resuspended 
in fresh PBS at various time points. Rhodamine concentration was 
determined by measuring the supernatant absorbance at 550 nm as described 
above. Rhodamine release was summed with the amounts at each previous 
time point, and the total divided by the amount of Rhodamine in the 
microspheres (experimental loading of microspheres), to arrive at the 
“cumulative percent released. 
When NIR laser was applied using laser generator (Model MDL-H-
808/2W; Infrared Diode Laser at 808 nm power 2W from Changchun new 
Industries Optoelectronics Technology Co., Ltd., Changchun, China) 
samples were incubated at 37°C exposed to NIR irradiation for a period of 
time between 1 and 5 minutes, then samples were centrifuged, and 
Rhodamine concentration in the supernatant was analyzed as described 
above. Temperature profile in the suspension was also measured during 
irradiation. 
 
X.3 Results and discussion 
X.3.1 Phototermally controlled delivery PLA devices production & 
characterization 
Double emulsion w-o-w were prepared for the production of PLA 
nanoparticles encapsulating Rhodamine (used as a model drug) and HGNs. 
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Rhodamine was dissolvend in the internal water phase, while HGNs were 
dispersed in the oil phase. SEE process was used to extract ethylacetate form 
the oil phase of the emulsions. PLA particles produced after SEE process are 
nanocapsules containing inside small droples of the water internal phase; 
HGNs instead are dispersed in the polymer matrix. Four batches of PLA 
devices, with the same Rhodamine loading (0.5% w/w with respect to the 
polymer), were produced in this way. One batch of PLA devices was 
charged only with Rhodamine, while the others were also charged with 
increasing concentrations of  HGNs. All the data related to the samples are 
reported in Table X. 1.  
 
Table X. 1 PSD of samples produced after SEE process. Emulsions were 
obtained: S/O: sonicating at 40% for 1 minute (repeated until stabilization 
of the suspension); W1/O sonicating at 40% of the power for 1 minute; 
W1/O/W2 7000 rpm for 6 min and 60% sonication for 30 seconds, repeated 






(w/w %)  
MD 
(nm) PDI 
G1 0 208 0.17 
G2 0.5 237 0.18 
G3 1.0 227 0.22 
G4 1.5 269 0.21 
 
In all cases, PLA particles produced have a mean diameter around 200-
250 nm. The smallest particles with the narrower PSD were produced when 
only Rhodamine was charged (G1 sample). Increasing the HGN content in 
the oil phase a weak increase of MD and PDI can be noted from data in 
Table X. 1 and also in Figure X. 2, where PSD are reported. About the 
macroscopic aspect, samples produced have a pink color, for the presence of 
Rhodamine inside; increasing the HGNs content in the polymer matrix the 









































Figure X. 2 Frequency PSD curves of PLA-HGNs nanoparticles 
encapsulating Rhodamine with different HGN % in the polymer matrix. 
Photographs of powders obtained are also reported.   
 
 
SEM images are reported in Figure X. 3 for all the samples discussed in 
this section. SEM images show that the SEE technique allows the production 
of spherical and not aggregated PLA nanoparticles. The yield of the process 
(gr of particles recovered after the process/ gr of polymer charged in the oil 
phase) is always >90%. SEM images are reported at the same magnification 
and it can be noticed that samples have more or less the same mean diameter 
and polydispersity, that confirms the data obtained from DLS analysis of the 
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suspensions. The SEE process gives high reproducible results, that are more 
or less independent from the amount of drug and HGNs charged inside. 
 
G1: Rhod 0.5% HGNs 0% G2: Rhod 0.5% HGNs 0.5% 
G3: Rhod 0.5% HGNs 1% G4: Rhod 0.5% HGNs 1.5% 
 
Figure X. 3 SEM images of PLA-HGNs particles encapsulating Rhodamine. 
PLA nanoparticles were further characterized to investigate the efficiency 
of incapsulation of HGNs in the polymer matrix. For this reason a first EDX 
analysis was conducted, to investigate, if HGNs were encapsulated in 
nanospheres, results are reported in Figure X. 4 (b), for the experiments with 
1.5% theoretical HGN loading obtained. TEM images of the related sample 
are also reported in the same image, Figure X. 4 (b). From EDX spectra it is 
evident that HGNs are present in the sample. From this spectra also some 
impurities of HGNs are detected (as Co or Cl), related to the synthesis of the 
HGNs process and confirming the presence of HGNs in the nanospheres. 
From the TEM images HGNs are well visible inside the polymeric spheres, 
and are homogeneously dispersed.  
Quantitative HGNs loadings were evaluated with ICP analysis, 
confirming that the SEE technique allows high loading efficiency, as also 









Figure X. 4 TEM mages of PLA/HGN particles encapsulating Rhodamine 
(a); EDX spectra of related sample (b).  
X.3.2 Rhodamine loading and NIR controlled release from PLA 
particles 
Rhodamine encapsulation efficiency was evaluated according to the 
procedure described in the materials, apparatus and methods section. In all 
cases Rhodamine encapsulation efficiency was around 80% and was not 
affected by the HGNs loading. 
Regarding the study of NIR controlled Rhodamine delivery from PLA-
HGNs devices, first drug release was performed without NIR application for 
all the samples for comparison purposes with the NIR controlled releases. 
Rhodamine release in PBS from PLA nanospheres was completed in about 
10 days, see Figure X. 5 (a), where Rhodamine release is reported in the 
case of spheres with no loading of HGNs. A burst initial release is obtained 
in the first 0.2 days, around 45% of the drug is released immediately. The 
remaining part of the drug, entrapped in the inner polymer matrix  is released 
slowly consequently with the degradation of the polymer. In the same figure 
it is also reported the release of Rhodamine form PLA nanocarrier with 1% 
of HGN loading. The presence of the HGNs does not affect the release when 
NIR is not applied. SEM images reported in Figure X. 5 shows particles 
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after 1 day (b) and at the end of the release (c). After one day of release in 
PBS at 37°C particles maintains their spherical shape while at the end of the 








Figure X. 5 Rhodamine release from PLA nanoparticles; Sample G1 and G3 
results are compared (a); SEM images of particles after one day of release 
(b) and at the end of the release (c) are also reported. 
 
When NIR irradiation is applied to the suspension of PLA nanocarriers 
containing HGNs and encapsulating Rhodamine, what is expected is that 
HGNs, that are resonant nanomaterials, absorb the radiation and convert it 
into heat. This heating effect could speed the Rhodamine release rate 
depending on the power and duration of irradiation and HGN loading.  
The heating effect for different power intensity and for different HGN 
loading in PLA carriers was preliminary studied. Temperature of 
suspensions of PLA nanocarriers during time was monitored when the 
suspension were exposed to NIR irradiation for 5 minutes. Figure X. 6 (a) 
reports heating effects generated when NIR irradiation was performed at 
80% of the power. Suspensions of PLA carriers with different HGNs loading 
where tested and also a blank test was performed exposing to NIR irradiation 
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also pure PBS and suspension of PLA particles without HGNs. With these 
conditions of irradiation there is a weak increase of temperature in the 
suspensions used as a blank (from initial 37°C to final temperature of 
38.5°C, for pure PBS and sample G1); for the suspension prepared with the 
sample G2, with the lowest amount of HGNs (0.5%), the heating effect is 
small considering also the blank test (final temperature reached with 5 
minutes of NIR irradiation 39°C); probably the HGN loading is not enough 
to generate a considerable heating. Increasing the amount of HGNs charged 
in the PLA nanoparticles an increasing heating effect is recorded. In the case 
of HGN theoretical loading of 1% (sample G3 in the figure) maximum 
temperature of 42°C is obtained, while in the case of HGN theoretical 
loading of 1.5% a maximum temperature of 43.5°C was reached in the 
suspension. Increasing the power of NIR irradiation, maintaining the 
exposition time to 5 minutes, an increasing heating effect is obtained Figure 
X. 6 (b). Final temperature around 45-46°C was obtained in samples loaded 
with HGNs. In the case of biomedical application the 80% power irradiation 
is to be preferred because the final temperature reached is compatible with 
human tissue tissues that can resists to a maximum temperature of 42°C 
without degeneration (Field S.B. and Morris C.C., 1983). In the same Figure 
also the temperature decrease in the sample is reported after NIR exposure, 
to understand how the sample lose the heat after the treatment. Higher is the 
final temperature reached larger is the time required by the system to lose the 
heat generated under NIR irradiation. Considering the heating and the 
subsequent cooling of the sample, exposing the suspension to NIR 
irradiation for 5 min a period of temperature variation in the sample is 
generated in the range 15-20 min.   
. 




Figure X. 6 Temperature in PLA nanoparticles suspension during NIR 
irradiation at 80% of the power (a) and 100% of the power (b). NIR 
irradiation 5 min.  
The effect of NIR irradiation condition on Rhodamine release is reported 
in Figure X. 7 in the case of sample G3. Drug release without NIR 
irradiation is also reported for comparison. NIR irradiation was always 
applied after 0.2 hr of release, when the initial fast diffusion of the drug was 
completed, in this way it is better appreciated the effect of NIR irradiation. 
Irradiation were repeated each hour until the complete release of the drug 
was obtained. Concentration of Rhodamine in the suspension was analyzed 
before and after the irradiation. In general, from Figure X. 7, it is possible to 
see that PLA carriers produced in this work respond to NIR irradiation; it is 
possible to control externally the release rate of Rhodamine, changing the 
NIR irradiation conditions.  When NIR is applied Rhodamine release was 
increased considerably. Complete release of the drug was obtained in less 
than one day, while without NIR irradiation the release takes 15 days. Slopes 
of the drug release curves change drastically when NIR was applied (from 
around 5 day-1 without NIR irradiation to several hundred when NIR was 
applied), indicating that a different release mechanisms are involved in this 
case. In details, when NIR was applied with the maximum of the power for 5 
minutes the fastest release was obtained; just to applications of NIR 
irradiation were necessary to release all the encapsulated drug. When 80% of 
irradiation power was used three applications were required to release totally 
the drug when the duration of application was of 5 minutes. When, instead, 
shorter applications were used (2 minutes) the complete release is obtained 
after four NIR irradiations of the suspensions.  

































































 NIR 100%, 5 min
 NIR 80%, 5 min
 NIR 80%, 2 min
 without NIR
 
Figure X. 7 NIR controlled Rhodamine release from PLA particles loaded 
with 1% of HGNs in the polymer matrix (sample G3) 
 
In Figure X. 8 (a) a comparison is reported of different Rhodamine 
release obtained irradiating suspensions of PLA nanoparticles with different 
HGN loading. 80% of the irradiation power was used and applied for 5 
minutes each hour until the complete drug release. From this figure it is 
possible to notice that an increase of the release rate is obtained with the 
increase of the theoretical HGN loading in PLA nanoparticles, as also 
indicated by the slopes of the release curves reported in the same figure. 
Release rates were also plotted performed at different HGNs contents 
(reported in Figure X. 8 (a)); the release rate plot for the sample G2 is 
shown in Figure X. 8 (b). When NIR irradiation was applied a peak of the 
drug concentration in the suspensions was always obtained; for this reason 
each peak of the release rate represents a different NIR application, 
therefore, a pulsatile drug delivery is obtained on demand. This is an 
important results, difficult to achieve otherwise. In the case of PLA 
nanoparticles suspension with the highest HGN loading (1.5%) the complete 
release is obtained after 2 irradiation of 5 minutes, as shown in Figure X. 8 
(a); in the case of 1% and 0.5% HGN loading 2 and 5 applications of NIR 
irradiation are respectively necessary to release totally the drug.  A 
progressive increase of the release kinetic was obtained increasing the HGNs 
loading, probably connected with the larger temperature increase (previously 
discussed and reported in Figure X. 6 (a)).  
In Figure X. 8 (c) and (d) SEM images of sample G4 (PLA nanoparticles 
encapsulating Rhodamine with 1.5% theoretical HGN loading) after first 
NIR irradiation, at the end of the release are reported. Polymer particles are 
partially fused and aggregated; considering all the experimental evidences, 
the most reasonable mechanism of release seems the softening of the 
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polymer shell of the PLA carriers due to temperature increase for 
photothermal  effect. Consequently diffusion of water in the polymer matrix 
is increased and Rhodamine release in the medium accelerates. Thanks to 
these phenomena induced by NIR application, a pulsatile drug delivery can 







Figure X. 8 (a) NIR controlled release of PLA particles with different HGN 
loading and related drug release rate (b) NIR conditions: irradiation at 80% 
of the power for 5 minutes, each application. (c) and (d) SEM pictures of G4 
particles at the end of NIR controlled Rhodamine release release. 
 
X.4 Conclusions 
In this work biocompatible and biodegradable PLA-HGNs 
nanostructured  devices for photothermal induced delivery of Rhodamine 

















































were successfully produced using the SEE technique. Photoactivation of 
Rhodamine delivery from PLA carriers has been demonstrated successfully 
under different NIR exposition conditions, obtaining  a pulsatile delivery of 
the drug when NIR is applied. Considering the experimental evidences 
obtained during this work, the release of the drug during NIR irradiation is 
probably due to the partial softening of the polymer shell of the PLA caused 
by temperature local increase for photothermal effect and consequent 
diffusion of water in the polymer matrix. Thanks to this phenomena, induced 
by NIR application, drug delivery can be induced on demand with release 
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According to what previously stated, nanoparticles of polymers, drugs 
and their co-precipitates are currently investigated to target drugs to specific 
tissues and to overcome internal membranes that are inaccessible to larger 
particulate systems (Salata O., 2004). 
Several methods have been proposed for nanoparticles formation; they 
include solvent evaporation/extraction from emulsions (Feng S.S. and Huang 
G.F., 2001, Li Y.P. et al., 2001, Vila A. et al., 2002), dispersion 
polymerization (Zhang X. et al., 2008, Lee J.M. et al., 2009), supercritical 
antisolvent precipitation (Reverchon E. et al., 1998, Reverchon E. et al., 
2007, Adami R. et al., 2008) , and nanoprecipitation (Barichello J.M. et al., 
1999, Govender T. et al., 1999, Peltonen L. et al., 2002, Jin C. et al., 2008). 
This last method was first developed by Fessi et al.(Fessi H. et al., 1989) and 
it is a simple and reproducible process. It requires two miscible solvents; the 
polymer and/or the drug must dissolve in the first one (the solvent) and to be 
not soluble in the second one (the non-solvent or dispersing phase). 
Nanoprecipitation occurs instantaneously when the primary polymer solution 
is added drop wise to the non-solvent phase. The original nanoprecipitation 
method uses an organic solvent to dissolve the polymer and/or the drug; 
water or a water solution is used as the non-solvent. A modified 
nanoprecipitation method has also been developed using two (or more) 
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organic solvents, as the solvent and the non-solvent; thus extending the 
application field of the process (Bilati U. et al., 2005b). 
Several biopolymers and/or drugs have been processed by 
nanoprecipitation; among the others, PLGA (Poly-lactic-co-glycolic acid) 
(Beck-Broichsitter M. et al., 2010), PMMA (Polymetylmetacrylate) (Aubry 
J. et al., 2009), cellulose acetate (Kulterer M.R. et al., 2011), cyclosporin A, 
indomethacin, valproic acid, insulin, ketoprofen, vancomycin and 
phenobarbital nanoprecipitated with PLGA. Some coprecipitates polymer 
plus drug have also been proposed (Bilati U. et al., 2005a, Zili Z. et al., 
2005, Das S. et al., 2010) 
In this context, until now only a marginal attention has been given to the 
problem of the solvent elimination from the non-solvent phase. The classical 
solvent evaporation technique can fail in the effective removal of solvent 
residues and can induce thermal or stress solicitations on the nanoparticles 
system, producing degradation or coalescence of the product. 
Supercritical extraction processes allows an effective elimination of the 
organic solvents from emulsions (Chattopadhyay P. et al., 2006, Della Porta 
G. et al., 2010). Therefore, the scope of this part of the work was to adapt the 
supercritical fluid continuous emulsion extraction process (SEE) to solvents 
removal from nanoparticles suspensions obtained by nanoprecipitation. 
Suspensions of model biopolymers PCL and PLGA were produced by 
nanoprecipitation, using  solvents like acetone and acetone/ethanol mixtures 
as solvent phase and processed with the supercritical extraction process. 
Different nanoprecipitation condition were tested to evaluate the efficiency 
on the supercritical solvent elimination process. 
 
XI.2 Experimental methods 
XI.2.1 Materials 
CO2 (99.9%, SON, Naples, Italy), Polysorbate (Tween 80, Aldrich 
Chemical Co.), Sorbitan monolaurate (Span 20, Aldrich Chemical Co.) as 
surfactants, distilled water, Acetone (Ac, purity 99.9%, Aldrich Chemical 
Co.) as solvent, Ethanol (Et, purity 99.9%, Aldrich Chemical Co.) as 
cosolvent, Poly(lactic-co-glycolic) acid (PLGA, 75:25 MW: 20000, Resomer 
RG 752S, Boehringer), Polycaprolactone (PCL, MW 14000, Aldrich 
Chemical Co.), were used as received. 
 
XI.2.2 Nanoparticles Preparation 
The polymer was dissolved in 25 mL of acetone or in acetone/ethanol 
mixtures used as the organic solvents,  at concentrations from 5 to 20 mg/mL 
to form the solvent phase; this solution was, then, added dropwise to the 
dispersing phase (50 mL) under magnetic stirring; stirring rate was varied 
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from 400 to 1500 rpm. The dispersing phase was formed by a liquid, water, 
in which the polymer is insoluble: the non-solvent. Both the solvent and the 
non-solvent phase optionally contained a surfactant; in detail, Span 20 and 
Tween 80 were dissolved in the solvent phase and the non-solvent phase at 
0.2%w/w respectively. After the solvent removal, nanoparticles were 
recovered by filtration with a membrane and dried at air. The above 
procedure was always used, unless otherwise stated.  
 
XI.2.3 Conventional Evaporation and Supercritical Fluids 
Extraction Process 
The suspension of nanoparticles prepared according to the illustrated 
nanoprecipitation method, needs a post-processing to remove the organic 
solvent. When the solvent was removed by evaporation, the suspension was 
placed in a 200 mL beaker magnetically stirred at 400 rpm for 2.5 h, at 38°C, 
at ambient pressure. 
When the solvent was removed by supercritical fluid processing, the 
nanoparticle suspension was fed into a packed column for the continuous 
counter-current contact with SC-CO2. A schematic representation of the 
supercritical process layout is reported in  Figure VII. 1 (pag.  38).  
 
XI.2.4 Nanoparticles  morphology, size distributions and zeta 
potential determination  
Particle size distribution and zeta-potential of the suspensions after the 
solvent removal were determined by dynamic light scattering (DLS) using a 
Zetasizer  (mod. 5000, Malvern Instruments Ltd). Mean size and distribution 
was measured three times for each sample. Nanoparticles morphology was 
analysed by FESEM (mod. LEO 1525, Carl Zeiss SMT AG). Samples were 
prepared by cutting a piece of membrane and placing it over aluminium 
stabs. The samples were then coated with a Gold layer (mod.108 A, Agar 
Scientific).  
 
XI.2.5 Solvent Residue Analysis 
Acetone and ethanol residues in the suspensions were measured to 
determine the efficiency of solvent removal. Solvent residues were measured 
using a head space sampler (mod. 50 Scan, Hewlett & Packard) coupled to a 
gas chromatograph interfaced with a flame ionization detector (GC-FID, 
mod. 6890 Agilent Series, Agilent Technologies Inc). The solvent was 
separated using a fused-silica capillary column 30 m length, 0.55 mm 
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internal diameter, 0.1 µm film thickness (mod. DB-WAX). Oven 
temperature in the GC was set to 45°C for 10 min, then 15°C/min until 
150°C. The inlet temperature was set at 250°C, detector at 270°C. Helium 
was used as carrier gas (5 mL/min), split mode, ratio 1:10. Head space 
conditions were: vial temperature 95°C, loop temperature 95°C, transfer line 
temperature 105°C. Head space samples were prepared in 10 mL vials filled 
with 1 mL of suspension.  
 
XI.3 Results and discussion 
XI.3.1 Acetone elimination from PCL water suspensions  
The evaporation of solvents from nanoparticle suspensions prepared by 
nanoprecipitation technique is a very long process and can induce 
degradation of thermolabile compounds or aggregation of the particles (Li 
M. et al., 2008); other purification techniques, such as, high speed 
centrifugation and dialysis can lead to the formation of cakes which are not 
readily dispersible.  In the case of a suspension in an organic solvent, the 
problem could be even more complex: nanoparticles may give coalescence 
that occurs during the progressive replacement of the non-solvent, that 
causes instability of the suspensions. Bilati et al. also reported that 
flocculation can take place during the washing steps with water.  
In this work, we adapted the continuous solvent elimination process 
previously proposed for emulsions extraction. This technique was used until 
now to produce microspheres of biopolymers for controlled drug release, 
starting from emulsions. The process is based on the continuous counter-
current contact between two films (liquid and SC-CO2) in a packed tower; 
the mixing between the fluids takes place on the extremely high surface area 
of the packing; thus the extraction is fast and efficient. In this specific work, 
the tower is used to put in contact the suspension of nanoparticles, freshly 
formed using the nanoprecipitation method, with SC-CO2. 
The operating conditions, in terms of pressure and temperature, were 
chosen from high pressure vapor liquid equilibrium diagrams (VLE) to 
ensure the selective extraction of organic solvents from water based 
suspensions (Chin H.Y. et al., 2008). Considering the VLE diagram of the 
solvent/s to be extracted with CO2, the operating points of the process should 
be typically located over the mixture critical point (MCP). Temperature was 
fixed at 38°C, i.e. at a temperature lower than the glass transition 
temperature of PLGA. Another important operating parameter, to take into 
account when operating with the continuous extraction tower, is the liquid to 
gas ratio (L/G). Difficult separations are characterized by very low L/G ratio, 
it means that high quantities of SC-CO2 are necessary per unit of liquid, to 
obtain the desired  extraction efficiency. Anyway it is not possible to 
decrease freely the L/G ratio; at elevated flow rates of the gas stream, the 
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liquid is entrained by the gas and discharged at the top of the column: this 
condition does not allow proper working of the tower (flooding) and has to 
be avoided (Brunner G., 2009). Based on the previous experiments on this 
process, L/G ratios were varied between 0.05 and 0.2 by weight. 
A first set of the results obtained in terms of acetone residues and 
suspensions stability is reported in Table XI. 1, and is referred to PCL 
nanoparticles in an acetone/water solution. The best results, as expected, 
have been obtained at a low L/G value (0.1), that, as previously explained, 
allows the best contact between the two phases and guarantees the contact of 
a larger quantity of solvent (CO2) with the organic residue. It is also evident 
that an increase of CO2 solvent power, obtained increasing the process 
pressure improves largely the solvent elimination, that (at L/G=0.1), is 
reduced from 967 ppm at 80 bar to 74 ppm at 100 bar, i.e. well below the 
limits imposed for this solvent by current good manufacturing practices (C-
GMP) of the pharmaceutical industry (ICH guidelines for residual solvent). 
It is also worth of note that the nanoparticles obtained at the end of the 





Table XI. 1 Acetone residue after continuous supercritical fluid extraction 
(SFE). CO2 flow rate=1.4 Kg/h. An example of traditional solvent 
evaporation is also reported for comparison (SE). All the suspensions were 
prepared with 0.5% w/w of PCL and at 800 rpm. 





SC1 80 0.2 192±36.5 2700 
SC2 90 0.2 184±34.0 2507 
SC3 100 0.2 203±48.8 176 
SC4 80 0.1 173±32.9 967 
SC5 90 0.1 191±42.0 712 
SC6 100 0.1 187±43.0 74 
SE Time [h] Rpm  
Solvent 
residue [ppm] 
SE1 2.5 400 178±32.1 >3000 
 
The results are also summarized in Figure XI. 1, where it is also possible 
to observe that, when a pressure of 100 bar is used, the solvent residues for 
different L/G ratio are very similar: it means that the increase of the CO2 
solvent power overcomes the influence of L/G ratio. 
In Table XI. 1 it is also proposed the solvent residue of a suspension 
purified by evaporation; this process was performed at 38°C for 2.5 h. A 
higher solvent residue was found. In addition supercritical process does not 
modify particle size distribution, as indicated by PSDs data reported in Table 
XI. 1 and SEM image of PCL nanoparticles recovered after supercritical 
fluids extraction in Figure XI. 2 demonstrates that particles are spherical and 
not aggregated. 
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Figure XI. 1 Acetone residue diagram in PCL nanoparticle suspension for 
different operating pressures and L/G ratios 
 
Figure XI. 2 SEM image of PCL nanoparticles recovered after filtration and 
drying 
XI.3.2 Acetone/ethanol elimination from PLGA water suspensions  
Another possible nanoprecipitation formulation proposed in the literature 
(Tsukada Y. et al., 2009) and here applied, is the precipitation of PLGA 
using a mixture of ethanol plus acetone as the solvent phase. Ethanol is a 
non-solvent for PLGA therefore, its presence should favour the formation of 
smaller particles. For this reason, supercritical solvent  elimination process 
conditions have to be optimized also in the case of acetone/ethanol mixtures. 
The solubility of PLGA in the mixture of solvents decreases increasing the 
ethanol content. First tests on solvent residues were performed using 
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suspensions produced with 0.5% of PLGA in 25 ml of acetone/ethanol 
mixture 50/50 (PLGA does not dissolve in mixtures with higher content of 
ethanol). The effect of pressure and L/G ratio were measured to reduce the 
ethanol content below the Pharmacopoeia limit of 5000 ppm.  
In the case of mixtures of solvents the optimized operating conditions 
used for acetone residues (100 bar, 38°C, L/G 0.1) demonstrated to be not 
useful for elimination (Table XI. 2); even if acetone and ethanol are both 
well miscible in SC-CO2 and in principle can be completely extracted by the 
supercritical fluid. Looking at the VLE diagrams of acetone and ethanol with 
SC-CO2  at 38°C (Chin H.Y. et al., 2008), reported in Figure XI. 3, it is 
possible to note that although the mixture critical point pressure is below 80 
bar and very similar in both cases, the immiscibility region is wider in the 
case of ethanol. This difference could explain the  different results obtained 
using these two solvents: the larger immiscibility hole in the case of ethanol 
can be a signal of a lower affinity between this solvent and SC-CO2. 
 
Table XI. 2 Acetone and ethanol residues after continuous supercritical 
fluid extraction. CO2 flow rate=1.4 Kg/h, temperature 38°C. All the 
suspensions were prepared with 0.5% w/w of PLGA in 25 mL of 
acetone/ethanol 50/50 and at 400 rpm. 









SC7 100 0.1 >20000 85 167±22 
SC8 120 0.1 21680 112 170±31 
SC9 130 0.1 11088 55 162±16 
SC10 140 0.1 6313 38 158±25 
SC11 120 0.05 3862 38 162±28 
SC12 130 0.05 2986 38 167±20 
SC13 140 0.05 1299 31 163±19 
 
To increase solvent power of SC-CO2, pressure was varied in the range 
from 100 and 140 bar. L/G was also reduced to 0.05 reducing liquid flow 
rate.  
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XCO2, YCO2  
Figure XI. 3 VLE diagram of acetone ■ and ethanol ● with SC-CO2  at 38°C  
adapted from Chiu et al.(Chin H.Y. et al., 2008) 
From data reported in Table XI. 2, and from Figure XI. 4 a, it is evident 
that an increase of CO2 solvent power, improves largely the solvent 
elimination. However  also at 140 bar ethanol residues is higher than the 
acceptable limit when operating with L/G ratio of 0.1. But better results were 
obtained when operating at L/G 0.05. In this case ethanol residues are 
always below the acceptable limit. At 140 bar 1299 ppm of ethanol residue 
was obtained, well below the Pharmacopoeia limit. 
We measure also solvent residue for acetone at these pressure and L/G 
and, obviously, acetone residue further reduced (Table XI. 2, Figure XI. 4 
b) with respect to the tests performed at lower pressure (see Table XI. 1).   
To verify if the presence of acetone modified ethanol elimination when 
acetone/ethanol mixtures were tested we also performed experiments on 
ethanol alone in water; no relevant differences were found.  
At this point solvent elimination feasibility has been confirmed; thus, we 
performed further experiments to verify if the other nanoprecipitation 
process parameters like the kind of polymer or different solvents or solvent 
mixtures could influence the solvent elimination. These further results are 




























































Figure XI. 4 Ethanol and acetone residue in PLGA nanoparticle suspension 
for different operating pressures and L/G ratios. 
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XI.3.3 Influence of the nanoprecipitation parameters on the 
efficiency of the supercritical post processing 
The first part of this study has been performed again on PCL dissolved in 
acetone plus small quantities of Span 20 (0.2% w/w), 0.5-2.0% w/w using 
water plus Tween 80 (0.2% w/w), as the non-solvent. Nanoparticles with 
mean size (MS) ranging between about 210 and 360 nm were obtained. Then 
similar  experiments were performed with PLGA using acetone. Again the 
results are reported in Table XI. 3 considering also the presence of mixtures 
acetone/ethanol was considered.  
The photo in  
Figure XI. 5 shows the macroscopic aspect of the suspensions obtained 
after the supercritical extraction process, relative to the PCL nanoparticles 
obtained at three different polymer concentrations 0.5, 1.0 and 2.0% in the 
solvent phase. The samples show the characteristic opalescence formed by 
nanoparticle suspensions, the colour of the suspensions varies from lightly 






Figure XI. 5 Macroscopic aspect of nanoparticle suspensions obtained with 
different PCL content. The polymer percentage in solvent phase is 0.5, 1.0, 
2.0  from the left to the right of the image 
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SEM images reported in  
Figure XI. 6, show the microscopic aspect of the PLGA particles: they 
have a regular spherical shape and their diameters substantially confirm the 
measurements performed using the DLS technique. It is also evident the 
enlargement of the PSD passing from 0.5% to 2.0% w/w concentration.  
 
  
(a)                                                   (b) 
 
Figure XI. 6 SEM images of nanoparticles recovered after filtration  and 
drying. (a): PLGA 0.5%; (b): PLGA 2% 
Looking at Table XI. 3 , it is possible to observe that acetone residue is 
not affected by the kind of polymer processed or by its concentration and 
ranges around 50 ppm,  as expected from the previous optimization of the 
supercritical extraction process. This value is well reproducible and always 
lower then  pharmacopeia limits. Also when the  mixtures of solvents are 
used an efficient solvents removal was confirmed. 
Zeta potential values of the processed suspensions (Table XI. 3) ranged 
between about -18 and -7.84 mV; the suspensions before supercritical 
processing show approximatively the same values, showing that the process 
proposed does not compromise the stability of nanoparticles. The smallest 
nanoparticles were observed for PLGA using 50/50 ethanol/acetone (167 
nm) and the sharpest distribution with a PDI of 0.04 was observed for 
ethanol/acetone 20/80 (Table XI. 3). The supercritical processing 
successfully contributed in preserving the nanoparticles identity.  
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Table XI. 3 Nanoprecipitation conditions of the experiment performed with 
different stirring rate and with different PCL and PLGA content using 
acetone and ethanol/ acetone mixtures as solvent phase and 50 mL of water 
as non-solvent phase. Solvent residue values were measured at the optimized 
processing conditions: 140 bar, 38°C, L/G 0.05. 
  (%w/w) Solvent (mL )  rpm 
MS ±SD 
(nm) PDI [mV] 
 
[ppm] 
SC14 PCL 0.5% 25 mL Ac 
400 255±23.5 0.09 -7.67 
50 800 210±25.2 0.12 -19.9 
1500 230±29.9 0.13 -11.1 
SC15 PCL 1.0% 25 mL Ac 
400 284±25.6 0.09 -11.8 
58 800 273±32.8 0.12 -18.4 
1500 280±56 0.2 -15 
SC16 PCL 2.0% 25 mL Ac 
400 362±54 0.16 -17.2 
52 800 317±57 0.18 -11.8 
1500 320±70.4 0.22 -10.1 
SC17 PCL 0.5% 
25 mL Ac 400 
215±23.6 0.11 -9.97 50 
SC18 PCL 1.0% 248±19.8 0.08 -9.21 55 
SC19 PCL 2.0% 340±57.8 0.17 -7.84 55 
SC20 PLGA 0.5% 
25 mL  





SC21 PLGA 0.5% 
25 mL  





SC22 PLGA 0.5% 
25 mL  






XI.4 Conclusions and perspectives 
A new post processing technology was proposed and successfully applied 
for the removal of the solvents from water based nanoparticle suspensions; it 
takes advantage of the enhanced mass transfer between supercritical CO2 and 
the organic solvents and their mixtures tested were rapidly removed  with 
continuous process. Polymer nanoparticles were successfully processed 
changing nanoprecipitation solvent and process condition.  
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The next part of the thesis work is related to encapsulation of drugs, 
proteins and metal oxides for the production of multifunctional carriers, the 
SEE technique was used for this scope because it allows the highest 






Supercritical Assisted Injection 






There are several of ways to fabricate the nanomaterials. The various 
processes that have been proposed to obtain nanomaterials follow two main 
approaches: “top down” and “bottom up”. Top-down is characterized by the 
production of nanoproducts departing from normal size materials; i.e., 
reducing the dimensions of the original material; for example, using special 
size reduction techniques. The bottom-up approach is related to the 
“synthesis” of nanosized materials, starting from the molecular scale; for 
example, the formation of particles by precipitation from a fluid phase. The 
“widely known” methods to obtain nanomaterials are sol-gel synthesis, inert 
gas condensation, mechanical alloying or high-energy ball milling, high 
pressure homogenization, plasma synthesis, and electrodeposition. 
All these processes synthesize nanomaterials to varying degrees of 
commercially quanlities.  
Thermal methods of making nanoparticles involve the hydrolysis of 
compounds in an oxygen-hydrogen gas flame, but these methods can 
sometimes be undesirable because of the extremely high temperatures 
required for processing (approximately 2000 °C). A much more widely used 
and popular method of manufacturing nanoparticles is the sol-gel processing 
technique. With this technique particles are precipitated using two main 
methods but both involve hydrolysis and then subsequent condensation using 
solvents. Recently, other authors synthesized nanoparticles by directing a 
high-temperature plasma jet of an inert gas onto a particles-containing 
compound, thereby forming vapor and condensing the vapor to form 
nanoparticles (Schultz S. et al., 2002, Schultz S. et al., 2004).  
Mainly, these processes are involved in the production of inorganic 
nanoparticles. However, nanoparticles are also receiving considerable 
attention for the delivery of therapeutic drugs or nutraceutical compounds. 
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The literature emphasizes the advantages of nanoparticles over 
microparticles. The submicron size of nanoparticles offers a number of 
distinct advantages over microparticles, including relatively higher 
intracellular uptake compared with microparticles. Other advantages are high 
stability, high carrier capacity, the feasibility of incorporation of both 
hydrophilic and hydrophobic substances, and the feasibility of variable 
routes of administration, including oral application and inhalation. 
Nanoparticles can also be designed to allow controlled (sustained) drug 
release from the matrix. These properties of nanoparticles enable the 
improvement of drug bioavailability, the reduction of side effects and of the 
problem related to the dosing frequency. This kind of nanoparticles is 
usually produced by techniques such as emulsification-solvent evaporation 
micronization, high-pressure homogenization, solubilization using co-
solvents (Tomasko D.L. et al., 2003).  
The above described processes are well established and widely studied 
but suffer from some drowbacks that, depending on the cases, range from the 
control of particle size distribution to the processing of thermolabile 
compounds. In this prospective, supercritical fluids may provide a way to 
overcome the above-mentioned disadvantages, via innovative processing 
conditions and methods. Indeed, in recent years, the huge interest in 
nanomaterials has also involved supercritical fluid technologies and because 
of the supercritical fluid properties, the use of CO2 may well provide a very 
promising alternative strategy in nanoparticle production (Reverchon E. and 
Adami R., 2006).  
Several supercritical based techniques have been proposed in the 
literature for the production of micro and nanomaterials, since several 
processes can operate in the micronic or in the nanometric domain 
depending on the operating conditions and on the process arrangement.  
Particularly useful for the introduction of the innovative process 
developed during this work, the Rapid Expansion of Supercritical Solutions 
(RESS) process consists of the saturation of the supercritical fluid with a 
solid substrate; then, the depressurization of the solution through a heated 
nozzle into a low pressure chamber produces a rapid nucleation of the 
substrate in the form of very small particles which are collected from the 
gaseous stream. Turk et al. used the RESS process to produce β-sitosterol 
(an anticholesteremic) nanoparticles of about 200 nm mean diameter. They 
also used this process for the production of griseofulvin (an antibiotic) 
nanoparticles using supercritical CHF3 (Turk M. et al., 2002).  Sane et al. 
used RESS to produce fluorinated tetraphenylporphyrin (a photosensitizer 
for photodynamic therapy) spherical, agglomerated nanoparticles with 
average particle sizes from 60 to 80 nm, at different pre-expansion 





Figure XII. 1 RESS equipment concept (Jung J. and Perrut M., 2001) 
The results from RESS experiments suggest that the RESS process 
generally produces micron- or submicron-sized particles (Helfgen B. 
et al., 2000, Kröber H. et al., 2000).For nano-sized particles, it has 
been made a simple but significant modification to the traditional 
RESS by using a liquid solvent or solution at the receiving end of the 
supercritical solution expansion, named the Rapid Expansion of a 
Supercritical Solution into a Liquid Solvent (RESOLV). The 
RESOLV process produces exclusively nanoparticles from a variety 
of materials. For example, cadmium sulfide (CdS) nanoparticles of ~3 
nm in average diameter were prepared by means of RESOLV by 
rapidly expanding a supercritical ammonia solution of Cd(NO3)2 into 
a room-temperature solution of Na2S in water or ethanol (Sun Y.-P. 
and Rollins H.W., 1998). The nanoparticles produced in the process 
could be prevented from aggregating by the presence of a polymeric 
or other protection agent in the receiving solution. It should be noted 
that there was a precipitation reaction accompanying the rapid 
expansion process in the formation of CdS nanoparticles. The same 
RESOLV process with a similar reaction scheme has been applied to 
the production of many other semiconductor and metal nanoparticles. 
These nanoparticles are all small, on average less than 10 nm in 






Figure XII. 2 Schematic RESOLV experimental apparatus (Turk M. and 
Lietzow R., 2004)  
 
The traditional RESS process has been also particularly popular in the 
processing of polymeric materials. Particle formation in RESS from a 
large number of polymeric materials has been reported (Mishima K. et 
al., 2000). For example, Smith and co-workers used RESS to prepare 
a variety of micronsized polymer particles, including polystyrene, 
polypropylene, poly(carbosilane), poly(phenyl sulfone), poly(methyl 
methacrylate), and cellulose acetate. However, formation of nano-
sized particles has apparently not been a focus of the community. 
Instead, much effort has been on an understanding of the RESS 
process for different products, particles versus fibers.  
The rapid expansion in both RESS and RESOLV should probably 
produce nanoscale particles in the absence of any secondary 
processes. Theoretical modeling of the traditional RESS process has 
predicted the formation of sub-50 nm particles upstream of the Mach 
disk in the supersonic free jet region and that the typically observed 
micron-sized particles are from the particle growth processes of 
condensation and coagulation that occur downstream of the Mach disk 
in the transonic and subsonic free jet regions. A similar conclusion 
was reached according to the computational fluid dynamics 
calculation for the RESS processing of a perfluoropolyether diamide 
oil, though the final product was a liquid instead of solid particles 
(Franklin R.K. et al., 2001). In this context, the use of a liquid at the 
receiving end of the rapid expansion in RESOLV probably inhibits or 
disrupts the condensation and coagulation in the expansion jet, thus 
effectively quenching the rapid particle growth processes. In 
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highlighting the RESOLV production of nanoscale polymeric 
particles. 
The production of polymeric nanoparticles through RESOLV may 
conceptually be divided into two somewhat related processes. One is 
the initial formation of nanoparticles in the rapid expansion, and the 
other is the stabilization of the suspended nanoparticles. Evidently, the 
protection of initially formed polymeric nanoparticles represents a 
different set of technical challenges, which are largely independent of 
the rapid expansion process itself, especially if the protection agent is 
added immediately after the expansion. The good news is that many 
methods for stabilizing nanoparticle suspensions are already available 
in the literature, some of which have shown promise in use with 
RESOLV. 
One common limitation of the RESS and RESS-derived technique is 
the limited solubility of most the compounds of interest in the SCFs. 
All these techniques share a solubilisation step in a SCF; but many 
compounds of industrial interest show very limited or negligible 
solubility in SC-CO2, even at high pressure. Therefore, the 
applicability of these techniques is limited and/or their productivity is 
small. One possibility to overcome these limitations is to use an 
expanded liquid; i.e., to form a solution between a liquid solvent and a 
gas. For example, SC-CO2 shows a relevant affinity with almost all 
the organic solvents: the corresponding pressure-composition (p-x) 
diagrams are characterized by a miscibility hole (two phase system), 
but also by regions of the diagram in which large quantities of CO2 
can be mixed with the liquid to form a single phase mixture 
(Reverchon E. and De Marco I., 2011). In this conditions large 
quantity of solute can be solubilised in the expanded liquid solution. 
The basic idea of the new process we have proposed with this thesis, 
is the continuous injection of an expanded ternary solution (SC-CO2-
Solvent-Solute), by depressurization through a nozzle,  directly into a 
second solvent (in which a surfactant can be added)  where the solute 
is not soluble and the organic solvent of the expanded liquid is 
completely miscible; therefore, the receiving solution works as a 
liquid antisolvent.  Operating in this manner, nanoparticles can be 
generated.  
The proposal of SAILA process takes origin from the following 
general considerations: liquid-liquid antisolvent precipitation is 
obtained when the processed compound is soluble in the solvent and 
not soluble in the antisolvent; the particles size of the precipitates 
depends on the efficiency of the micromixing between the two liquids 
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that, in turn, is related to their surface tension (Umemura A. and 
Wakashima Y., 2002). Therefore, the continuous injection of an 
expanded liquid solution should be more effective than the mixing 
with an ordinary liquid. Indeed, expanded liquid are characterized by a 
reduced surface tension that at high gas molar fractions is near to zero 
(Brunner G., 1994); this characteristic should improve the 
micromixing with the antisolvent and produce smaller particles.  
The process developed and proposed with this thesis is named 
Supercritical Assisted Injection in Liquid Antisolvent (SAILA); from the 
review of the state of the art of the supercritical based technique for the 
production of micro and nanoparticles reported in this introduction it is clear 
that the process developed is completely new and brings several conceptual 
innovations to the RESS and RESS-derived technique, from which it takes 
inspiration. First of all the use of an expanded liquid solution instead of a 
supercritical solution used in the RESS technique, which allows to solubilise 
larger quantity of solute, that in principle can also be completely non-soluble 
in SC-CO2, thus enlarging the range of applicability of this process to many 
class of compound not soluble in SC-CO2; second the principle of 
nanoparticles formation is completely different; indeed, it does not evolve 
from the sovrasaturation and precipitation of particles produced during 
expansion of the supercritical solution, as in the RESS technique, but 
sovrasaturation is produced thanks to the solvent-antisolvent effect that takes 
place at the exit of the nozzle. Furthermore, liquid-liquid antisolvent 
precipitation is improved by the reduced surface tension of the expanded 
liquid that enhance the micromixing promoting the fast precipitation of 
particles. If rapid precipitation conditions are achieved during SAILA 
process, compact crystalline structures cannot be formed due to insufficient 
time available for crystal growth. This results in formation of amorphous 
particles (Li X.-S. et al., 2007). Transforming the physical state of drug to 
highly disordered amorphous state increases the dissolution rates (Pathak P. 
et al., 2004, Won D.H. et al., 2005).  
In view of all these innovations of our idea a considerable afford has 
been done to the construction of the most appropriate process layout 
to convert in practice this innovative idea, with the realization a new 
experimental apparatus, for the concept validation. Than a wide 
experimental plane has been done on several different compounds to 
demonstrate the feasibility of the process, to understand the influence 
of the process parameters on particles size distributions and to develop 




XII.2 Experimental SAILA apparatus description 
A schematic representation of the SAILA process layout is reported in 




Figure XII. 3 Schematic representation of the SAILA process layout. CO2: 
Carbon Dioxide reservoir; V1, V2, V3, V4: on-off valves; CB: cooling bath, 
P1: CO2 pump; P2: liquid pump; P3: peristaltic pump SR: solvent reservoir; 
WR: water reservoir; RV receiving vessel 
 
Figure XII. 4 Detail of the saturation-injection of the SAILA process 
apparatus. A: SC-CO2 feeding line; B: Liquid Solution feeding line; C: 
Saturator; D: packing elements; E: heating elements; F: injector; G: non-
solvent receiving phase; H: manometer; I: thermocouple. 
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It mainly consists of two feed lines, used to deliver the compressed 
CO2 (A) and the liquid solvent (B) to a mixing vessel (saturator, C). 
Carbon dioxide is cooled, pumped (P1), preheated and delivered to the 
saturator (C). The liquid mixture formed by the solvent (in which a 
solid solute is dissolved), is delivered to the saturator by a membrane 
pump (P2) and is preheated before the inlet to saturator. The saturator 
is a high-pressure vessel with an internal volume of 0.15 dm3, heated 
by thin band heaters (E) and packed with stainless steel perforated 
saddles with a high specific surface area (D). It provides a large 
contacting surface and an adequate residence time (3-5 min, 
depending on the flow rates) for the liquid-gas mixing. Therefore, an 
efficient, continuous solubilisation of SC-CO2 in the liquid solution is 
obtained. As a result, the two fluids form an expanded liquid, whose 
position in the vapor-liquid equilibrium diagram (VLE) of the system 
CO2-organic solvent depends on the conditions of temperature, 
pressure and on gas to liquid ratio (GLR, here expressed as weight 
ratio). The solution at the exit of the mixer is injected into the 
receiving water phase using an orifice that has a diameter of 80 μm 
and a length to diameter ratio of 6.67. The water phase is continuously 
taken from a reservoir (WR) and pumped with a peristaltic pump (P3) 
in the  receiving vessel (RV); the suspension is continuously 
recovered through a regulation valve (V4), that is also used to 
maintain a constant liquid level in the vessel. 
The CAD project of the plant is also reported in Figure XII. 5. 
 




Specifically, the liquid solution is prepared dissolving a known 
amount of solute in acetone. The receiving phase is formed by a water 
solution containing Tween 80 (0.2% w/w), used as surfactant.  
 
XII.3 SAILA process description and mechanism of particles 
formations 
In the SAILA process particles are mainly produced due to the 
achievement of instantaneous supersaturation thanks to the micromixing of 
solvent and antisolvent obtained with the injection of the expanded liquid in 
the antisolvent solution.  
 
XII.3.1 Role of the antisolvent 
The precipitation of nanoparticles proceeds in steps of mixing of 
expanded liquid solution and antisolvent, generation of supersaturation, 
nucleation, and growth by coagulation and condensation, followed by 
agglomeration in case of uncontrolled growth as shown in Figure XII. 6. 
The main driving force for precipitation is rapid and high supersaturation. 
The crucial particle properties such as size, morphology and purity are 
significantly dependent on the rate, magnitude and uniformity of 
supersaturation generated during the process of precipitation (Mayrhofer B. 
and Nyvlt J., 1988, Jones A.G. and Mullin J.W., 1974). The supersaturation, 
according to crystallization theory, for one-component in liquids is defined 
as 
 1) 
where c is the actual concentration of solute in the solution (mol/L) and 
c* is the equilibrium solubility (mol/L) of the solute in a mixture of organic 










Figure XII. 6 Schematic of particle precipitation process 
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The energy barrier for particle precipitation from saturated solution 
depends on the metastable zone width. The metastable zone is the 
concentration range where no precipitation is observed within given time. 
Guo et al.(Guo Z. et al., 2005) reported that when metastable zone is wide, 
inducing nucleation is difficult and therefore in order to achieve higher 
nucleation rates, metastable zone width should be shorter. Another important 
parameter is induction time(Granberg R.A. et al., 2001). Induction time is 
the time elapsed between supersaturation of a solution and appearance of 
detectable crystals (Mahajan A.J. and Kirwan D.J., 1993). Higher nucleation 
rates result in precipitation of nanoparticles, as in such a case, 
supersaturation is mainly consumed by nucleation and not for growth of 
particles. Therefore, to obtain nanoparticles with narrow size distribution it 
is necessary to, 
(a) create a high degree of supersaturation,  
(b) uniform spatial concentration distributions in solutions, and  
(c) the negligible growth of all crystals (Dalvi S.V. and Dave R.N., 
2009). 
 
The nucleation and growth of particles occur simultaneously and both 
compete for consumption of supersaturation (Thybo P. et al., 2008). Once 
nucleation occurs particles grow by condensation (τcond), (as molecules 
diffuse to the particle surface and become incorporated into the solid phase), 
and by coagulation (τcoag). Condensation competes with nucleation by 
decreasing supersaturation. Coagulation can reduce the rate of condensation 
by reducing the total number of particles and therefore the surface area (Staff 
S. and Sun Y.P., 2002). As particles grow, they start agglomerating too. The 
agglomeration process depends on the population density. It has been 
reported that higher the population density higher is the agglomeration rate.  
Thus, there are several parameters such as, metastable zone width, 
induction time, interfacial surface energy and supersaturation which control 
the precipitation of particles from supersaturated solutions. Particle 
engineering therefore, requires fine-tuning of these variables to obtain 
desired particle characteristics.  
 
XII.3.2 Role of Mixing 
In liquid antisolvent precipitation process, mixing generates 
supersaturation which is followed by, nucleation and growth. Accordingly, 
there are two main time scales associated with the process of particle 
formation, namely mixing time (τmix) and the precipitation or induction time 
(τprecipitation) (Johnson B.K. and Prud'homme R.K., 2003). Mixing time (τmix) 
comprises of the time required for macromixing, mesomixing, and 
micromixing. Mixing occurring on a macroscale scale is termed as 
macromixing. Mesomixing consists of the large-scale mass transfer of a 
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solution which is also known as turbulent mixing (Shekunov B.Y. et al., 
2001). Molecular diffusion of different solvent composition region below 
Kolmogorow microscale is termed as micromixing (Bałdyga J. et al., 1997). 
τprecipitation is composed of nucleation time (τnucleation) and growth time 
(τgrowth) (Matteucci M.E. et al., 2006). The dimensionless Damkohler 
number (Da) is the ratio of τmix to τprecipitation. The particle formation process 
is controlled by mixing when Da is greater than 1. In this situation, the 
mixing process is slower than precipitation process and supersaturation is 
attained at a slower rate. This results in dominance of particle growth leading 
to large crystals. On the other hand when Da is less than 1, τmix is reduced 
relative to τprecipitation, up to certain threshold where supersaturation is 
attained rapidly, solution is mixed uniformly at the micro-level and 
nucleation takes place rapidly. The process of mixing is faster than 
precipitation and precipitation step controls overall particle formation. In this 
situation nucleation dominates in the precipitation process. This leads to a 
large number of nuclei and precipitation of ultrafine particles. Under such a 
situation longer time is required for condensation and coagulation, which 
leads to reduction in particle size . Thus, it is necessary to decrease τmix and 
increase τprecipitation in order to keep Da < 1, for production of nanoparticles 
with narrower size distribution. To decrease τmix below τprecipitation, mixing 
rate has to be increased.  
In the experimental apparatus we have developed the expanded liquid is 
directly injected through a nozzle in to the antisolvent solution. Different jet 
behavior can be obtained, but to maximize the mixing efficacy atomization 
regime is the preferred one.  
There is an extended literature on the atomization of liquids into gases at 
room pressure and jets in liquid-liquid systems; but, little is known about the 
characteristic features of the atomization occurring in high pressure 
conditions near the critical value of the injected liquid. It is easy to suppose 
that hydrodynamic contributions to liquid breakup will become more 
important as surface tension is small, when the surface of a liquid jet 
approaches the critical mixing state at high pressure (Umemura A. and 
Wakashima Y., 2002). Thanks to the reduced surface tension of the 
expanded liquid, the turbulent atomization regime can emerge at lower jet 
speeds, and can maximize the intermixing of the two phases with the 
creation of a large surface area which leads to an enhanced mass transfer. 
 
XII.3.3 Stability of nanoparticle suspensions 
Stabilization of nanoparticles suspensions is critical to ensure their 
usability in various drug formulations. Decrease in particle size to nanometer 
scale increases surface area to volume ratio. This large increase in surface 
area increases excessive surface energy, which is thermodynamically 
unfavorable (Lee J. et al., 2005, Liu Y. et al., 2007). An increase in surface 
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energy accelerates agglomeration of particles in order to minimize excessive 
surface energy. During agglomeration, two smaller particles condense and 
form agglomerates of larger size. Agglomeration affects the overall stability 
of nanoparticles formulation. Apart from agglomeration there are several 
other mechanisms such as, secondary crystallization, and Ostwald ripening 
which destabilize the nanoparticles formulation. In secondary crystallization, 
crystal growth takes place over the initially formed crystals in mother liquor, 
whereas in Ostwald ripening the small particles shrink/dissolve, due to 
enhanced solubility arising from their high curvature. The solute thus 
dissolving diffuses towards the surface of larger particles causing them to 
grow. The interaction of nanometer sized particles is dependent on 
interfacial forces such as attractive, repulsive forces, and steric forces. Such 
interactions between two colloidal particles are collectively referred as 
colloidal interactions and stability of nanoparticles is strongly influenced by 
these colloidal interactions (Kind M., 2002). Therefore, nanoparticles 
stabilization is done by minimizing these colloidal interactions. There are 
two approaches, namely thermodynamic approach and kinetic approach (Liu 
R. and Liu R., 2008). Thermodynamic approach uses stabilizers to stabilize 
nanoparticles. The stabilizer-coated nanoparticles are considerably more 
stable than the bare nanoparticles. The stabilizer molecules actually preclude 
or minimize the surface functional groups available on particle surface and 
thus reduce particle-particle interaction (Maity D. and Agrawal D.C., 2007). 
Various surfactants, block co-polymers, cellulose based derivatives have 
been used for the stabilization of nanoparticles (Rasenack N. and Muller 
B.W., 2002, Dong Y.C. et al., 2009). 
On the other hand, kinetic approach uses the energy input to compensate 
excess surface energy. The high mixing rate provides a high density energy 
dissipation, which increases the kinetic energy of nanoparticles. The 
stabilization is achieved due to the inhibition of agglomeration to some 
degree by increased kinetic energy of nanoparticles (Zhu Z.X. et al., 2010). 
The kinetic energy in the form of ultrasonic waves or high jet velocities 
generated by rapid mixing devices can be used for particle stabilization 
(Gindy M.E. et al., 2008).  
Precipitation of particles and formation of protective stabilizer layer on 
the particle surface simultaneously, leads to controlled growth and 
agglomeration and hence, formation of nanoparticles. The stabilizers can be 
added either in solvent or antisolvent (Matteucci M.E. et al., 2006). The 
strength of adsorption of stabilizer molecules on the drug surface depends on 
the nature of the stabilizer and drug surface and is usually based on simple 
rules namely, i) the quantity of the stabilizer adsorbed on the surface is 
inversely proportional to its solubility in liquid phase, ii) the quantity of 
stabilizer adsorbed is directly proportional to the strength of stabilizer-
particle interaction and inversely proportional to the strength of stabilizer-
solution (liquid phase) interactions (Ross S. and Morrison I.D., 1988, Duro 
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R. et al., 1999). Two main mechanisms of thermodynamic stabilization, i.e. 
steric stabilization and electrostatic repulsion are discussed in the following. 
In steric stabilization, non ionic polymers, and amphiphilic block 
copolymers are usually used. Polymer molecules start adsorbing on the 
hydrophobic drug surface through nonspecific interactions between 
hydrophobic group of the drug and polymer. Adsorption of polymer 
molecules on the drug particle surface reduces interfacial tension at the 
solid-liquid interface. This results in increase in nucleation rates and hence 
decreases the size of the precipitated particles.  
A stabilizer monolayer is then formed on drug surface. Depending on its 
structural interactions with drug surface functional groups, a stabilizer 
molecule does not lie flat and adopts various conformations. Depending on 
confirmation and interactions of stabilizer with particle surface, stabilizer 
provides complete or partial coverage of drug nanoparticles. This affects the 
stability and therefore it is important to take into consideration 
conformations of a stabilizer molecule at the solid-liquid interface 
(Rozenberg B.A. and Tenne R., 2008). Polymer molecules adsorbed on 
particle surface generally form a structure of tail-train loop. The portion 
adsorbed on the particle surface is called as train, while parts of polymer 
chain with both ends in contact with particle surface are called as loops. The 
portion which extends away from surface is called as tail (Scheutjens 
J.M.H.M. and Fleer G.J., 1980). The portions of polymer chain extending in 
solution  provide steric protection depending on the molecular weight of 
polymer (Heller W. et al., 1960). The size and molecular weight of stabilizer 
are thus important for stabilization effect. Apart from size and molecular 
weight, the concentration of polymer is a very crucial parameter. When 
concentrations above critical flocculation concentration (CFC) of polymer is 
used, polymer molecules initiate depletion or bridging flocculation of the 
particles in suspension as shown schematically in Figure XII. 7. Also, at 
increased concentration of polymer, increase in osmotic pressure leads to 
increased attraction among colloidal particles leading to agglomeration. The 
larger size stabilizer molecules provide the good particle surface coverage 
and higher excluded volume because of their bigger size. Therefore, lower 
concentration of larger size stabilizers is required for stabilization as 




Increase of Polymer Concentration
Polymer Adsorption
Increase in Osmotic Pressure
Depletion Flocculation
Bridging Flocculation  
 
 Figure XII. 7 Schematic of polymer-particle interaction in aqueous 
suspension with an increase in polymer concentration 
In electrostatic stabilization, the most effective procedure for stabilization 
of nanoparticles dispersions is to use ionic surfactants and ionic polymers. 
These ionic surfactants and ionic polymers adsorb very strongly on the 
particle surface which is attributed to the strong van der Waals interaction 
between the surface and the numerous repeating monomer units of the 
polymer chain (Napper D.H., 1983). Surfactants can provide stabilization at 
concentrations below critical micelle concentration (CMC), as the 
concentration above CMC causes micelle formation leaving the particles 
unprotected as shown schematically in Figure XII. 8 (Hillgren A. et al., 
2002).  
 





Figure XII. 8 The schematic of particle-surfactant interaction in the 
aqueous solution with an increase in surfactant concentration. 
The schematic shown in Figure XII. 8 is applicable for a situation where 
τprecipitation of drug is lower than τmicellization of the surfactant. In case of 
polyelectrolytes, the charged nature of polyelectrolyte forms a strong double 
layer around hydrophobic drug particle and, if polyelectrolyte adsorbs 
loosely, the extending polymer loops provide the steric stabilization. In 
electrostatic stabilization mechanism, charged stabilizers cause repulsion 
between approaching particles due to similar charges on particle surface; 
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which leads to prevention of agglomeration. The electrostatic stabilization 
depends on repulsive electrostatic forces and attractive van der Waals forces. 
Due to the charge on particle surface, there exists a double layer surrounding 
the particle surface. This double layer is referred as electric double layer 
(Grahame D.C., 1947) . There exists a potential difference between bulk of 
solution and the outer layer of double layer which is called as zeta potential. 
The zeta potential is a measure of the stabilization provided by electrostatic 
stabilization. As a thumb rule, zeta potential higher than ±30mV provides 
good suspension stability (Wu L.B. et al., 2011).  
 
XII.4 Process parameters 
As a preliminary study we have focused the attention to the relevant 
process parameters influencing the efficiency of the precipitation process, 
the particle size (PS) and particle size distribution (PSD). These parameters 
are: 
the mass flow ratio (GLR) between CO2 and liquid solution, 
the operating pressure (Pmix) and temperature (Tmix) in the saturator, 
the solute concentration in the liquid solution (Csol), 
concentration of the surfactant in the antisolvent solution, 
the ratio solvent/antisolvet.  
Pmix, Tmix, GLR and Csol influence the thermodynamics of the process. 
Although vapour-liquid equilibrium (VLE) data are available for many 
solvent/CO2 binary systems, quantitative data at high pressure on multiple 
(ternary and quaternary) systems is still missing and difficult to determine. 
For this reason, we usually consider the binary solvent/CO2 system involved 
at fixed process conditions (Tmix) as the starting point to choose the operating 
conditions that assure the complete system miscibility, and the formation of 
the expanded liquid mixture in the saturator. An empirical study of the 
effects of GLR and Csol on VLE and PSD is, then, necessary to optimize the 
process conditions. The presence of the third component could significantly 
modify the VLE respect to the binary one. This modification often consists 
of the shifting of the mixture critical point towards higher pressures and it is 
the more pronounced the higher is Csol (Figure XII. 9). 
When Pmix and Tmix are fixed, the mass flow ratio GLR corresponds to a 
given operating point into the VLE diagram of the system considered. A 
change of the molar fractions of system components produces a modification 
of GLR, and if GLR increases, the operating point shifts towards a phase 
richer in CO2 (Figure XII. 9). Since an efficient atomization process occurs 
when the operating point falls in the expanded liquid phase, the choice of 





















Figure XII. 9 Effect of the process parameter on the miscibility hole. The 
continuous line refers to the binary system Acetone-CO2 
The solvent antisolvent ratio and the concentration of the solute could 
have effect on the generation of supersaturation, thus affecting the PS and 
PSD. 
The effect of all these parameters have been the objective of the study 
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Nanoparticle Precipitation by 
Supercritical Assisted Injection 






Supercritical fluid (SCF) based literature has proposed some 
processes aimed at the production of nanoparticles of organic compounds, 
that can be used in several industrial fields (Adami R. et al., 2008, 
Reverchon E. and Adami R., 2006, Reverchon E. and De Marco I., 2011, 
Wang Q. et al., 2010, Mayo A.S. et al., 2010). These processes try to take 
advantage of the possibility to modulate the SCF mass transport, 
solubilisation properties and the intrinsic non toxicity and environmental 
friendly nature of supercritical carbon dioxide (SC-CO2), that is the 
supercritical fluid of election in the applications involving the use of 
thermolable and or organic compounds (Reverchon E. et al., 2009). More 
specifically, nanoparticle suspensions techniques assisted by SCFs derive 
mainly from RESS (Rapid Expansion of Supercritical Solution), in which a 
supercritical solution formed by SC-CO2 plus a dissolved solid compound is 
depressurized inside a precipitation vessel. The solid released can precipitate 
as micro or submicro-nanoparticles (Turk M. et al., 2002). The main 
limitation of the REss technique is the limited solubility of many compounds 
in the SC-CO2. 
One possibility to overcome this limitation is to use an expanded liquid; 
i.e., to form a solution between a liquid solvent and a gas. Expanded liquid 
solution have been proposed in some SC-CO2 assisted processes: Particle 
Generation form Gas Saturated Solution (PGSS) (Martin A. and Weidner E., 
2010), Depressurization of an Expanded Liquid Organic Solution (DELOS) 
(Ventosa N. et al., 2001) and Supercritical Assisted Atomization (SAA) 
(Reverchon E., 2002); though these processes were aimed at different 
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targets. PGSS can produce micrometric polymer particles by solidification of 
the  ELS (Pemsel M. et al., 2010); DELOS can produce microcrystals by fast 
cooling crystallization of the solute contained in the ELS; SAA can produce 
micro and sub-microparticles by atomization and drying of the expanded 
liquid solution (Adami R. et al., 2009).  
In this thesis, we propose the adoption of a new technique, called 
Supercritical Assisted Injection in Liquid Antisolvent (SAILA), in which an 
expanded liquid (a ternary mixture acetone-CO2-solute) is directly injected 
in a liquid antisolvent, water, causing nanoparticle fast precipitation. The 
aims of this chapter will be the demonstration of the feasibility of the SAILA 
process and its application to Polycaprolactone (PCL), as a model 
biopolymer. The analysis of the influence of process parameters on 
nanoparticle size and a first attempt at explaining the mechanisms that 
induce nanoparticle formation will be also performed.   
 
XIII.2 Materials & Methods 
XIII.2.1 Materials 
CO2 (99.9%, SON, Naples, Italy), Polysorbate (Tween 80, Aldrich 
Chemical Co.), Sorbitan monolaurate (Span 20, Aldrich Chemical Co.), 
Acetone (AC, purity 99.9%, Aldrich Chemical Co.), distilled water, 
Polycaprolactone  (PCL, MW 14.000 Aldrich Chemical Co.). 
XIII.2.2 Nanoparticle  morphology, size distributions and solvent 
residue analysis   
Particle size distribution (PSD) of the produced suspensions were 
determined by dynamic light scattering (DLS) (Zetasizer,  mod. 5000, 
Malvern Instruments Ltd). Mean size and particle size distribution were 
measured three times for each sample. Nanoparticle morphology was 
analysed by FESEM (LEO 1525, Carl Zeiss SMT AG). Samples were 
prepared by spreading concentrated nanoparticle dispersions over aluminium 
stubs and drying them at air. Then, the samples were coated with a Gold 
layer, thickness 250 Å (mod.108 Å, Agar Scientific).  
Acetone was removed from SAILA produced suspensions using the 
Supercritical Fluids Extraction Process described in section 3.4. Solvent 
residues in the suspensions was measured by a headspace (HS) sampler 
(model 7694E, Hewlett Packard) coupled to a gas chromatograph (GC) 
interfaced with a flame ionization detector (GC-FID, model 6890 GC-
SYSTEM, Hewlett Packard). Acetone was separated using a fused-silica 
capillary column (model Carbowax EASYSEP, Stepbios) connected to the 
detector, 30 m length, 0.53 mm i.d., 1 μm film thickness. GC conditions 
Nanoparticles precipitation by SAILA 
123 
were: oven temperature from 45 to 210 °C for 15 min. The injector was 
maintained at 135 °C (split mode, ratio 4:1) and helium was used as carrier 
gas (5 mL/min). Head space conditions were: equilibration time, 30 min at 
95 °C; pressurization time, 0.15 min and loop fill time, 0.15 min. Head space 
samples were prepared in 20 mL vials filled with 3 mL of the suspension. 
XIII.3 Results and Discussion 
XIII.3.1 Feasibility tests  
The proposal of SAILA process takes origin from the following general 
considerations: liquid-liquid antisolvent precipitation is obtained when the 
processed compound is soluble in the solvent and not soluble in the 
antisolvent; the particles size of the precipitates depends on the efficiency of 
the micromixing between the two liquids that, in turn, is related to their 
surface tension (Umemura A. and Wakashima Y., 2002). Therefore, the 
continuous injection of an expanded liquid solution should be more effective 
than the mixing with an ordinary liquid. Indeed, expanded liquid are 
characterized by a reduced surface tension that at high gas molar fractions is 
near to zero (Brunner G., 1994); this characteristic should improve the 
micromixing with the antisolvent and produce smaller particles.  
The first set of experiments was performed setting the temperature in the 
saturator at 80°C, CO2 flow rate at 7 gr/min and varying the acetone solution 
flow rate. Operating in this way, different gas to liquid ratio (GLR) were 
produced and, correspondingly, expanded liquid mixtures with different CO2 
molar fractions were obtained. The polymeric solution used in the 
experiments discussed in this paragraph was prepared dissolving PCL in 
acetone at a concentration of 5 mg/mL. The ratio between the solvent 
(acetone) and the antisolvent (water) flow rates (S/NS) was fixed at 0.25. 
Small quantities of surfactant were added to water and to the organic solvent 
solution to try to control particles coalescence and stability. Tween 80, an 
hydrophilic surfactant, was added to water since it is approved in 
pharmaceutical formulations and it has been frequently used to control 
particles coalescence. Span 20 was added, as a cosurfactant, to the acetone 
PCL solution, since it is reported in literature that the addition of this 
lipophilic surfactant can improve suspension stability against sedimentation, 
flocculation and coalescence (Cho Y.H. et al., 2008). A final consideration is 
required for the use of a continuous flow of water in the precipitator; this 
process feature allows to operate at steady state conditions from the point of 
view of the concentration of the nanoparticles in water, that can influence 
possible effects of coalescence. Therefore, continuous operation is obtained 
instead of a semi-batch process and reproducibility problems are avoided. 
In Table XIII. 1 data related to preliminary experiments are reported; the 
decrease of GLR can also produce a lowering of the pressure in the saturator.  
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The representation of the vapour-liquid equilibria (VLEs) of the system 
acetone-SCCO2 is reported in Figure XIII. 1, adapted from literature. The 
operating points related to the experiments reported in Table 1 are also 
represented in this figure. Mean diameter (MD), standard deviation (SD) and 
polydispersity index (PI) of the produced nanosuspensions were calculate by 
DLS measurements and are also reported in the same table. 
Table XIII. 1 Mean diameter (MD), standard deviation (SD) and 
Polidispersity index (PI) of PCL nanoparticles at 5 mg/mL in acetone. 
Saturator temperature was set at 80°C. 
 GLR P (bar) XCO2 MD (nm)±SD PI 
SAILA-1 4.0 120 0.84 171±63 0.37 
SAILA-2 2.7 100 0.78 174±50 0.29 
SAILA-3 1.4 90 0.65 171±66 0.39 
SAILA-4 0.8 80 0.52 178±49 0.28 
SAILA-5 0.6 75 0.38 206±39 0.19 
SAILA-6 0.4 70 0.34 222±67 0.30 
 






















Figure XIII. 1 Representation of the high pressure VLE of  the system 
acetone-SCCO2 at 80°C, adapted from Sato et al.(Sato Y. et al., 2010). The 
operating point of the experiments reported in Table 10 is also represented. 
These results show that SAILA technique was successful in the 
production of PCL nanoparticles at all process conditions tested. Examples 
of corresponding SEM images are reported in Figure XIII. 2 and show that 
nanoparticles were approximately spherical, with a smooth surface and were 
not aggregated. The images were taken at two different enlargements, to 
better appreciate the uniformity (lower enlargement) and the shape (higher 
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enlargement) of the processed materials. The results of this series of 
experiments are also graphically reported in Figure XIII. 3. Particle 
diameter depends asymptotically on XCO2; the asymptotic value is at about 
170 nm. It is also worth to note that the mean particle size largely increases 
at XCO2 smaller then about 0.5. Figure XIII. 4 reports a comparison of  the 
volumetric particle size distributions obtained in the experiments performed 
at the maximum and minimum value of GLR explored. The tail of the size 
distributions ends at about 600 nm in the case of GLR 0.4; the presence of 
larger particles is reduced in the case of GLR 4, in which the PSD ends at 
about 530 nm. The differences are enhanced by the use of volumetric 





Figure XIII. 2 FESEM images of PCL nanoparticles produced by SAILA-1 
(MD 171±63 nm). Process conditions are reported in Table 10. 
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Figure XIII. 3 Effect of CO2 mole fraction on the mean diameter of PCL 
nanoparticles  
 




















Figure XIII. 4 PSD of PCL nanoparticles obtained by SAILA at GLR 4.0 
and  0.4 
The results produced until now show a marked influence of the surface 
tension of the expanded liquid (whose dependence on XCO2 we have 
previously discussed) on particle size. The fact that at XCO2 > 0.5 there is no 
further variation of the mean diameter of the nanoparticles can be explained 
observing the behaviour of the surface tension for CO2-solvent mixtures: it 
decreases almost linearly for XCO2 up to 0.6-0.7, then a plateau is reached at 
Nanoparticles precipitation by SAILA 
127 
a near zero value (Thorat A.A. and Dalvi S.V., 2012). This property also 
depends on temperature: the higher is the temperature, the lower is the value 
of the CO2 molar fraction at which the plateau is obtained. This concept 
should also be expressed as: the higher is the temperature, the sharper is the 
decrease of the surface tension of the expanded solution with the increase of 
XCO2. 
The second possible consideration is that an increase of XCO2, leaving all 
the other process parameters constant, produces also higher pressures in the 
SAILA saturator. As a consequence, a higher turbulence can be produced in 
the liquid put in the precipitator. Can an increase of the pneumatic effect also 
explain the results reported in Table XIII. 1? It is in principle possible that 
an increase of turbulence can produce smaller particles. In this hypothesis, 
the diameter of the nanoparticles should continuously decrease, increasing 
GLR; i.e., increasing the pressure in the saturator. There is an extended 
literature on the atomization of liquids into gases at room pressure and jets in 
liquid-liquid systems; but, little is known about the characteristic features of 
the atomization occurring in high pressure conditions near the critical value 
of the injected liquid. However, diameter and shape of the nanoparticles 
(irregularly spherical) are in favour of a formation mechanism that does not 
evolve through the formation of liquid droplets and subsequent drying. In 
conclusion, the results in Table XIII. 1 and Figure XIII. 3 suggest that the 
interpretation based on nanoparticle formation guided by almost 
instantaneous nanomixing plus nucleation and growth of nanoparticles is the 
most probable. The presence of the two surfactants in the expanded liquid 
and in the water receiving solution blocks particles coalescence. 
XIII.3.2 Temperature effect 
As discussed in the previous chapter, the surface tension of the expanded 
liquid is also a function of temperature: increasing the temperature, surface 
tension of the liquid mixtures containing SC-CO2 decreases. Therefore, if the 
previous considerations developed about the SAILA precipitation 
mechanism are correct, increasing the temperature in the saturator, a 
reduction in nanoparticle diameters is expected.  Thus, the effect of 
temperature was investigated and experiments were performed at two further 
temperatures: 60°C and 100°C; the results were compared with the set of 
experiments performed at 80°C. These experiments at different temperatures 
were performed at GLR values between 0.4 and 1.8. Table XIII. 2 
summarizes the results obtained that are also graphically organized in 
Figure XIII. 5.  
Increasing the saturator temperature smaller nanoparticles were 
systematically produced, from a maximum mean diameter of 268 nm at 
60°C, to a minimum of 165 nm at 100°C. However, looking at the overall 
effect of the saturator temperature, the effect of temperature is more evident 
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at lower XCO2 (see Figure XIII. 5). These results also confirm the indications 
obtained in the previous chapter: for XCO2 larger than about 0.5, the diameter 
of PCL nanoparticles produced by SAILA  is no more sensitive to XCO2 and 
to saturator temperature. The possible explanation for this evidence is the 
same given to explain the GLR effect: at larger XCO2 the surface tension of 
the expanded liquid is near to zero. 
 
Table XIII. 2 Mean diameter (MD), standard deviation (SD) and 
Polidispersity index (PI) of PCL nanoparticles produced at different 
saturator temperatures and at different GLR. PCL concentration = 5 mg/mL, 
S/NS = 1/4., P 70 bar 
 T (°C) GLR XCO2 MD (nm)±SD PI 
SAILA_7 100 1.80 0.65 170±34 0.20 
SAILA_8 60 1.80 0.65 198±49 0.25 
SAILA_9 100 0.92 0.52 165±56 0.34 
SAILA_10 60 0.92 0.52 200±54 0.27 
SAILA_11 100 0.60 0.38 190±51 0.27 
SAILA_12 60 0.60 0.38 236±78 0.33 
SAILA_13 100 0.36 0.35 206±62 0.30 





















Figure XIII. 5 Effect of temperature on PCL particles mean diameter 
(▲=60°C, ■=80°C, ●=100°C) at different XCO2 values 
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XIII.3.3 Effect of solvent/non-solvent ratio and polymer 
concentration 
The effect of solvent/non-solvent ratio (S/NS) and polymer concentration 
were investigated in this set of experiments, performed fixing GLR  at 1.8, 
saturator temperature at 100°C and pressure at 70 bar. The results obtained 
are summarized in Table XIII. 3. They show that increasing the dilution in 
water, smaller particles are obtained; indeed, S/NS ratio represents the 
quantity by volume of the solvent in water; therefore, for a given PCL 
quantity in the organic solvent, it is connected the  concentration of solute (at 
steady state conditions) in the liquid suspension. These results can be 
explained considering that a larger driving force for the nanomixing of the 
two liquids is expressed at lower concentrations of the organic solvent in 
water. It is also possible that decreasing S/NS value the possible interactions 
among nanoparticles in the suspensions are reduced. Particles with a mean 
diameter of 169 nm were obtained in the case of S/NS ratio 1/4; whereas 
reducing S/NS at 1/16 smaller particles with a MD of 118 nm were 
produced.  
In Table XIII. 3 the effect of the PCL concentration in acetone is also 
reported. Reducing the polymer concentration, fixed all the other SAILA 
parameters (GLR=1.8, T=100°C, P=70 bar, S/NS=1/16), smaller particles 
were obtained. During these experiments the smallest PCL nanoparticles 
were produced, down to a mean diameter of 64 nm, that represent the best 
result obtained in this work from the point of view of nanoparticles 
diameters. The results obtained at 2.5 and 1 mg/mL are reported in Figure 
XIII. 6 and show that also sharper PSDs were obtained, with a maximum 
particles diameter of about 140 nm. 
This result can be explained considering the nucleation process and its 
dependence on the concentration of the solute: a higher supersaturation 
favors particles growth; therefore, increasing the solute concentration, larger 
particles are obtained.  
 
Table XIII. 3 Mean diameter (MD), standard deviation (SD) and 
Polidispersity index (PI) of PCL nanoparticles obtained at different solvent/ 
non solvent (S/NS) ratios and at PCL concentrations ranging from 1 to 5 mg/ 
mL. GLR=1.8, T=100°C and p=70 bar 
 mg/mL S/NS MD (nm)±SD PI 
SAILA_7 5 1/4 169±34 0.20 
SAILA_15 5 1/8 168±58 0.35 
SAILA_16 5 1/16 118±28 0.24 
SAILA_17 2.5 1/16 98±29 0.30 

























Figure XIII. 6 PSD of the smallest particles obtained in the experiments 
SAILA_17 and SAILA_18 
XIII.4 Conclusions and perspectives  
A novel supercritical assisted process for the production of nanoparticles 
of organic compound has been proposed and successfully demonstrated for 
PCL. Non coalescing nanoparticles down to 64 nm mean diameter were 
produced; this result is particularly interesting since 100 nm diameter 
represents a benchmark that is very difficult to overcome when organic 
compounds are processed. One possible question could be: is it the process 
applicable to other compounds? Some SAILA preliminary experiments 





Chapter XIV  
Preparation of stable aqueous 
nanodispersions of poorly water 
soluble drugs by supercritical 







The bioavailability of poorly water soluble drugs is limited due to their 
low solubility and dissolution rate. Various drug formulation development 
strategies have been extensively studied to  improve the dissolution rate of 
these drugs over the past two decade. One of the newest formulation 
strategies is to prepare nanoparticles/microparticles of these drugs. Decrease 
in particle size increases the surface area to volume ratio which increases the 
dissolution rate of poorly water soluble molecules and hence bioavailability 
(Merisko-Liversidge E.M. and Liversidge G.G., 2008). 
The nanoparticles can be produced by either top-down methods or 
bottom-up methods. The top-down methods start with larger solid particles 
and break them mechanically down to nano/microparticles. However 
breaking drug particles to nanoparticles with size below 100 nm is 
extremally difficult with the top-down methods. The bottom-up methods on 
the other hand, produce fine particles starting at the atomic level. These 
methods give, in general, better control over particles properties, such as, 
size, morphology and crystallinity. However, also these processes have some 
disadvantages, such as, low yields, degradation of hot sensitive drugs, 
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difficulties to scale up and low reproducibility, since they are batch 
processes (Reverchon E. and Adami R., 2006).  
SAILA process reveals to be an efficient process for the production of 
stable PCL water suspensions. For this reason, we propose the adoption of a 
new technique called the Supercritical Assisted Injection in Liquid 
Antisolvent (SAILA), for the production of poorly water soluble drug 
nanoparticles suspensions.  
Several different compounds were tested (β-carotene, ketoprofene, 
beclomethasone, budesonide, triclabenzadol). Acetone was selected as the 
organic solvent for the expanded liquid preparation, whereas water was used 
as the antisolvent. A systematic study of the effect of the operating 
parameters was conducted in the case of two selected compounds:  β-
carotene and ketoprofene.  
 
XIV.2 Materials & Methods 
XIV.2.1 Materials 
CO2 (99.9%, SON, Naples, Italy), Polysorbate (Tween 80), Acetone (AC, 
purity 99.9%), β-carotene  (β-C), ketoprofene, beclomethasone, budesonide, 
triclabenzadol, were all bought from Aldrich Chemical Co. and were used as 
received. 
 
XIV.2.2  Nanoparticle  morphology, size distributions and solvent 
residue analysis 
Nanoparticle morphology was analysed by FESEM (LEO 1525, Carl 
Zeiss SMT AG). Samples were prepared by spreading concentrated 
nanoparticle dispersions over aluminium stubs and drying them at air. Then, 
the samples were coated with a gold layer, thickness 250 Å (mod.108 Å, 
Agar Scientific). Particle size (PS) and particle size distribution (PSD) were 
measured from SEM photomicrographs using the Sigma Scan Pro Software 
(release 5.0, Aspire Software International Ashburn, VA). Approximately 
1000 particles were measured for each particle size distribution calculation. 
Histograms, representing the particle size distribution, were fitted using 
Microcal Origin Software (release 8.0, Microcal Software, Inc., 
Northampton, MA). 
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XIV.3 Results and Discussion 
XIV.3.1 Feasibility test 
Several different poorly soluble drugs were tested with the SAILA 
process, in order to investigate the applicability of this process to different 
class of compounds. SAILA process conditions were fixed: saturator 
pressure 80 bar, saturator temperature 80°C, GLR 1.8, solvent/antisolvent 
ratio ¼. All the suspensions produced were characterized in therms of 
morphology. With the same process conditions different morphology were 
obtained depending on the compound used, as shown in Table XIV. 1. In 
many cases spherical amorphous particles were obtained. In some other 
cases different morphologies were obtained such as cubic or hexagonal  
crystals or fibers, see Table XIV. 1.  
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Table XIV. 1 SAILA feasibility tests for the production of nanosuspensions 
of different compound poorly water soluble 
Drug 
(concentration 
in solvent phase) 
Morphology 
 FESEM image 
β –Carotene 
(0.3 mg/mL) spherical 
 
Beclometasone 
(5 mg/mL) Fiber 
 
Budesonide 
(5 mg/mL) Hexagonal 
 
Nimesulide 
(5 mg/mL) spherical 
 
Ketoprofene 
(5 mg/mL) spherical 
 
Triclabendazol 
(5 mg/mL) spherical 
 
 
A possible explanation of the different morphologies obtained using the 
same process conditions, can be found in the different crystallization width 
of the metastabile zone. Indeed, if the metastable zine is crossed quickly 
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nucleation rate is high and determines the formations many nuclei, thus 
sovrasaturation is manly consumed by nucleation; spherical amouphus 
nanoparticles are obtained. Whereas, if the metastable zone is crossed 
slowly, slow  nucleation rate are obtained and sovrasaturation is consumed 
mainly by growth of crystals formed. Crystalline particles are thus formed. 
In the following a systematic study of the effect of the operating 
parameters is reported in the case of two selected compounds:  β-carotene 
and ketoprofene.  
 
XIV.3.2 Production of β-carotene nanoparticles suspensions 
The experiments were performed setting the temperature in the saturator 
at 80°C, CO2 flow rate at 10 gr/min and varying the acetone solution flow 
rate. Operating in this way, different gas to liquid ratio (GLR) were 
produced and, correspondingly, expanded liquid mixtures with different CO2 
molar fractions were obtained. The β-C solution used in the experiments for 
the study of GLR effect was prepared dissolving β-C in acetone at a 
concentration of 0.03 mg/mL. The ratio between the solvent (acetone) and 
the antisolvent (water) flow rates (S/NS) was fixed at 0.25. Small quantities 
of surfactant were added to water solution to control particles stability. 
Tween 80, an hydrophilic surfactant, was added to water since it is approved 
in pharmaceutical formulations and it has been frequently used to control 
particles coalescence (Turk M. and Lietzow R., 2004)1. A consideration is 
required for the use of a continuous flow of water in the precipitator: this 
process feature allows to operate at steady state conditions from the point of 
view of the concentration of the nanoparticles in water, that can influence 
possible effects of coalescence. Therefore, continuous operation is obtained 
instead of a semi-batch process and reproducibility problems are avoided. 
In Table XIV. 2 data related to the experiments are reported; the decrease 
of GLR can also produce a lowering of the pressure in the saturator.  The 
representation of the vapour-liquid equilibria (VLEs) of the system acetone-
SCCO2 is reported in Figure XIV. 1, adapted from literature. The operating 
points related to the experiments reported in Table 1 are also reported in this 
figure. Mean diameter (MD), standard deviation (SD) and polydispersity 
index (PI) of the produced nanosuspensions were calculate by DLS 
measurements and are reported in the same table.  
 





Table XIV. 2 Mean diameter (MD), standard deviation (SD) and 
Polidispersity index (PI) of β-C nanoparticles obtained from a 0.03 mg/mL 
β-C solution in acetone. Saturator temperature was set at 80°C 





P1 1.58 90 0.68 0.03 37±5 0.13 
P2 1.48 80 0.66 0.03 40±5 0.12 
P3 1.16 75 0.60 0.03 48±6 0.13 
P4 0.81 70 0.52 0.03 56±7 0.12 
P5 0.81 70 0.52 0.1 71±8 0.15 
P6 0.81 70 0.52 0.2 90±14 0.16 
 


















x, y (CO2)  
Figure XIV. 1 Representation of the high pressure VLE of  the system 
acetone-SCCO2 at 80°C, adapted from Sato et al.  [14]. The operating points 
of the experiments reported in Table 1 are also represented. 
These results show that SAILA technique was successful in the 
production of β-C nanoparticle suspension at all GLR tested, moreover the 
suspensions produced were stable. The macroscopic aspect of the produced 
suspensions is reported in Figure XIV. 2. Suspensions were stable with zeta 
potential mean value of about -20 mV. Stability of suspensions was also 
monitored over time: they maintain stability over months. Examples of 
corresponding SEM images are reported in Figure XIV. 3 and show that 
nanoparticles were approximately spherical, with a smooth surface and were 
not aggregated. To obtain this kind of SEM image a nanoparticles dilute 
dispersion was produced and high contrast images were taken. 




Figure XIV. 2 Macroscopic aspect of β-C nanoparticles suspensions 
produced by SAILA with variation of GLR. Process conditions are reported 




Figure XIV. 3 FESEM image of β-C nanoparticles produced by SAILA (P4). 
Process conditions are reported in Table 14. 
Figure XIV. 4 reports a comparison of  the volumetric particle size 
distributions obtained in the experiments performed at the maximum and 
minimum value of GLR explored. The PSD of the obtained suspensions 
demonstrated that there is a sensible effect of XCO2 on particle diameters, that 
is particle size decreases with the increase of GLR and consequently the 
increase of XCO2. This result is related to the fact that antisolvent 
precipitation is obtained when the processed compound is soluble in the 
solvent and not soluble in the antisolvent. The particle size of the precipitates 
depends on the efficiency of the micromixing between the two liquids that, 
in turn, is related to their surface tension. Expanded liquid are characterized 
by a reduced surface tension that at high gas molar fractions is near to zero. 
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Therefore, the continuous injection of an expanded liquid solution is more 
effective than the mixing with an ordinary liquid. This characteristic should 
improve the micromixing with the antisolvent and produce smaller particles 
increasing the XCO2, i.e. reducing the surface tension of the expanded liquid. 
From Figure XIV. 4 it is also possible to see that D100 is below 100 nm in 
all the cases explored.  




Figure XIV. 4 PSD of β-C  nanoparticles suspensions obtained by SAILA at 
GLR 0.81 and  1.58 
The effect of β-C concentration in the acetone solution  was also 
investigated; experiments were performed fixing GLR  at 0.81, saturator 
temperature at 100°C and pressure at 70 bar. The results obtained are 
summarized in Table XIV. 2. Stable suspensions were obtained also with 
higher concentrations of β-C. A considerable effect on particles MD was 
observed, as shown in Table XIV. 2. This result can be explained 
considering the nucleation process and its dependence on the concentration 
of the solute: a higher supersaturation favors particles growth; therefore, 
increasing the solute concentration, larger particles are obtained. FESEM 
image of nanoparticles obtained at 0.2 mg/mL concentration is reported in 
Figure XIV. 5. Particles are spherical also in this case and non coalescing 
with a mean diameter of about 90 nm. Figure XIV. 6 reports PSD of 
nanoparticles obtained at minimum and maximum concentration of β-C.  




Figure XIV. 5 FESEM image of  β-C  nanoparticles obtained by SAILA 
obtained from a solution at 0.2 mg/mL of β-C 
 
Figure XIV. 6 PSD of β-C  nanoparticles suspensions obtained by SAILA 
operating  GLR 0.81. 
 
From Figure XIV. 5 and from Figure XIV. 6 it is possible to  see that in 
the case of higher concentration larger particles are obtained with D100 
located at 150 nm, whereas at a concentration of β-C of 0.03 mg/mL PSD is 
all below 100 nm, with D100 at 86 nm.  
 
XIV.3.3 Production of ketoprofene nanoparticles suspensions 
The experiments for the production of ketoprofene nanoparticles were 
conducted fixing the temperature in the saturator at 80°C, CO2 flow rate at 
10 gr/min, and solvent flow rate at 14 mL/min, obtaining a GLR of 0.85. The 
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effect of ketoprofene concentration in acetone solution was evaluated, 20 
g/mL and 30 g/mL, as shown in Table 15. Solvent/antisolvent ratio was 
fixed at 0.25. Water solution of Tween 80 at 0.2% w/w was used as 
antisolvent. 
 
Table XIV. 3 Mean diameter (MD), and Polidispersity index (PI) of 
ketoprofene nanoparticles obtained from a 20 and 30 mg/mL ketoprofene 
solution in acetone. Saturator temperature was set at 80°C, GLR 0.85. 
 
 
GLR P (bar) XCO2 Kp 
(mg/mL) 
MD (nm) PI 
K1 0.85 70 0.7 20 200 0.077 
K2 0.85 70 0.7 30 1250 0.061 
 
The case of ketoprofene is particularly relevant to highlight a possible 
phenomena that can be verified precipitating drugs. Indeed in the case of 
ketoprofene nanoparticles are formed with spherical shape, as in the case of 
betacarotene, see Figure XIV. 7(a) and (b); the effect of concentration on 
mean size is evident from Table XIV. 3 and Figure XIV. 7 (a) and (b), an 
increase of mean size is observed increasing the drug concentration in the 
expanded liquid. Nevertheless the suspensions were not stable, because 
during time a phenomena of recrystalization led to the formation of big 
crystal, as shown in Figure XIV. 7 (c) and (d). This phenomena is probably 
due to the partial of the small particles that dissolve, due to enhanced 
solubility arising from their high curvature. The solute thus dissolving 
diffuses towards the surface of larger particles causing them to grow. 
 






Figure XIV. 7 SEM images of ketoprofene nanoparticles obtained with the 
SAILA technique at concentration of 20 mg/mL (a) and 30 mg/mL (b). SEM 
images of crystals formed after 1 day are also reported I figure (c) for the 
case of 20 mg/mL and (d) for the case of 30 mg/mL 
To improve the stability of nanoparticles suspensions a steric stabilization 
should be tried.  
 
XIV.4 Conclusions 
SAILA, the novel supercritical assisted process for the production of 
nanoparticles of organic compounds, has been successfully demonstrated for 
many different drugs, improving poorly hydrophilic  drugs dispersability in 
water solutions. Non coalescing spherical nanoparticles down to 100 nm 
mean diameter were produced in some cases; nanoparticle diameters can be 
modulated varying two main conditions: GLR and drug concentration in the 
solvent, with the possibility to produce particles with diameters in the micro 
and nano range. Different morphologies were also obtained depending of the 
crystallization rate of the specific compound. When very fast precipitation is 












The aim of this thesis was the development of  supercritical assisted 
processes for the production of micro and nanoparticles for biomedical and 
pharmaceutical applications.  
In this work SEE continuous technology has been applied successfully to 
the production of sub-micro and nanoparticles. SEE process conditions have 
been optimized in order to obtain nanoparticles production. Operating in this 
way nanoparticles in the range 150-400 nm have been obtained using both 
single and double emulsions.  Particles where also loaded with a model drug, 
metal nanoparticles, proteins and peptides.  Indeed, exploiting the possibility 
to work with multiple emulsions it was possible to produce successfully 
multifunctional nanocarriers. Fruitful collaboration with specialized foreign 
center confirmed that the SEE process can be applied successfully to the 
production of multifunctional nanocarriers for pharmaceutical and 
biomedical applications.  
The development of a completely new supercritical based process, 
SAILA, has been done, with the aim of improving the existing processes in 
the field of supercritical fluids techniques. The feasibility of this new process 
has been demonstrated for polymers and drugs. Nanoparticles aqueous 
suspensions were successfully produced, nanoparticles with mean diameters 
down to 100 nm were produced. This dimension is an important benchmark 
that is really difficult to overcome.  It has also been demonstrated that the 
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